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Surgical	 treatment	of	early	stage	 lung	cancer	offers	 the	best	chance	of	 long-term	survival,	
either	on	its	own,	or	as	part	of	multi-modality	treatment.	However,	the	potential	for	future	
recurrence	of	cancer	is	a	realistic	concern	and	increases	strongly	by	cancer	stage.	Research	
findings	around	 information	needs	of	patients	with	 cancer	are	 complex	and	contradictory	
and	few	studies	have	included	patients	with	early	stage	lung	cancer.		
	
This	 study	 explores	 communication	 regarding	 risk	 of	 recurrence	 following	 lung	 cancer	
surgery	 using	 a	 qualitative	 multiple	 case	 study	 approach.	 Purposive	 sampling	 identified	
twelve	cases	centred	on	patients	with	a	range	of	lung	cancer	stages	and	management	plans.	
Case	 studies	 began	 at	 first	 post-surgical	 consultation	 and	 continued	 for	 six	 months	 after	
surgery.	Patient	participants	followed	two	distinct	treatment	pathways	after	surgery,	either	
straight	 into	 long-term	 follow-up,	 or	 to	 see	 an	 oncologist	 to	 discuss	 adjuvant	 treatment.	
Data	collection	included	audio	recordings	of	consultations,	in-depth	interviews	with	patients	




This	multi-perspectival	dataset	gave	 rich,	 longitudinal	 insights	 into	communication	around	
recurrence	 risk	 following	 lung	cancer	 surgery.	Three	overarching	 themes	were	developed:	
‘Predicting	 the	 Future’,	 ‘Maintaining	 hope’	 and	 ‘Hope	 Dances’.	 Fundamentally	 different	
conceptions	 of	 long-term	 outcome	 were	 seen	 amongst	 patient	 and	 professional	
participants.	 Discussion	 of	 recurrence	 risk	 was	 generally	 minimised	 during	 observed	
consultations.	 However,	 patients	 with	 more	 favourable	 prognoses	 tended	 to	 have	 more	
explicit	discussions	around	the	subject.	Patients	and	professionals	shared	an	imperative	to	
maintain	 patient	 hope,	 which	 powerfully	 determined	 how	 potential	 recurrence	 was	
discussed.	 Participants	 engaged	 in	 active	 strategies	 to	 support	 hope,	which	 included	 tacit	
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This	 study	explores	 the	 issues	around	communication	between	professionals	and	patients	
about	 possible	 cancer	 recurrence	 following	 lung	 cancer	 surgery.	 This	 brief	 introduction	
chapter	sets	the	scene	of	the	research,	starting	by	identifying	the	initial	research	aims	and	
why	 this	 particular	 issue	was	 seen	 as	 a	 problem	 that	 required	 further	 investigation.	 I	will	
then	outline	the	study	aims	and	objectives.	In	order	to	place	this	study	in	context,	I	will	give	
an	introduction	to	the	clinical	settings	and	indicate	my	own	clinical	and	research	roles.	This	







chance	 to	 eradicate	 the	 disease	 (Powell	 et	 al.,	 2015).	 Following	 surgery	 patients	 are	
commonly	 told	 that	 the	 cancer	 has	 been	 completely	 resected.	 Although	 many	 patients	
appear	 fully	 aware	 that	 cancer	 can	 recur,	 sometimes	 after	 a	 long	 period	 of	 time,	 others	
seem	to	assume	that	since	the	cancer	was	completely	removed	during	surgery,	there	is	no	
















subject	 of	 potential	 recurrence	 of	 the	 cancer	 after	 surgery	was	 often	 not	 something	 that	
was	discussed	in	detail.	Even	where	patients	were	going	to	be	referred	on	to	an	oncologist	
to	 consider	 having	 chemotherapy,	 intended	 to	 reduce	 their	 risk	 of	 recurrence	 (known	 as	
adjuvant	therapy),	the	subject	was	dealt	with	briefly.	 In	my	clinical	role	 I	did	not	routinely	
attend	 the	 subsequent	oncology	 consultations,	 and	 I	 had	assumed	 that	 a	 fuller	 and	more	
explicit	 discussion	 about	 recurrence	 and	 risk	 would	 take	 place	 during	 that	 appointment.	
















The	 aim	 of	 the	 research	 is	 to	 gain	 an	 in-depth	 understanding	 of	 the	 communication	 of	
recurrence	 risk	 following	potentially	 curative	 lung	cancer	 surgery,	 from	the	perspective	of	
both	patients	and	professionals	involved.		
Objectives	
1. To	 explore,	 using	 case	 study	 methodology,	 how	 a	 range	 of	 patients	 who	 have	








3. To	 explore	 how	 a	 range	 of	 health	 professionals	 caring	 for	 these	 patients	





5. To	 identify	 the	 nature	 and	 delivery	 of	 communication	 about	 risk	 of	 recurrence	
between	 this	 group	 of	 patients	 and	 their	 associated	 professionals	 during	 post-
operative	surgical,	oncology	and	follow-up	consultations.	





lung	 cancer	 surgery	 service	 for	 a	 number	 of	 local	 lung	 cancer	 teams	 based	 in	 general	
hospitals	without	thoracic	surgical	services	on	site.	For	reasons	of	research	governance	and	
practicality,	I	needed	to	select	local	lung	cancer	teams	that	were	willing	to	engage	with	the	
research	 and	were	 relatively	 accessible,	 as	 a	 significant	 proportion	 of	 the	 data	 collection	
occurred	 at	 the	 local	 hospitals.	 Although	 surgery	 took	 place	 in	 one	 of	 the	 two	 thoracic	






The	 research	 study	was	 undertaken	 on	 a	 part-time	 basis	while	 I	was	 also	working	 as	 the	







part	 of	 the	 lung	 cancer	 multidisciplinary	 team	 and	 provision	 of	 the	 role	 is	 mandated	 in	
current	national	guidelines	on	lung	cancer	management	(National	Collaborating	Centre	for	
Cancer,	 2011).	 Central	 to	 the	 role	 is	 providing	 continuity	 for	 patients	 and	 their	 family	
members	by	being	a	point	of	contact,	offering	emotional	and	practical	support	and	helping	
patients	 and	 their	 families	 access	 the	 information	 they	 need	 about	 their	 diagnosis	 and	
treatment	(Leary,	White,	&	Yarnell,	2014;	Maguire,	R.	et	al.,	2013).		
	
The	 research	 questions	 had	 direct	 connection	 to	 my	 clinical	 role.	 This	 factor	 makes	 the	
findings	especially	relevant	at	a	clinical	and	theoretical	 level.	Such	close	connection	to	the	
research	subject	did	have	a	number	of	practical,	methodological	and	ethical	dimensions	that	
needed	 careful	 consideration.	 Adoption	 of	 a	 qualitative	methodology	 intensified	many	 of	




My	clinical	role	as	a	specialist	 lung	cancer	nurse	gave	me	clear	 insights	 into	the	pathways,	
management	 and	 decision-making	 regarding	 patient	 care,	 all	 of	 which	make	 interpreting	
events	 at	 a	 superficial	 level	 easy.	 Seeing	 things	 as	 they	 actually	 are,	 however,	 sometimes	
requires	coming	into	a	situation	with	‘fresh	eyes’,	avoiding	preconceptions,	and	questioning	
assumptions.	Being	a	member	of	 staff	 at	 the	 surgical	hospitals	 compounded	 these	 issues.	
Although	strenuous	efforts	were	taken	to	ensure	that	the	study	patients	were	not	also	part	


















also	given	a	 lot	of	 consideration.	 The	 term	 ‘professional’	was	 chosen	 to	 refer	 to	a	 clinical	
practitioner	 of	 any	 discipline	 involved	 in	 the	 observed	 consultations	 and	 interviews.	 In	
practice	this	was	consultant	and	trainee	thoracic	surgeons,	consultant	medical	and	clinical	
oncologists,	consultant	chest	physicians,	and	LCNS	working	 in	 the	surgical	and	 in	 the	 local	
hospitals.	The	term	‘patient’	can	be	seen	as	reflective	of	only	the	aspect	of	the	person’s	life	
during	their	contact	with	the	healthcare	system	and	therefore	negates	the	vast	majority	of	
time	 in	which	 the	 ‘ill	 person’	 is	 not	 being	 a	 patient	 (Frank,	 2000).	While	 I	 recognised	 the	
need	 to	 represent	 people	 as	 multidimensional	 beings,	 with	 lives	 outside	 their	 hospital	
experience,	 ultimately	 I	 chose	 to	 use	 the	 term	 ‘patient’	 throughout.	 The	 rationale	 was	
twofold.	The	first	was	practical,	in	wanting	to	avoid	the	clunky	‘person	affected	by	cancer’.	
The	second	was	more	fundamental.	The	study	was	primarily	about	clinical	communication	in	
which	 the	 relationship	 between	 professional	 and	 patient	 was	 central	 to	 the	 research	
question.	 Recognition	 of	 this	 power	 imbalance	 between	 participants	 became	 essential	 to	
the	findings.		
	
Throughout	 the	 thesis	 I	 have	made	extensive	use	of	 verbatim	quotes	 and	 longer	 extracts	
from	 the	data.	Quotations	within	 the	 text	 are	 denoted	by	 italicised	 text	within	 quotation	
marks.	Longer	extracts	are	indented	and	single-spaced,	again	in	italics.	These	direct	quotes	
have	often	been	edited	for	confidentiality,	clarity	and	brevity,	designated	by	use	of	square	
brackets.	 Full	 orthographic	 conventions	 used	 are	 listed	 in	 appendix	 10.	 Professional	
speakers	 are	 identified	by	 their	 discipline	 and	participant	number	 and	which	patient	 case	








In	 the	 next	 chapter	 I	 will	 set	 out	 the	 background	 to	 lung	 cancer	 management	 and	 the	
surgical	treatment	pathways.	I	will	introduce	some	of	the	current	national	policy	drivers	for	
lung	 cancer	 and	 the	 wider	 general	 cancer	 agenda.	 I	 will	 then	 consider	 some	 of	 the	
background	 theory	 on	 clinical	 communication,	 uncertainty	 and	 hope,	which	 underpin	 the	
later	 findings.	 In	 the	 third	 chapter	 I	 will	 present	 a	 literature	 review	 of	 prognostic	
communication	 in	 cancer	 care,	 initially	 done	 at	 the	 beginning	 of	 the	 study	 in	 2014.	 Since	
further	relevant	studies	have	since	been	published,	the	review	was	refreshed	later	towards	
the	end	of	the	study	and	these	findings	are	also	presented.	Chapter	four	provides	details	of	




twelve	 cases	 and	 their	 treatment	 pathways,	 with	 information	 about	 the	 patient	 and	
professional	participants.	The	following	three	chapters	will	provide	cross-case	analyses,	with	
each	chapter	exploring	a	particular	theme.	Chapter	6	will	present	the	theme	‘Predicting	the	
Future’,	examining	how	professionals	and	patients	conceived	 the	 future	outcomes	 for	 the	
individual	 patient	 participants.	 The	 following	 chapter	 looks	 at	 the	 theme	 of	 ‘Maintaining	
Hope’	and	explores	the	shared	goals	of	patient	and	professional	participants	around	hope.	
The	final	findings	chapter	uses	the	theme	‘Hope	Dances’	to	explore	key	clinical	consultations	
observed	 during	 the	 study	 in-depth	 to	 identify	 how	 interactions	 between	 professionals,	
patients	and	their	families	play	out	in	ways	that	are	aimed	to	support	patient	hope.	These	
findings	 are	 then	 discussed	 in	 chapter	 9	 in	 relation	 to	 the	 extant	 literature	 and	 their	
contribution	to	current	knowledge	is	 identified.	Finally	the	implications	for	clinical	practice	







The	aim	of	 this	 chapter	 is	 to	position	my	 research	 in	 the	context	of	 the	 literature,	and	 to	
provide	some	theoretical	underpinning	for	the	study.	I	will	begin	by	describing	the	current	













highest	 in	 the	ninth	decade	of	 life	 (Cancer	Research	UK,	2017).	While	 lung	cancer	 is	often	
assumed	to	be	linked	to	smoking,	around	10	to	15	per	cent	of	lung	cancers	occur	in	patients	







surgery	 in	 very	 limited	 disease	 is	 being	 evaluated	 (Lim,	 Belcher,	 Yap,	 Nicholson,	 &	
Goldstraw,	 2008).	 NSCLC	 is	 the	 commonest	 form	 of	 lung	 cancer,	 accounting	 for	 89%	 of	
patients	 diagnosed	with	 lung	 cancer	 (Royal	 College	of	 Physicians	 London,	 2018).	NSCLC	 is	
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classified	 into	 histological	 sub-types.	 The	 most	 common	 are	 adenocarcinomas,	 cancers	
arising	from	glandular	tissues,	followed	by	squamous	cell	carcinomas,	which	arise	from	the	
outer,	protective	layers	of	the	body	(Cancer	Research	UK,	2017).	A	small	proportion	of	lung	
malignancies	 are	 classified	 as	 neuroendocrine	 tumours,	 which	 include	 carcinoid	 tumours	
and	large	cell	neuroendocrine	carcinomas	(Travis	et	al.,	2015).	
2.2.2 Staging	and	survival	
Lung	 cancer	 is	 staged	 using	 the	 ‘TNM’	 system,	 as	 devised	 by	 the	 Union	 for	 International	
Cancer	 Control.	 The	 current	 eighth	 edition	 version	 was	 published	 in	 2016	 (Brierley,	
Gospodarowicz,	 &	 Wittekind,	 2016).	 The	 current	 study	 was	 initiated	 when	 the	 seventh	
edition	 TNM	 system	was	 in	 use	 and	 therefore	 this	 has	 been	 used	 throughout	 this	 thesis	
(Goldstraw	2009).	Details	of	the	seventh	edition	staging	system	are	available	in	Appendix	1.	
The	 system	 characterises	 the	 size	 and	 position	 of	 the	 primary	 tumour	 (‘T’	 stage),	 the	
presence	 or	 absence	 of	 cancer	 in	 local	 and	 distant	 lymph	 nodes	 (‘N’	 stage)	 and	whether	







Research	 UK,	 2014).	 Five-year	 overall	 survival1	was	 9.5%.	 This	 means	 that	 if	 you	 have	 a	
group	of	 100	patients	 all	 diagnosed	at	 the	 same	 time	with	 lung	 cancer,	 on	average	 there	
would	be	fewer	than	ten	patients	alive	after	five	years.	The	International	Association	for	the	
Study	 of	 Lung	 Cancer	 (IASLC)	 developed	 a	 database	 of	 over	 90,000	 patients	 from	 16	
countries,	 treated	 between	 1999	 and	 2010.	 This	 database	 has	 been	 used	 to	 develop	 and	









staging’,	based	on	 the	additional	 results	of	 the	 surgical	histopathology	 reports.	 Significant	
changes	may	be	seen	between	the	 initial	clinical	staging	and	the	final	pathological	staging	
available	following	surgery,	based	on	the	final	results	of	lymph	node	sampling	and	size	and	
anatomical	 positioning	 of	 the	 primary	 tumour	 (Naidoo,	 Windsor,	 &	 Goldstraw,	 2013).	
Pathological	 staging	 represents	 a	more	 accurate	 picture	 of	 the	 extent	 of	 the	 cancer	 than	





5-year	 survival	 (per	 cent)	
by	clinical	stage	














meaning	 that	 by	 the	 time	 that	 symptoms	 develop	many	 patients	 already	 have	 advanced	
cancer.	 Late	 presentation	 and	 diagnosis	 of	 lung	 cancer	 is	 considered	 to	 be	 the	 principal	
reason	for	the	overall	poor	survival	figures	(Holmberg	et	al.,	2010).	Significant	work	is	going	
into	improving	early	detection	by	means	of	professional	and	patient	awareness	campaigns	
(Athey,	 Suckling,	 Tod,	 Walters,	 &	 Rogers,	 2012).	 Several	 trials	 have	 reported	 positive	
benefits	 of	 lung	 cancer	 screening	 programmes	 (Crosbie	 et	 al.,	 2019;	 De	 Koning,	 Van	 Der	
Aalst,	Ten	Haaf,	&	Oudkerk,	2018;	Field	et	al.,	2016;	National	Lung	Screening	Trial	Research	
Team,	 2011).	 The	 overall	 aim	 is	 to	 increase	 the	 numbers	 of	 patients	 offered	 surgical	





Current	 UK	 guidelines	 for	 the	 management	 of	 patients	 with	 lung	 cancer	 mandate	 that	
patients	 should	be	managed	within	 a	 lung	 cancer	MDT	 (National	Collaborating	Centre	 for	
Cancer,	 2011).	 The	 MDT	 should	 include	 chest	 physician,	 radiologist,	 histopathologist,	
thoracic	 surgeon,	 radiation	 and	 medical	 oncologist,	 nurse	 specialist,	 palliative	 care	 and	
administrative	support.	General	Practitioners	(GPs)	are	encouraged	to	refer	any	patient	with	
signs	 that	might	 indicate	 a	 diagnosis	 of	 lung	 cancer	 to	 the	 local	 lung	 cancer	MDT	 via	 an	
urgent	 ‘two-week	wait	 pathway’.	 These	patients	 should	be	 seen	 in	 secondary	 care	within	
two	weeks	from	the	GP	referral.	The	aim	of	the	two-week	wait	pathway	is	to	diagnose	and	
treat	patients	as	early	as	possible.	In	practice,	only	28%	of	patients	diagnosed	between	2012	
and	 2013	were	 referred	 via	 two-week	 wait	 route	 (Cancer	 Research	 UK,	 2017).	 The	most	
common	route	of	diagnosis	is	as	an	emergency,	usually	via	a	casualty	department.	Patients	
diagnosed	as	an	emergency	are	more	likely	to	have	advanced	cancer,	while	those	referred	





Several	 factors	 identified	 in	 the	 preceding	 sections	 lead	 to	 particular	 challenges	 faced	 by	




Schiller,	 &	 Hyde,	 2009).	 Public	 perceptions	 of	 smoking	 and	 lung	 cancer,	 along	 with	
awareness	of	the	generally	poor	prognosis	associated	with	the	condition,	are	two	of	the	key	
factors	 that	 have	 the	 greatest	 impact	 for	 this	 group	 (American	 Lung	 Association,	 2014;	








UK,	 2017).	Changes	 in	 attitudes	have	 resulted	 in	 smoking	being	perceived	as	undesirable,	
and	 in	 many	 areas	 of	 society,	 as	 socially	 unacceptable.	 However,	 smoking	 rates	 remain	
significantly	higher	amongst	both	male	and	female	unskilled	and	manual	workers,	compared	
with	 those	 working	 in	 professional	 roles	 (Graham,	 2012).	While	 the	 general	 reduction	 in	
smoking	 rates	 has	 brought	 obvious	 health	 benefits,	 attitudinal	 changes	 around	 smoking	
have	also	 led	 to	negative	consequences	 for	 those	affected	by	 lung	cancer	 (Hamann	et	al.,	
2018).	 Perceptions	 about	 smoking	 in	 relation	 to	 social	 class	 and	 education	 levels	 further	
reinforce	these	stigmatising	characteristics	for	people	with	lung	cancer	(Graham,	2012).	
	
The	 stigma	 around	 smoking	 has	 significant	 influence	 on	 patients’	 personal	 feelings	 about	
their	 illness,	 wider	 public	 opinion,	 as	 well	 as	 professional	 attitudes	 towards	 people	
diagnosed	with	lung	cancer	(Hamann	et	al.,	2018).	There	are	a	number	of	qualitative	studies	
that	have	explored	the	stigmatising	effect	of	smoking	on	patients	with	lung	cancer	(Chapple,	
Ziebland,	 &	 McPherson,	 2004;	 Conlon	 et	 al.,	 2010;	 Lehto,	 2014).	 These	 effects	 are	
multidimensional,	 having	 implications	 for	 personal,	 interpersonal,	 and	 societal	 attitudes	
around	 lung	 cancer	 (Hamann	 et	 al.,	 2018).	 People	 who	 have	 smoked	 often	 experience	 a	
sense	 of	 self-blame,	 shame	 and	 guilt	 due	 to	 their	 perceived	 role	 in	 causing	 their	 cancer.	
Such	 feelings	 are	 associated	 with	 increased	 levels	 of	 depression	 and	 feelings	 of	 lack	 of	
entitlement	to,	or	not	being	deserving	of,	treatment	and	support	(Else-Quest	et	al.,	2009).	
On	 an	 inter-personal	 level,	 patients	 with	 lung	 cancer	 can	 be	 reluctant	 to	 disclose	 their	
diagnosis	to	friends	and	acquaintances	for	fear	of	 judgemental	reactions.	Family	members	
can	 sometimes	 chastise	 patients	 for	 their	 smoking	 following	 a	 diagnosis	 of	 lung	 cancer	
(Chapple	 et	 al.,	 2004).	 Repeated	 focus	 on	 smoking	 history	 in	 clinical	 interactions	 can	
reinforce	 the	 sense	 of	 self-blame	 felt	 by	 patients	 (Lehto,	 2014).	 Those	 who	 have	 not	
smoked,	 or	 had	 a	 trivial	 and	 distant	 smoking	 history,	 can	 feel	 judged	 by	 implication	 and	
often	want	to	stress	their	non-smoking	status	(Chapple	et	al.,	2004).		
	
On	 a	 societal	 level,	 attitudes	 to	 smoking	 and	 lung	 cancer	 can	 influence	 health	 funding,	
charities,	 research	 effort,	 as	 well	 as	 general	 attitudes	 to	 the	 condition.	 Professional	 and	





some	 extent	 for	 late	 diagnosis	 and	 low	 rates	 of	 referral	 to	 surgeons	 and	 oncologists	 for	
active	treatment	(Chambers	et	al.,	2012;	Wassenaar	et	al.,	2007).	Conlon	et	al.	(2010)	argue	
that,	with	 some	exceptions,	 there	 is	a	 lack	of	a	 strong	advocating	voice	on	behalf	of	 lung	
cancer	 patients,	 such	 as	 is	 seen	 in	 the	 powerful	 breast	 cancer	 lobby,	which	 can	 begin	 to	
address	 these	 inequalities	 and	 provide	 improvements	 in	 care	 and	 treatment.	 All	 these	
issues,	 such	 as	 stigmatisation,	 socio-economic	 and	 demographic	 factors,	 prognosis,	 social	
and	professional	attitudes,	 combine	 to	create	a	uniquely	 challenging	 treatment	 landscape	
for	lung	cancer.	
2.2.5 The	surgical	pathway	
Patients	 referred	with	 suspected	 lung	 cancer	 undergo	 a	 series	 of	 investigations	 aimed	 at	
achieving	 a	 diagnosis	 and	 clinical	 stage,	 and	 determining	 the	 optimal	 treatment	 options.	
Investigations	 include	 radiological	 imaging	 (e.g.	CT,	MRI	and	PET	 scans)	 and	biopsy	of	 the	
tumour	or	lymph	nodes,	as	well	as	an	overall	assessment	of	fitness	for	surgery	(Brunelli	et	
al.,	2009;	Lim	et	al.,	2010).	For	patients	who	are	suitable	for	surgery,	optimal	treatment	 is	





tumours	 who	 have	 poor	 lung	 function	 may	 be	 considered	 for	 surgery	 removing	 only	 an	
anatomical	portion	of	the	lobe,	known	as	a	segmentectomy	(Lim	et	al.,	2010).		
	
After	 surgery	 patients	 follow	 two	 distinct	 management	 pathways:	 either	 referral	 for	 an	
oncology	 opinion,	 or	 straight	 to	 long-term	 follow-up.	 Current	 guidelines	 suggest	 that	
patients	who	have	evidence	of	cancer	spread	to	any	lymph	node	following	surgery,	or	with	




chance	 of	 future	 cancer	 recurrence.	Meta-analyses	 of	 clinical	 trials	 indicate	 that	 adjuvant	
chemotherapy	 can	 add	 an	 average	 of	 around	 four	 per	 cent	 improvement	 in	 absolute	
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survival	 at	 five	 years	 (Burdett	 et	 al.,	 2015).	 Postoperative	 radiotherapy	 is	 usually	 only	




of	 five	 years	 and	 is	 aimed	 at	 monitoring	 patients	 for	 signs	 of	 cancer	 recurrence,	 either	
locally	 at	 the	 site	 of	 surgery,	 or	 systemically.	 Follow-up	 appointments	 usually	 include	
physical	 examination,	 plain	 chest	 x-ray	 and	 often	 CT	 scans.	 However,	 there	 is	 lack	 of	
consensus	 on	 the	 most	 effective	 strategy	 and	 frequency	 for	 following	 up	 patients	 after	
surgery	(Colombi	et	al.,	2013;	Schmidt-Hansen,	Baldwin	&	Hasler,	2012).	
	
Significant	unaddressed	psychological	 and	physical	 needs	have	been	 identified	 in	patients	
who	 have	 completed	 treatment	 for	 cancer	 (Armes	 et	 al.,	 2009;	 Richards,	 M.,	 Corner,	 &	
Maher,	2011).	 The	national	 Living	With	and	Beyond	Cancer	programme	 forms	part	of	 the	
government’s	 cancer	 strategy	 and	 research	agenda	 (Independent	Cancer	 Taskforce,	 2015;	
National	Cancer	Research	Institute	[NCRI],	2018).	Part	of	the	Living	With	and	Beyond	Cancer	
strategy	is	the	Recovery	Package.	This	comprises	of	a	suite	of	measures	aimed	at	identifying	
needs,	 promoting	 self-care	 through	 education	 and	 information,	 and	 access	 to	 health	 and	
wellbeing	or	rehabilitation	programmes	(Department	of	Health,	Macmillan	Cancer	Support	
&	NHS	Improvement,	2013).	Ultimately	the	aims	of	the	strategy	are	to	reduce	demands	on	
secondary	 care	 services,	 improve	 patients’	 quality	 of	 life	 and	 ultimately	 assist	 patients	 to	
resume	 a	 meaningful	 role	 in	 society.	 One	 of	 the	 elements	 of	 the	 Recovery	 Package	 is	
provision	 of	 a	 summary	 of	 treatment	 that	 includes	 information	 for	 patients	 on	 potential	






entire	 tumour	or	affected	 lymph	nodes	and	 is	designated	as	macroscopic	 residual	disease	
(R2).	Residual	disease	can	also	be	determined	by	the	pathologist	when	he/she	examines	the	
resection	edge.	Where	there	is	evidence	of	cancer	cells	at	the	cut	edge	of	the	resected	lung,	





The	 term	 ‘radical	 management’	 is	 defined	 as	 “…	 treatment	 given	 with	 the	 intention	 to	
improve	survival	substantially,	which	may	amount	to	a	cure”	(Lim,	et	al.	2010	pii4).	Surgery	
is	seen	as	the	best	chance	of	effecting	a	cure	in	patients	with	stage	I	or	II	NSCLC	and	some	
patients	 with	 stage	 IIIA	 (National	 Collaborating	 Centre	 for	 Cancer,	 2011).	 More	 recent	
guidance	includes	surgery	as	an	option	as	part	of	multi-modality	treatment	for	patients	with	
any	nodal	disease	(NICE,	2019).	The	term	‘cure’	 itself,	however,	 is	more	challenging	to	pin	
down.	Widely	 used	 as	 a	 lay	 term,	 the	 Oxford	 English	 Dictionary	 offers	 one	 definition	 as	
“Eliminate	(a	disease	or	condition)	with	medical	treatment”	(OED,	2018).	By	undergoing	lung	
cancer	 surgery,	 a	 patient	 can	 be	 seen	 to	 have	 eliminated	 the	 tumour.	 But	 surgically	
resecting	 the	 cancer,	 albeit	 with	 a	 wide	margin	 of	 unaffected	 tissue	 around	 it,	 does	 not	
guarantee	a	cure.		
	
Survival	 statistics	 represent	deaths	 from	any	cause	and	do	not	necessarily	 indicate	cancer	
recurrence.	But	 in	practice,	 the	vast	majority	of	deaths	are	cancer	related	 (Colombi	et	al.,	
2013;	 Pignon	 et	 al.,	 2008).	 Many	 professionals	 take	 overall	 survival	 as	 a	 proxy	 for	
recurrence,	 due	 to	 the	 availability	 of	 large-scale	 data	 by	 stage.	 Studies	 that	 do	 report	
disease-free	 survival3	show	 slightly	 lower	 rates	 than	 for	 overall	 survival,	 as	 can	 be	 seen	
where	disease	free	and	overall	survival	are	given	 in	some	adjuvant	chemotherapy	studies,	
such	as	Pignon	et	al.	 (2008).	Five	years	after	surgery	 is	 largely	taken	as	being	synonymous	
with	cure.	However,	recurrence	after	this	time	is	possible	and	is	sometimes	seen	clinically.	
Distinguishing	this	from	a	new	primary	lung	cancer	can	sometimes	be	a	challenge	(Colombi	





reflected	 in	 the	 cancer	 staging	 system,	 such	 as	 pathological	 sub-type,	 evidence	 of	 cancer	






tumour	 necrosis,	 amongst	 other	 factors,	 can	 have	 a	 bearing	 on	 risk	 of	 recurrence	 and	
prognosis	(Travis	et	al.,	2015).	Co-morbidities,	such	as	other	cancer,	heart	or	 lung	disease,	
combined	with	an	older	age	group	of	 the	 lung	cancer	population,	also	have	an	 impact	on	
survival	 (Friedel	 et	 al.,	 2013).	 The	 plethora	 of	 highly	 complex	 biomedical	 information	
available	following	surgery	for	lung	cancer	illustrates	the	challenges	faced	by	professionals	
in	 interpreting	what	 this	means	 for	 the	 individual	 patient	 regarding	 risk	 of	 future	 cancer	
recurrence.	Each	element	may	have	an	implication,	often	conflicting,	for	the	patient’s	future	
outcome.	The	professional	needs	to	make	sense	of	this	for	him	or	herself,	before	presenting	





Information	 about	 risk	 or	 the	 chances	 of	 particular	 outcomes	 are	 integral	 to	 modern	
healthcare.	 Such	 information	 supports	 informed	 consent,	 medical	 and	 patient	 decision-
making	 (Ahmed	 et	 al.,	 2012).	 It	 also	 has	 a	 role	 in	 patients	 making	 sense	 of	 their	 illness	
experiences	and	future	planning	(Thorne,	Hislop,	Kuo,	&	Armstrong,	2006).	Understanding,	
interpreting	 and	 conveying	 this	 sort	 of	 information	 also	 comes	 with	 its	 own	 range	 of	




with	 problems,	 and	 is	 inherently	 prone	 to	 error	 (Han	 et	 al.,	 2009).	 Risk	 information	 is	




uncertainty	 arises	 from	 the	 limitations	 of	 current	 knowledge	 that	 underpins	 the	 models	
used	to	generate	the	risk	data.	An	example	could	be	the	impact	of	cancer	histological	sub-
type	 on	 long-term	 survival,	 about	 which	 there	 is	 only	 emerging	 knowledge	 (Ujiie	 et	 al.,	
2015).	 Aleatory	 uncertainty,	 on	 the	 other	 hand,	 pertains	 to	 the	 “fundamental,	 irreducible	
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randomness	 and	 indeterminacy	 of	 natural	 events”	 (Han	 et	 al.	 2011,	 p832).	 This	 type	 of	
uncertainty	sits	at	the	heart	of	arguments	around	the	application	of	population	data	to	the	







wider	population	 from	which	 the	data	was	derived	will	 strongly	 influence	the	precision	of	
the	 risk	 estimate,	 and	 the	 credence	 placed	 on	 the	 data	 by	 the	 individual	 and	 his	 or	 her	
healthcare	 team.	 Survival	 data	 in	 healthcare	 is	 necessarily	 historical,	 and	 so	may	 not	 be	
reflective	of	new	medical	advances	and	changes	in	practice.	Ultimately,	Spiegelhalter	(2008)	
argues	 that	 all	 risk	 estimates	 are	 subjective	 and	 need	 to	 be	 constructed	 by	 argument,	
contingent	 on	 available	 information	 and	 dependent	 on	 the	 relationship	 between	 the	
individual	and	the	issue	in	question.		
2.3.2 Communication	of	risk	
Information	about	 future	possible	outcomes	 can	be	presented	 in	many	different	 formats.	
This	 can	 range	 from	 detailed	 statistical	 information	 about	 risks	 or	 chances,	 to	 implicit	
information,	 or	 even	 by	 the	 way	 in	 which	 someone	 behaves	 and	 their	 body	 language.	
Information	exchange	about	 risk	never	occurs	 in	 a	purely	objective	manner	and	 is	 always	




dominant	 part	 of	 what	 patients	 retain	 about	 their	 situation	 (Zikmund-Fisher,	 Fagerlin,	 &	
Ubel,	2010).		
	
At	 the	more	 explicit	 end	 of	 the	 spectrum	of	 risk	 communication,	 a	 key	 distinction	 in	 the	
types	of	risk	information	lies	between	discussion	of	the	possibility	that	an	event	can	happen	
on	 one	 hand,	 and	 numerical	 probability	 estimates	 on	 the	 other	 (Zikmund-Fisher,	 2013).	
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Possibility	 is	 simply	 the	statement	 that	 something	could	occur.	Such	 information	discloses	
that	an	event	could	happen,	but	not	the	magnitude	of	the	risk.	Possibility	 information	can	
be	 tailored	 to	 the	 needs	 of	 a	 specific	 situation	 by	 the	 way	 that	 the	 risk	 is	 presented	
(Zikmund-Fisher,	2013).	For	example,	 information	can	be	made	more	specific	by	providing	
verbal	 categories,	 using	 terms	 such	 as	 high,	 medium	 or	 low	 risk.	 While	 a	 categorical	
evaluation	 of	 possibility	 can	 provide	 some	 concept	 of	 the	 degree	 of	 risk,	 it	 remains	 a	








precision	 using	 numbers.	 An	 absolute	 estimate	 of	 probability	 provides	 a	 numerical	





level,	 but	 focuses	 on	 the	 degree	 of	 benefit	 to	 be	 gained	 by	 having	 treatment.	 However,	
many	 authors	 recognise	 the	 challenges	 patients,	 and	 indeed	 professionals,	 have	 in	 fully	
understanding	 and	 interpreting	 numerical	 risk	 information	 (Brust-Renck,	 Royer,	 &	 Reyna,	
2013;	Gigerenzer	et	al.,	2007;	Thorne	et	al.,	2006).	
	
Fuzzy	 Trace	 Theory	 differentiates	 between	 ‘verbatim’	 and	 ‘gist’	 memory:	 two	 different	
mental	representations	of	information	presented	to	patients	(Reyna	&	Brainerd,	1991).	This	







about	 prognosis	 following	 surgery,	 most	 patients	 will	 work	 at	 the	 level	 of	 mentally	
processing	 the	meaning	 of	 what	 they	 have	 heard,	 which	 favours	 gist	 level	 recall	 (Reyna,	
2008;	 Reyna,	 2012).	 This	 is	 coupled	with	 the	 fact	 that	much	 information	 is	 complex	 and	
unfamiliar,	and	 is	also	highly	emotionally	 charged.	 It	 is	 therefore	 likely	 that	most	patients	
will	take	away	only	a	limited	impression	of	the	information	that	they	were	given.	Zikmund-
Fisher	 (2013)	 argues	 that	 due	 to	 people’s	 preference	 for	 gist	 level	 information,	 where	
possible	information	should	be	given	with	the	minimum	level	of	precision	that	will	achieve	






Uncertainty	 is	 at	 the	 core	 of	 human	 existence.	 Most	 agree	 that	 we	 do	 not	 live	 in	 a	
deterministic	 universe,	 or	 even	 if	 we	 do	 believe	 our	 future	 is	 mapped	 out,	 there	 is	







1984,	 p103).	 This	 definition	 leaves	 the	 focus	 of	 the	 uncertainty	 deliberately	 vague.	 The	
theory	 of	 stress	 and	 coping	 involves	 a	 process	 of	 appraisal	 of	 both	 the	 situation	 and	 the	
resources	available	to	cope	with	the	problem.	They	identify	this	as	primary	appraisal	of	the	
target,	 to	 identify	 the	 nature	 of	 the	 threat.	 Secondary	 appraisal	 is	 then	 employed	 to	
determine	what	can	be	done	to	address	the	problem.		
	
Lazarus	 and	 Folkman	 identify	 two	main	 types	of	 coping;	 ‘problem	 focused’,	 and	 ‘emotion	
focused’	coping.	Problem	focused	coping	 includes	strategies	such	as	planning,	 information	






focused’	 coping,	 which	 is	 associated	 with	 positive	 emotions	 and	 includes	 things	 such	 as	
positive	 re-appraisal	 of	 events	 and	 goal	 revision	 (Folkman,	 1997).	 Lazarus	 and	 Folkman	





Uncertainty	 is	 frequently	seen	as	something	that	humans	always	strive	 to	minimise	 (Case,	
Andrews,	Johnson,	&	Allard,	2005).	Minimising	uncertainty	is	usually	equated	with	a	quest	
for	information	until	the	source	of	uncertainty	is	eliminated.	Some	questions	have	no	known	
answer	 and	 are	not	 amenable	 to	 a	 search	 for	 information,	 or	 just	 raise	 further	 questions	
(Bradac,	2001).	Nevertheless,	some	communication	theories	have	tried	to	reflect	this	desire	
to	 minimise	 uncertainty,	 for	 example	 Uncertainty	 Reduction	 Theory	 (Berger,	 C.R.	 &	
Calabrese,	 1974).	 There	 is	 general	 recognition	 that	 seeking	 and	 accessing	 health	 related	
information	 is	 a	 vital	 part	 of	 adjusting	 and	 coping	with	 an	 illness	 (Brashers,	Goldsmith,	&	
Hsieh,	2002).	But,	despite	the	view	that	uncertainty	is	undesirable,	there	is	also	recognition	
that	there	are	times	when	increased	levels	of	uncertainty	can	be	beneficial	to	the	individual	
(Babrow,	 Kasch,	 &	 Ford,	 1998;	 Babrow,	 2001;	 Brashers	 et	 al.,	 2002;	 Mishel,	 1988).	 For	
example,	a	patient	with	cancer	starting	a	new	treatment	with	a	realistic,	but	low	chance	of	
benefit	 might	 construe	 uncertainty	 about	 outcome	 in	 a	 positive	 light.	 Increasing	 mental	
uncertainty	 about	 the	 chance	 of	 benefit	 could	 allow	 the	 patient	 to	 continue	 to	 view	 the	
treatment	as	a	good	thing,	despite	difficult	side	effects.	In	this	way	the	patient	can	maintain	








illness-related	 events”	 (p225).	 Several	 researchers	 have	 created	 models	 of	 patient	
uncertainty	(Babrow	et	al.,	1998;	Kasper,	Geiger,	Freiberger,	&	Schmidt,	2008;	Mishel	1988).	
These	 have	 included	 aspects	 such	 as	 the	 ambiguity	 about	 the	 nature	 of	 the	 illness,	 the	
complexity	of	medical	management,	the	sufficiency	of	information	and	the	unpredictability	
of	the	illness	and	its	prognosis.	Han,	Klein	and	Aurora	(2011)	argued	that,	while	useful,	these	
models	 often	 lacked	 precision	 and	were	 limited	 in	 the	 reflection	 of	 the	multidimensional	
nature	 of	 uncertainty.	 The	 team	 developed	 a	 model	 that	 attempted	 to	 address	 these	
shortcomings.	 They	 defined	 uncertainty	 at	 its	 most	 fundamental	 level	 as	 “the	 subjective	
perception	of	 ignorance”	 (p830).	Their	description	of	uncertainty	as	a	perception	 is	key	 to	






In	 the	 first	dimension,	 the	Source,	Han	et	al.	 (2011)	 identify	 three	aspects	of	uncertainty:	
‘Probability’,	 ‘Ambiguity’	 and	 ‘Complexity’.	 Probability	 is	 the	 risk	 or	 chance	 of	 something	
happening,	 for	 example	 quoted	 mortality	 risk	 during	 surgery.	 Uncertainty	 is	 an	 intrinsic	
element	of	probability.	Even	given	specific	odds	of	something	happening,	one	cannot	know	
if	the	event	will	or	will	not	happen	to	a	particular	individual.	Ambiguity	covers	the	precision,	





The	Complexity	aspect	of	uncertainty	 reflects	 the	 vast	 array	of	potential	 information	 that	
might	 need	 to	 be	 taken	 into	 consideration.	 Examples	 include	 multiple	 interpretive	 cues,	




the	 particular	 case.	 This	 dimension	 is	 divided	 into	 ‘Scientific’,	 ‘Practical’	 and	 ‘Personal’	
aspects.	 Scientific	 aspects	 include	 establishing	 and	 certainty	 of	 the	 diagnosis,	
prognostication,	 causation,	 treatment	 options	 and	 their	 effectiveness.	 These	 aspects	 are	
highly	disease	focused.	Practical	uncertainties	relate	to	aspects	such	as	accessing	the	right	
care,	 negotiating	 the	 care	 system	 and	 the	 competence	 of	 the	 healthcare	 staff.	 Personal	
aspects	 of	 uncertainty	 cover	 psychosocial	 impacts,	 such	 as	 potential	 loss	 of	 employment,	
effects	on	relationships	and	existential	questions.	These	uncertainties	are	highly	centred	on	




at	 any	 given	 time.	 A	 patient,	 their	 family	 member,	 the	 professional,	 all,	 or	 none	 may	
experience	uncertainty	about	a	particular	aspect	at	any	particular	time.	This	final	dimension	
underlines	 the	 notion	 that	 uncertainty	 is	 not	 just	 something	 that	 patients	 face,	 but	 is	
experienced	by	everyone	involved,	from	his	or	her	own	perspective.	It	is	this	aspect	of	the	
model	 by	 Han	 and	 colleagues	 that	 sets	 it	 apart	 from	 less	 comprehensive	 conceptions	 of	
uncertainty	 in	 healthcare.	 This	 means	 that	 uncertainty	 takes	 on	 an	 interactional	 aspect,	





in	 health	 (Mishel,	 1988;	 Selder,	 1989).	 Mishel’s	 Uncertainty	 in	 Illness	 Theory	 (UIT)	 was	
originally	 conceived	 around	 situations	 of	 acute	 illness	 (Mishel,	 1988).	Drawing	 on	 Lazarus	
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and	 Folkman	 (1984)	 Stress	 and	 Coping	 theory,	 UIT	 takes	 as	 the	 starting	 point	 the	 stimuli	
patients	experience	about	their	 illness	as	the	cause	of	uncertainty.	This	could	 include	new	
symptoms,	 or	 the	 familiarity	 and	 congruity	 of	 the	 events	 around	 the	 illness.	 How	 people	
interpret	 these	 stimuli	 could	 be	 affected	 by	 their	 cognitive	 capacity,	 education,	 social	
support	 and	 access	 to	 credible	 information.	As	with	 Stress	 and	Coping	 theory,	 feelings	 of	
uncertainty	 are	 characterised	 as	 essentially	 neutral.	 The	 uncertainty	 is	 appraised	 and	











of	 uncertainty.	 Illusions	 emphasise	 the	 especially	 favourable	 aspects	 of	 the	 situation,	 and	
make	 use	 of	 such	 processes	 as	 downward	 comparison	 with	 others	 in	 the	 same	 position	
(Taylor,	S.	1983).	Mishel	 identified	 illusions	as	being	 important	 in	maintaining	hope	 in	 the	
face	 of	 negative	 and	 life-threatening	 information.	 Depending	 on	 whether	 uncertainty	 is	
appraised	 as	 opportunity	 or	 danger,	 Mishel	 proposed	 different	 coping	 strategies.	 If	
uncertainty	 is	 seen	 as	 danger	 to	 them,	 patients	 could	mobilise	 resources,	 such	 as	 taking	
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action,	 vigilance	 and	 information	 seeking	 to	 try	 to	 reduce	 it.	 Additionally,	 strategies	 to	
control	 affect,	 such	 as	 redefining	 events,	 self-talk	 and	 wishful	 thinking	 might	 be	 used.	




In	 the	 situation	of	 chronic	 illness,	where	uncertainty	may	 extend	over	 years,	Mishel	 later	
adapted	 the	 theory	 (Mishel,	 1990).	 The	 reconceptualised	 theory	 suggested	 that	 people’s	
orientation	might	 adapt	 and	 shift,	whereby	uncertainty	 is	more	 likely	 to	 be	 viewed	as	 an	
opportunity.	 Situations	 such	 as	 undergoing	 surveillance	 following	 cancer	 surgery,	 where	
people	 live	 with	 uncertainty	 of	 potential	 recurrence	 over	 years	 are	 identified	 as	 such	 a	
scenario.	In	these	circumstances	the	deterministic	view	of	acute	care	can	give	way	to	a	more	
probabilistic	worldview,	where	uncertainty	is	accepted	as	part	of	the	natural	order	of	things.	





Uncertainty	 in	 healthcare	 is	 clearly	 linked	 to,	 but	 distinct	 from,	 a	 lack	 of	 available	 health	
information.	The	complex	multidimensional	nature	of	uncertainty	can	mean	that	providing	
or	searching	for	information	alone	will	not	address	the	whole	problem.	There	remain	many	





There	 has	 been	 extensive	 research	 over	 the	 last	 four	 decades	 and	 beyond	 regarding	
communication	between	patients	and	professionals	and	the	delivery	of	 information	about	
cancer.	This	body	of	 literature	will	be	explored	 in	more	depth	 in	the	next	chapter.	Several	
highly	influential	studies	have	indicated	that	patients	with	cancer	want	to	be	fully	informed	
about	 their	 condition	 and	 have	 shaped	 subsequent	 health	 service	 policy	 and	 guidelines	
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(Cassileth,	 Zupkis,	 Sutton-Smith,	 &	 March,	 1980;	 Cox,	 A.,	 Jenkins,	 Catt,	 Langridge,	 &	
Fallowfield,	 2006;	 Jenkins,	 Fallowfield,	 &	 Saul,	 2001).	 Other	 studies	 suggest	 that	
professionals	 are	 frequently	 poor	 at	 communicating	 and	 avoid	 discussing	 difficult	 or	






Such	 research	 echoes	 a	 growing	 cultural	 shift	 towards	 patient	 empowerment	 and	 health	
consumerism	(Salmon	&	Young,	2017).	It	has	also	been	influential	in	developing	current	UK	
government	 health	 policy,	 and	 the	 growing	 movement	 towards	 Patient	 Centred	 Care	
(Department	 of	 Health,	 2010;	 Goodrich	 &	 Cornwell,	 2008;	 NHS	 England,	 2014).	 Patient	
information	 provision	 and	 empowering	 people	 to	 take	 a	 shared	 role	 in	medical	 decision-
making	also	form	a	central	element	of	current	national	cancer	strategy	(Independent	Cancer	
Taskforce,	2015).	However,	other	authors	argue	that	many	research	studies	do	not	support	
the	 idea	most	 patients	want	 to	 be	 consumers	 of	 information	 or	make	 complex	 decisions	
about	 their	 treatment	 (Salmon	 &	 Young,	 2017).	 Rather,	 they	 suggest,	 patients	 want	
information	 that	 sustains	 trust	 in	 clinical	 teams	 and	 enables	 patients	 and	 families	 to	






is	 not	 how	 all	 patients	 like	 to	 cope	 all	 of	 the	 time.	 Nonetheless,	 there	 is	 an	 implicit	
assumption	 that	 people	 always	 want	 to	 be	 given	 or	 look	 for	 information	 about	 their	
condition.	 In	 reality,	 many	 patients	 wish	 to	 avoid	 details	 that	 might	 be	 difficult	 to	 hear	
(Johnson,	J.	D.,	2014;	Sweeny,	Melnyk,	Miller,	&	Shepperd,	2010).	One	approach	has	been	
to	 view	 attitude	 to	 information	 seeking	 in	 terms	 of	 fixed	 personality	 traits	 (Miller,	 S.	M.,	







In	 contrast	 to	 this	 view	 of	 fixed	 personality	 types,	 other	 researchers	 have	 proposed	 that	
seeking	 or	 avoiding	 information	 is	 predominantly	 dependent	 on	 situation	 and	 context	
(Barbour,	 J.	B.,	Rintamaki,	Ramsey,	&	Brashers,	2012;	Germeni	&	Schulz,	2014;	 Johnson,	 J.	
D.,	2003;	Lazarus	&	Folkman,	1984).	People	seek	information	selectively;	directing	attention	
towards	certain	 information	 targets,	while	other	 sources	of	 information	might	be	avoided	
(Lambert	 &	 Loiselle,	 2007;	 Lambert,	 Loiselle,	 &	 Macdonald,	 2009).	 J.	 D.	 Johnson	 (1997;	
2003)	 identified	 context	 and	 salience	 of	 information	 as	 the	 central	 elements	 in	 his	
Comprehensive	Model	of	Information	Seeking.	Background	factors	such	as	age,	occupation,	






or	 avoid	 information	 as	 a	way	 of	 supporting	 information	 goals	 around	maintaining	 hope,	
their	 faith	 in	 the	medical	 team	 and	 the	 desire	 to	 resume	 normality.	 Leydon	 et	 al.	 (2000)	
identified	the	need	to	preserve	hope,	and	to	maintain	faith	in	their	medical	team’s	ability	to	




seeker,	 such	 as	 that	 described	 above	 by	 J.	 D.	 Johnson	 (1997).	 Others	 account	 for	 the	
interactive	process	of	 information	management,	 such	as	Theory	of	Motivated	 Information	
Management	(Afifi	&	Weiner,	2004;	Afifi	&	Morse,	2009).	This	model	acknowledges	that	not	
all	information	exchange	is	because	of	active	information	seeking	by	patients.	Information	is	
often	passively	 received,	as	well	as	patients	actively	attempting	 to	avoid	 information.	The	
roles	and	 influence	of	both	parties	 in	 information	management	 is	highlighted,	considering	
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the	 efficacy	 of	 both	 information	 giver	 and	 information	 provider	 in	 comprehension,	




A	 conceptual	 framework	 that	 focuses	 on	 the	 particular	 communication	 encountered	 in	
clinical	 encounters	 was	 developed	 by	 Feldman-Stewart,	 Brundage	 and	 Tishelman	 (2005).	
The	 framework	 includes	 four	 elements;	 the	 communication	 goals	 of	 each	participant,	 the	
personal	 attributes	 of	 the	 participants,	 the	 communication	 process,	 and	 finally	 the	
environment	 in	 which	 the	 communication	 takes	 place.	 Figure	 2.3	 gives	 an	 outline	 of	 the	
framework.	 The	 complexity	 of	 clinical	 communication	 is	 reflected	 by	 recognising	 the	
multiple	 messages	 conveyed,	 that	 the	 intention	 of	 the	 message	 might	 not	 be	 how	 it	 is	
interpreted,	 and	 in	 the	 range	 of	 external	 factors	 that	 impact	 on	 both	 patients	 and	
professionals.	 Both	 participants	 may	 have	 multiple	 goals	 they	 want	 out	 of	 a	 clinical	
encounter.	Each	needs	 to	convey	and	 receive	messages.	Primary	goals	 represent	 the	core	
information	that	needs	to	be	conveyed,	while	secondary	goals	enable	the	primary	goals	to	
be	achieved,	such	as	building	a	rapport.	Typically	there	will	be	several	communication	goals	
within	 an	 encounter,	 with	 changing	 priorities	 at	 different	 times	 in	 the	 interaction.	When	
goals	conflict,	either	between	participants,	or	 internally	between	the	different	messages	a	









	The	 framework	 highlights	 the	 intrinsic	 role	 of	 personal	 values	 and	 external	 factors	 in	
shaping	communication	for	both	professional	and	patient	participants	in	clinical	situations.	
It	 also	 identifies	 how	 communication	 occurs	 in	 a	 process	 involving	 simultaneous	 and	
sequential	messages,	conveyed	intentionally	and	unintentionally.	These	dynamic	processes	
act	 to	 provide	 feedback	 on	 what	 has	 been	 conveyed,	 as	 well	 as	 ‘feedforward’,	 so	 that	
information	 transmitted	 can	 influence	 subsequent	 elements	 of	 the	 conversation.	 The	







interactive	 process	 of	 communication,	 rather	 than	 ascribing	 fixed	 roles	 of	 information	







repeatedly	 been	 identified.	 However,	much	 of	 the	 time,	 what	 is	meant	 by	 hope	 has	 not	




speech,	 the	 concept	 of	 hope	 is	 complex	 and	 has	 meanings	 that	 range	 from	 trivial	 to	
profound.	Hope	has	been	explored	across	many	disciplines,	including	philosophy,	theology,	
linguistics,	psychology	and	healthcare.	In	the	healthcare	setting,	interest	in	the	concept	has	
come	 from	 nursing	 and	 palliative	 care	 research.	 I	 will	 begin	 to	 look	 at	 hope	 by	 briefly	
Chapter	2:	Background	to	the	study	
	 28	





to	 enable	 people	 to	 attain	 goals	 and	 progress	 in	 life,	 while	 others	 have	 seen	 hope	 as	 a	
destructive	and	evil	force4.	One	interpretation	of	hope	is	essentially	passive	and	a	block	to	
striving,	 trusting	 that	 fate,	 or	 some	 other	 force,	 will	 bring	 about	 the	 best	 outcome.	 The	
opposite	of	hope	in	this	scenario	might	be	considered	to	be	self-determination.	Others	view	









desired;	 to	 look	 (mentally)	with	expectation”	 (OED,	2018).	 These	definitions	underline	 the	
future	focus	of	hope.	Hope	in	noun	form	has	two	senses	(Eliott	&	Olver,	2002).	Firstly,	it	can	







the	 world,	 sent	 to	 plague	 humankind.	 But	 one	 evil	 remained	 trapped	 in	 the	 jar	 when	
Pandora	tried	to	close	it.	That	evil	was	hope.	Interpretations	of	this	story	have	varied	over	
the	millennia.	 One	 version	 says	 that	 trapping	 hope	was	 a	 further	 evil,	 by	 denying	 us	 the	
comfort	of	hope.	Others	have	argued	that	the	Greek	word	elpis	signified	expectation,	but	in	
the	 sense	 of	 foreboding.	 Hence	 by	 Pandora	 resealing	 the	 jar,	 it	 spared	 us	 the	 continual	
knowledge	 of	 our	 ultimate	 fate	 and	 meaninglessness	 of	 our	 existence.	 Another	





possess	 hope,	 as	 in	 ‘I	 have	 hope	 that	 X’,	 or	 used	 as	 an	 adjective,	 ‘I	 am	 hopeful’.	 These	
feelings	and	emotions	 reflect	an	 internal,	personal	experience	 (Godfrey,	1987).	The	direct	
opposite	of	hope	in	this	context	might	be	considered	to	be	fear.	The	second	use	is	that	of	an	
evaluation,	for	example,	‘there	is	hope’,	or	the	opposite,	‘there’s	no	hope’.	Such	evaluations	





were	 a	 ‘mere	 wish’.	 On	 the	 other	 hand,	 it	 is	 possible	 to	 hope	 for	 things	 that	 might	 be	
improbable,	but	conceivably	possible.	However,	what	 is	considered	as	 impossible	 is	 in	 the	
eye	 of	 the	 beholder	 and	 ‘miracles’	 might	 sit	 somewhere	 on	 the	 cusp	 of	 these	 two	












God	 is	 axiomatically	 certain.	 In	 this	 context	 hope	 can	 develop	 a	 different	meaning,	 being	
nearer	 to	 knowledge	 of	 future	 divine	 assistance,	 salvation,	 or	 attainment	 of	 eternal	 life	
(Bloeser	&	Stahl,	2017).	Outside	the	religious	context,	it	is	also	possible	to	make	a	distinction	
between	 a	 hope	 for	 a	 particular	 outcome,	 and	 a	 more	 indeterminate	 hope,	 sometimes	
called	 ‘fundamental	 hope’	 (Godfrey,	 1987,	 p64).	 In	 contrast	 to	 other	 forms	 of	 hope,	
fundamental	hope	is	conceived	to	lack	these	specific	aims,	but	is	rather	more	about	having	a	





or	 ‘spirit’;	 a	 vital	 life-force	 that	keeps	us	moving	 forward,	 fighting	 for	 life,	 and	 refusing	 to	
capitulate.	To	live	without	hope	has	been	equated	to	ceasing	to	function	as	a	human	being	




hope.	 Several	 multidimensional	 conceptual	 models	 of	 hope	 and	 corresponding	
measurement	 tools	 have	been	developed	over	 the	 last	 three	decades,	 for	 example	Herth	
(1992),	 J.F.	 Miller	 and	 Powers	 (1988),	 Nowotny	 (1989),	 Snyder	 et	 al.	 (1991),	 and	 Stoner	
(2004).	 Other	 researchers	 contend	 that	 by	 selecting	 particular	 aspects	 of	 the	 multiple	
meanings	 of	 hope	 and	 trying	 to	 render	 it	 into	 a	 score,	 researchers	 risk	 missing	 the	
complexity	of	 the	 concept	 in	healthcare	 (Eliott	&	Olver,	 2002;	 Folkman,	2010).	Numerous	
reviews	 and	 concept	 analyses	 attest	 to	 the	 multiplicity	 of	 interpretations	 of	 hope	 in	
healthcare	 (Benzein	 &	 Saveman,	 1998;	 Cutcliffe	 &	 Kaye,	 2002;	 Kylmä	 &	 Vehviläinen-
Julkunen,	 1997;	 Tutton,	 Seers,	 &	 Langstaff,	 2009;	 Wiles,	 Cott,	 &	 Gibson,	 2008).	







specific	 goal.	 However,	 others	 view	 this	 as	 a	 limited	 rendering	 of	 hope	 (Bloeser	 &	 Stahl,	
2017).	Many	argue	that	hope	can	be	present	even	in	circumstances	where	the	person	does	
not	have	the	ability	to	achieve	the	goal	(Folkman,	2010;	Lazarus,	1999;	McGeer,	2004;	Pettit,	
2004).	 Within	 the	 stress	 and	 coping	 literature,	 hope	 is	 seen	 as	 a	 vital	 emotion	 focused	
coping	 strategy	 (Folkman,	2010;	 Lazarus,	1999).	Due	 to	 the	 inherent	need	 to	be	aware	of	










the	 patient	 or	 family	 member	 to	 be	 in	 denial	 and	 to	 possess	 false	 hope.	 Snyder	 (2002)	
considers	false	hopes	as	psychologically	‘maladaptive’,	particularly	where	the	goals	of	hope	
are	 illusory,	 too	 big,	 or	 there	 are	 poor	 strategies	 for	 achieving	 them.	 However,	 several	
writers	 take	 issue	 with	 the	 whole	 idea	 of	 false	 hope.	 Pettit	 (2004)	 identifies	 hope	 as	 a	
rational	process,	through	which	people	cope	with	the	“turmoil	of	brute,	disheartening	fact”	
by	 acting	 and	 reacting	 as	 though	 the	 hoped-for	 outcome	 is	 definite	 (p161).	 Patients	 and	
families	may	continue	to	find	hope	beneficial,	even	in	the	most	extreme	situations	(Bennett,	




Del	 Vecchio	 Good,	 Good,	 Schaffer	 and	 Lind	 (1990)	 explored	 the	 centrality	 of	 hope	 in	
oncology	 care	 in	 the	 United	 States	 during	 the	 late	 twentieth	 century.	 They	 described	 a	
culture	 where	 the	 disclosure	 of	 a	 cancer	 diagnosis	 had	 become	 the	 norm.	 However,	 the	
perceived	 imperative	 to	 instil	 and	 maintain	 hope	 in	 patients,	 and	 in	 the	 professionals	
themselves,	 led	 to	 a	 more	 ambivalent	 approach	 to	 discussing	 prognosis	 and	 treatment	
outcomes.	Doctors	regulated	information	disclosure	to	patients.	This	led	to	a	‘balancing	act’	





constructing	 and	 bolstering	 patients’	 hope,	 as	 an	 automatic	 part	 of	 their	 daily	work.	 The	
amount	and	focus	of	this	Hope	Work	differed	with	different	care	scenarios.	Hope	Work	on	
an	acute	haematology	unit	was	 focused	on	hope	 for	 recovery	and	optimism.	During	work	
caring	for	patients	with	palliative	care	needs,	hope	was	directed	towards	short-term	goals	




was	almost	 absent,	possibly	due	 to	 the	 short	 time	over	which	events	developed,	 and	 the	
unknown	and	uncertain	potential	outcomes.	McGeer	(1994)	argues	in	her	essay	on	the	‘Art	
of	 Good	 Hope’,	 that	 an	 essential	 aspect	 of	 using	 hope	 in	 a	 positive	manner	 is	 what	 she	
describes	 as	 responsive	 hope.	 In	 this	 she	 emphasises	 hope	 as	 an	 interpersonal,	mutually	

















of	 the	 lung	 cancer	 surgical	 treatment	 pathway	 and	 the	 long-term	 patient	 outcomes.	 The	
issues	of	cure,	survival	and	recurrence	were	examined	and	the	limitations	that	are	inherent	
in	 information	 about	 risk.	 The	 challenges	 of	 risk	 communication	 were	 then	 considered.	


















briefly	 touched	 on	 some	 of	 the	 literature	 around	 communication	 in	 cancer	 care.	 In	 this	
chapter	I	will	present	a	more	in-depth	review	of	the	clinically	focused	studies	that	examine	
how	 prognosis	 is	 communicated	 in	 cancer	 care	 practice	 and	 explore	 the	 patient	 and	










Early	 broad	 reading	 around	 my	 research	 topic	 identified	 a	 comprehensive,	 systematic	
literature	 review	 on	 communication	 of	 prognosis	 in	 cancer	 care	 (Hagerty,	 Butow,	 Ellis,	
Dimitry,	&	Tattersall,	2005).	The	review	had	wide	aims	that	included	understanding	patient	
preferences,	 clinician	 views	 and	 current	 practice	 of	 prognosis	 communication	 in	 cancer.	
Studies	 included	 patients	 treated	 for	 early	 stage	 cancer,	 advanced	 cancers,	 and	 cancer	
patients	in	palliative	care	settings.	It	explored	93	papers	published	between	1973	and	2003.	









Multiple	 typologies	 of	 literature	 review	 have	 been	 documented	 (Grant	 &	 Booth,	 2009).	
Considerable	 methodological	 overlap	 exists	 between	 these	 approaches,	 and	 different	
methodologies	 may	 be	 given	 the	 same	 name	 by	 different	 researchers	 (Barnett-Page	 &	
Thomas,	2009).	These	factors	make	choosing	an	approach	challenging.	However,	 I	wanted	
to	 incorporate	 diverse	 research	 methodologies,	 so	 as	 to	 reflect	 the	 breadth	 of	 research	
knowledge	about	prognostic	communication.	Although	it	is	feasible	to	synthesise	data	from	
qualitative,	 quantitative,	 and	 mixed	 methods	 studies	 separately,	 such	 an	 approach	 risks	
failing	to	capture	the	breadth	and	complexity	contained	within	the	literature	(Dixon-Woods,	
Bonas	 et	 al.,	 2006).	 Critical	 Interpretive	 Synthesis	 (CIS)	 was	 chosen	 as	 the	 review	
methodology	that	offered	the	best	fit	with	my	aims	(Dixon-Woods,	Cavers	et	al.,	2006).		
	
CIS	 was	 developed	 from	 meta-ethnography	 (Noblit	 &	 Hare,	 1988).	 It	 employs	 strategies	
common	 across	 qualitative	 research	 techniques,	 particularly	 in	 terms	 of	 being	 non-linear	
and	iterative	in	nature.	The	approach	identifies	key	themes,	metaphors	and	concepts	from	
the	original	 studies,	 translates	 them	between	 the	other	 studies,	 and	 then	 looks	 for	wider	
patterns	and	constructs.	Contradictions	in	findings	are	explored	between	studies.	Constant	





accounts	 may	 exist	 of	 the	 evidence,	 but	 that	 the	 resulting	 synthesis	 is	 grounded	 in	 the	
evidence,	verifiable	and	plausible.		
3.2.2 Objectives:	
I	 used	 two	 search	 questions	 to	 help	 identify	 literature	 relevant	 to	 clinical	 prognostic	
communication	in	cancer	care.		
1. What	 is	 known	 about	 the	 process	 of	 communicating	 information	 about	 prognosis	 or	
recurrence	risk	with	adult	patients	with	cancer?	





Although	 I	 aimed	 to	 take	 a	 systematic	 approach	 to	 the	 literature,	 the	 rigour	 of	 a	 full	
systematic	review	was	not	achievable,	given	the	limitations	of	time	and	manpower	available	
to	 me	 as	 a	 part-time	 doctoral	 student.	 However,	 in	 order	 to	 ensure	 rigour	 I	 used	 the	
Enhancing	 Transparency	 in	 Reporting	 the	 Synthesis	 of	 Qualitative	 Research	 (ENTREQ)	












Authors	have	developed	a	 range	of	strategies	and	mnemonics	 to	 facilitate	comprehensive	
searches	using	electronic	databases	(Booth,	A.,	2016).	Some	approaches	specifically	aim	to	
identify	 qualitative	 research,	 such	 as	 the	 SPIDER	 tool	 (Cooke,	 Smith,	 &	 Booth,	 2012).	




Outcome,	 but	 requires	 some	modification	 in	 the	 context	 of	 observational	 studies,	 where	
there	 is	no	 intervention	or	 comparison	group	 (Lockwood,	Munn,	&	Porritt,	2015).	 For	 the	
purpose	of	this	review	I	considered	the	patient	group	as	‘patients	with	cancer’,	intervention	











The	 searches	 were	 adapted	 to	 reflect	 the	 specific	 database	 being	 used.	 The	 full	 search	
strategies	 used	 are	 available	 in	 appendix	 2.	 The	 Cochrane	 database	 of	 reviews	 was	 also	
accessed	 and	 searched	 for	 suitable	 studies.	 The	 journal	 Psycho	 Oncology,	 chosen	 for	 its	





January	 2004	 and	 June	 2014	 were	 included.	 Only	 papers	 published	 in	 English	 could	 be	
incorporated,	 as	 there	were	 no	 resources	 for	 translation.	 Published	 reviews	 of	 literature,	
expert	opinion,	or	best	practice	guidelines	were	also	not	included.	
Selection	of	studies	
Results	 from	 each	 of	 the	 database	 searches	 were	 downloaded	 into	 an	 Excel	 sheet	 and	

















































than	conceptual	clarity	and	 interpretation	of	 the	research.	Because	of	 this,	appraisal	 tools	
tend	to	over-emphasise	process	over	outcome.	With	this	in	mind,	I	used	the	appraisal	tools	




(CASP)	 tool,	 using	 ten	 questions	 to	 assess	 rigour	 of	 the	 overall	 research,	 selection	 of	
subjects,	data	collection	and	analysis	(CASP,	2013).	This	tool	has	been	recommended	in	the	
Cochrane	Systematic	Review	Handbook	(Hannes,	2011).	The	version	used	was	designed	to	
specifically	 assess	 the	 quality	 of	 in-depth	 interview	 and	 qualitative	 observational	 studies.	
However,	cross	sectional	survey	and	questionnaire	studies	were	also	included	in	this	review.	




There	 is	 currently	 a	 dearth	 of	 suitable	 appraisal	 tools	 to	 assess	 quality	 of	 questionnaire	
studies	for	inclusion	in	literature	reviews.	Boynton	and	Greenhalgh	(2004)	provide	a	critical	
appraisal	 checklist,	 but	 this	 is	 very	detailed	 and	 requires	 access	 to	 the	original	 surveys	or	
questionnaires	and	is	not	very	suitable	for	appraisal	of	published	papers.	Another	appraisal	
tool	 for	 questionnaires	 is	 published	 by	 the	 Center	 for	 Evidence	 Based	 Management	
(CEBMa),	but	 is	not	healthcare	specific	and	 limited	 in	 its	depth	 (CEBMa,	2014).	As	neither	
tool	provided	exactly	what	was	required	for	the	purpose	of	this	review,	I	felt	that	it	would	









published	 work	 and	 hence	 is	 open	 to	 publication	 bias	 (Aveyard,	 2010).	 It	 is	 also	
acknowledged	that	electronic	databases	are	not	good	at	retrieving	qualitative	papers	due	to	
poor	 indexing	 of	 qualitative	 terms	 and	 the	 elusive	 and	 complex	 nature	 of	 what	 is	 being	




Data	 were	 extracted	 from	 the	 studies	 using	 a	 form	 developed	 for	 use	 by	 Cochrane	
qualitative	 reviews	 (Glenton	 et	 al.,	 2013),	 which	 I	 adopted	 here	 with	 only	 minor	
modifications	(see	appendix	3).	I	then	coded	findings	from	within	the	results,	discussion	and	
conclusion	sections	of	the	papers,	and	these	were	emergent	from	the	studies.	Thomas	and	
Harden	 (2008)	 pointed	 out	 the	 importance	 of	 distinguishing	 between	 data,	 findings	 and	
interpretations	within	qualitative	published	reports.	I	checked	material	within	each	code	for	
consistency	and	coherence,	by	 reading	 through	 the	material	across	all	 the	studies.	Where	
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similarities	 and	differences	 can	be	explored.	 I	 developed	a	 framework	grid	 to	explore	 the	
translated	 findings,	 as	 described	 by	 Flemming	 (2010).	 Each	 paper	 included	 in	 the	 review	
formed	a	row	of	the	grid,	with	each	thematic	code	forming	a	column.	I	then	wrote	a	short	




papers.	 Reasons	 for	 divergent	 findings	 were	 accounted	 for	 where	 possible	 (Flemming,	
2010).	This	allowed	me	to	develop	synthesising	arguments	that	integrated	evidence	from	all	
the	papers	 to	 produce	new	 ideas	 that	went	 beyond	 the	 findings	 of	 the	 individual	 studies	
(Dixon-Woods,	Cavers,	et	al.,	2006).	At	 this	 level	of	analysis	 I	 incorporated	original	author	
interpretations	of	findings	within	the	reviewed	papers	 into	the	synthesis.	However,	Dixon-
Woods,	Cavers,	et	al.	(2006)	urge	caution	in	incorporating	such	interpretations	uncritically.	


































































al.,	 2012;	 Jansen	 et	 al.,	 2008),	 or	 used	 both	 strategies	 (Liu	 et	 al.,	 2014;	 Robinson	 et	 al.,	
2008).	 One	 study	 used	mixed-methods	 (Kelly	 et	 al.,	 2013).	 The	 remaining	 eleven	 studies	
used	 a	 qualitative	 methodology;	 including	 five	 interview	 studies	 (Curtis	 et	 al.,	 2008;	
Goldman	 et	 al.,	 2009;	 Lobb,	Halkett,	&	Nowak,	 2011;	Mitchison	 et	 al.,	 2012;	 Step	&	Ray,	
2011),	 two	 interview	and	 focus	 groups	 (Thorne	et	 al.,	 2006;	 Thorne,	Oglov,	Armstrong,	&	
Hislop,	 2007),	 two	 observations	 of	 medical	 consultations	 (Leydon,	 2008;	 Rodriguez,	
Gambino,	 Butow,	 Hagerty,	 &	 Arnold,	 2008),	 and	 two	 studies	 used	 multiple	 qualitative	














patients	 of	 mixed	 prognoses.	 Nine	 studies	 recruited	 patients	 in	 oncology	 out-patient	
settings,	 three	 in	 breast	 cancer	 units,	 and	 five	 in	 specialist	 haemato-oncology	 or	 surgical	






beyond	 ethical	 committee	 approval.	 None	 of	 the	 published	 accounts	 of	 the	 studies	
discussed	 the	 impact	 of	 the	 research	 on	 participants,	 despite	 the	 sensitive	 nature	 of	 the	
area.	 There	was	 limited	 researcher	 reflexivity	 evident	 in	 the	 qualitative	 studies,	 although	
this	 is	 common	 in	 published	 papers.	 Most	 of	 the	 studies	 provided	 good	 contextual	
information	 about	 the	 location	 and	 population.	 The	 papers	 by	 Thorne	 et	 al.	 (2006)	 and	
Thorne	et	al.	(2007)	provided	the	least	information	on	the	population	and	location,	due	to	
the	 amalgamation	 of	 multiple	 datasets,	 and	 diverse	 patient	 groups	 and	 settings.	
Descriptions	of	participant	sampling	were	variable.	Some	papers	gave	detailed	and	robust	
accounts	 of	 the	 process	 and	 had	 high	 response	 rates	 and	 accounted	 for	 non-responders,	
such	as	Franssen	et	al.	(2009)	and	Lagarde	et	al.	(2008).	Other	studies	gave	only	vague	and	






been	said	 in	 the	consultations	 (Goldman	et	al.,	2009).	Two	papers	employed	a	 theoretical	
model.	 Kelly	 et	 al	 (2013)	 used	 the	 self-regulation	 model	 (Leventhal,	 Kelly,	 &	 Leventhal,	
1999),	 and	 Step	 and	 Ray	 (2011)	 used	 Problematic	 Integration	 (Babrow,	 2001).	 In	 the	
quantitative	papers	 a	 variety	of	 validated	and	non-validated	 tools	were	employed,	 raising	
some	questions	regarding	their	validity	or	suitability.	Low	response	rates	in	some	questions	
in	 the	 study	by	Kelly	et	al.	 (2013)	were	 interpreted	as	a	 lack	of	knowledge	 in	 responders.	
However,	 no	 consideration	 was	 given	 to	 alternative	 explanations,	 such	 as	 patients’	
discomfort	in	answering	questions	about	prognosis.		
	
Conveying	 the	 process	 of	 data	 analysis	 and	 its	 rigour	 in	 qualitative	 research	 is	 often	 a	
problem	and	was	variable	across	the	papers.	Notably	the	papers	by	Mendick	and	colleagues	
demonstrated	a	high	level	of	rigour	by	their	explanation	of	the	codes,	testing	of	alternative	
thematic	 formulations	 and	 examination	 of	 divergent	 cases.	 Qualitative	 analysis	 methods	
within	 predominately	 questionnaire	 studies	 that	 included	 some	 free	 text	 response	
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et	al.,	 2013).	Presentation	of	 the	quantitative	data	varied	 in	quality.	 Some	papers	did	not	
clearly	 present	 all	 relevant	 data,	 and	 others	 provided	 only	 limited	 statistical	 analysis.	 For	
example,	 Kelly	 et	 al.	 (2013)	 gave	 no	 data	 in	 tables,	 making	 reading	 and	 interpretation	
difficult.	 Some	 studies	 identified	 statistically	 significant	 associations	 using	 correlation	




The	 review	 and	 its	 findings	 have	 been	 published	 (Johnson,	M.,	 Tod,	 Brummell,	 &	 Collins,	
2015).	An	overview	of	the	themes,	subthemes	and	the	constructs	identified	from	within	the	
papers	 are	 given	 in	 table	 3.2.	 A	 thematic	 framework	 was	 developed	 as	 a	 result	 of	 the	




combine	 these	 with	 those	 from	 the	 relevant	 papers	 included	 in	 the	 review	 by	 Hagerty,	
Butow,	 Ellis,	 Dimitry,	 and	 Tattersall	 (2005).	 This	 necessarily	 personal	 analysis	 of	 the	 large	
body	of	diverse	literature	around	prognostic	communication	identified	in	these	two	reviews	




Theme grouping Theme Constructs 
Diagnostic and 
prognostic factors 
The nature of prognostic 
information 
 
Provision of prognostic 
information 
Scope of prognostic information 
Spectrum of prognostic information 
Qualitative and quantitative prognoses 
Framing of information 
Format of information 
Disease factors Temporal / cancer trajectory 
Disease uncertainty 
Patient factors Patient desire for 
prognostic information 
Patient need for full prognostic disclosure 
Patient desire for a realistic approach 
Patient desire for optimistic approach 
Patient need for personalised information 
Significance of numerical information for patients 
Patient need to maintain a 
sense of hope 
Patients strive to maintain a sense of hope 
Patient avoidance of negative news 
Patient re-framing of negative news 
“Beating the odds” 
Statistics do not reflect individuals 
“Doctors get it wrong” 
Patient need to balance 
hope with prognostic 
information 
Avoiding “too much” information 
Information seeking paradox 
Ways patients balance hope and prognostic 
information 
Effect of professional communication on hope 
Individual patient factors 
 
Patients are individuals 
Patient anxiety 
Patient understanding of prognostic information 







Willingness to discuss prognostic information 
Desire to give hope preserving information 
Communication ethos Helpful and unhelpful communication strategies 
Clinician experience 
Communication guidelines in relation to 
prognostic disclosure 






Studies	 reflected	 the	wide	 range	 of	what	 constitutes	 prognostic	 information.	 Distinctions	
were	 made	 between	 information	 provided	 about	 whether	 or	 not	 the	 disease	 is	 curable,	
information	 given	 in	 numerical	 (quantitatively)	 or	 in	 verbal	 form	 (qualitatively),	 or	
information	 transmitted	 in	 less	 explicit	 form	 (Alexander	 et	 al.,	 2012).	 Indications	 about	
prognosis	can	be	given	to	patients	by	such	things	as	investigation	results,	tone	of	voice,	or	
body	 language	 (Alexander	et	 al.,	 2012;	Goldman	et	 al.,	 2009;	Gordon	&	Daugherty,	 2003;	
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Mendick	 et	 al.,	 2013;	 Thorne	 et	 al.,	 2007).	 Rodriguez	 et	 al.	 (2008)	 analysed	 recorded	
oncology	consultations	and	identified	how	the	way	in	which	information	is	framed	can	also	
influence	 the	 prognostic	 message	 delivered.	 Examples	 included	 discussing	 prognosis	 in	
terms	of	chance	of	death,	as	opposed	to	chance	of	cure,	as	well	as	presenting	information	in	
direct	 relation	 to	 the	 patient	 concerned	 (e.g.	 patients	 like	 you),	 or	 in	 relation	 to	 a	wider	
group	of	 less	 specific	patients	 (e.g.	 patients	with	 lung	 cancer).	Analysis	of	 second	opinion	
haemato-oncology	 consultations	 indicated	 that	 prognostic	 information	 might	 be	 given	 in	
several	 different	 forms	 during	 consultations	 (Alexander	 et	 al.,	 2012).	 Leydon	 (2008)	
analysed	 oncology	 consultations	 and	 identified	 how	 pairing	 bad	 news	 followed	 by	 more	
positive	information	could	significantly	soften	and	alter	the	message	that	patients	hear.		
Provision	of	prognostic	information	
Studies	 using	 observation	 of	 consultations,	 as	 well	 as	 reports	 from	 patients	 and	
professionals,	 indicated	 variability	 in	 whether	 or	 not	 patients	 were	 presented	 with	
prognostic	 information.	 Some	 studies	 suggested	 prognostic	 information	 was	 largely	 not	
discussed	 (Schofield	 et	 al.,	 2001;	 Sell	 et	 al.,	 1993),	while	 others	 indicated	 communication	
about	 prognosis	 was	 common	 (Kelly	 et	 al.,	 2013;	 Leighl,	 Gattellari,	 Butow,	 Brown,	 &	
Tattersall,	2001;	Siminoff,	Ravdin,	Colabianchi,	&	Saunders	Sturm,	2000).	A	comprehensive	
observational	study	of	surgical	consultations	following	breast	cancer	surgery	by	Mendick	et	
al.	 (2013)	 indicated	 that	 surgeons	 presented	 information	 about	 prognosis	 in	 non-explicit	
ways.	 Statistical	 estimates	 of	 prognosis	 were	 not	 given,	 and	 categorical	 and	 comparative	
statements	 were	 used	 to	 convey	 prognosis.	 Information	 was	 given	 on	 a	 spectrum	 of	
explicitness,	 with	 the	 most	 explicit	 prognostic	 detail	 disclosed	 to	 patients	 with	 the	 best	
prognoses.	Such	findings	suggest	that	explicit	prognostic	discussions	are	not	universal,	even	
in	with	patients	with	early	stage	cancer.	Notably,	studies	where	prognostic	communication	
was	 routine,	 the	 setting	 was	 either	 breast	 cancer,	 or	 consultations	 where	 adjuvant	
chemotherapy	 was	 discussed.	 This	 is,	 perhaps,	 unsurprising.	 Adjuvant	 treatment	 aims	 to	
reduce	 the	 risk	of	dying	 from	the	cancer	 following	complete	 surgical	excision.	 It	 is	 almost	





Across	 the	studies	 there	were	differences	 in	 the	way	prognosis	was	discussed	at	different	
points	along	the	cancer	pathway,	as	well	as	differences	related	to	type	of	cancer	diagnosis.	
Step	&	Ray	 (2011)	 used	 patient	 interviews	 to	 retrospectively	 recall	 the	 differences	 in	 the	
way	prognosis	was	discussed	with	patients	at	the	end	of	curative	treatment	and	when	they	






The	 availability	 of	 reliable	 prognostic	 information	 from	 population	 statistics	 also	 differed	
across	 cancer	 diagnoses.	 Prognostic	 information	 was	 readily	 available	 for	 common	
conditions,	such	as	breast	cancer.	Kelly	et	al.	(2013)	used	an	on-line	prognosis	calculator	in	






Studies	were	 consistent	 in	 recognising	 that	 patients	 have	 individual	 needs	 for	 prognostic	
information.	Several	studies	used	surveys	to	determine	the	proportion	of	patients	who	want	
to	be	given	prognostic	 information.	Most	of	 the	 tools	used	had	been	developed	 from	the	
Information	Styles	Questionnaire	(Cassileth	et	al.,	1980).	More	recently,	similar	approaches	
have	 produced	 remarkably	 consistent	 results	 (Cox,	 A.	 et	 al.,	 2006;	 Franssen	 et	 al.,	 2009;	
Hagerty	 et	 al.,	 2004;	 Jenkins	 et	 al.,	 2001;	 Lagarde	 et	 al.,	 2008;	 Lobb,	 Kenny,	 Butow,	 &	
Tattersall,	2001).	These	surveys	indicate	that	an	overwhelming	majority	of	patients	wanted	
to	 be	 given	 all	 available	 information	 about	 their	 condition,	 both	 good	 and	 bad,	 and	























Lobb,	 et	 al.,	 2005;	 Lagarde	 et	 al.,	 2008).	 Presentation	 of	 numerical	 information	 about	
prognosis	 appeared	 to	 have	 a	 particularly	 strong	 significance	 for	many	 patients.	 Findings	
from	 interview	 studies	 indicated	 how	 patients	 who	 were	 given	 statistics	 about	 their	
prognosis	found	these	numbers	could	dominate	their	thinking	and	stay	with	them	for	a	long	
time	(Step	&	Ray,	2011;	Thorne	et	al.,	2006).	Where	patients	perceived	odds	as	favourable,	
patients	 reported	 they	 found	 this	 information	 helpful.	 Where	 statistics	 were	 felt	 to	 be	
negative,	 this	could	be	particularly	difficult	 to	absorb	and	cope	with	 (Thorne	et	al.,	2006).	
Some	 patients	 also	 felt	 that	 doctors	 could	 use	 statistics	 in	 a	 coercive	 manner	 to	 steer	
patients,	 who	 might	 be	 reluctant,	 towards	 a	 particular	 treatment	 choice	 (Thorne	 et	 al.,	
2006).		
Patients’	need	to	maintain	a	sense	of	hope	
The	 central	 importance	 for	 patients	 with	 cancer	 of	 maintaining	 a	 sense	 of	 hope	 is	 well	
reported	 (Friis	 et	 al.,	 2003;	 Hagerty,	 Butow,	 Ellis,	 Lobb,	 et	 al.,	 2005;	 Koopmeiners	 et	 al.,	
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1997;	 Leydon	 et	 al.,	 2000;	 Lobb	 et	 al.,	 2011;	Mendick	 et	 al.,	 2013;	 Sardell	 &	 Trierweiler,	
1993;	Thorne	et	al.,	2007).	Findings	from	patient	interviews	indicated	how	patients	seek	out	










prognostic	 information.	 While	 it	 could	 have	 practical	 and	 psychologically	 useful	 aspects,	
prognostic	 information	 also	 had	 the	 ability	 to	 increase	 levels	 of	 anxiety.	 Some	 patients	
reported	 actively	 trying	 to	 limit	 prognostic	 information	 (Butow,	 Dowsett,	 Hagerty,	 &	
Tattersall,	 2002).	 Other	 studies	 indicated	 some	 patients	 might	 continue	 to	 seek	 further	
details	in	an	effort	to	bolster	hope	and	reduce	feelings	of	uncertainty	(Thorne	et	al.,	2006;	




Although	 many	 studies	 identified	 patients	 wanted	 honest	 information	 that	 reflected	 the	
realities	 of	 their	 clinical	 situation	 whilst	 also	 wanting	 information	 that	 was	 hopeful	 or	
optimistic,	fewer	studies	explored	the	tension	that	this	implied	(Curtis	et	al.,	2008;	Mendick	
et	 al.,	 2011;	 Mendick	 et	 al.,	 2013;	 Step	 &	 Ray,	 2011;	 Thorne	 et	 al.,	 2007).	 In	 their	
comprehensive	and	multi	perspectival	study	using	patient	and	surgeon	interviews,	coupled	
with	 observation	 of	 consultations,	 Mendick	 et	 al.	 (2011;	 2013)	 found	 that	 participants	
carefully	controlled	the	amount	and	detail	of	information	that	was	given.	Although	surgeons	
and	patients	 talked	about	 the	 importance	of	honesty	and	giving	all	 information,	 surgeons	











identified	 a	 range	of	ways	 patients	 attempted	 to	 integrate	 honesty	 about	 their	 prognosis	
with	 hope.	 The	 researchers	 concluded	 that	 simply	 asking	 patients	what	 information	 they	
wanted	 was	 unlikely	 to	 elicit	 their	 true	 requirements.	 Therefore	 clinicians	 need	 to	
understand	 individual	 patients’	 information	 and	 coping	 strategies	 in	 order	 to	 provide	 the	
right	balance	of	information.	Findings	from	several	studies	indicated	patients	reported	that	
being	 presented	 with	 prognostic	 information	 in	 a	 manner	 that	 was	 too	 direct	 could	 be	
interpreted	as	brutal	 and	damaging	 to	hope	 (Koopmeiners	et	al.,	 1997;	 Lobb	et	al.,	 2011;	
Thorne	et	al.,	2007).		
Individual	patient	factors	
A	number	of	 studies	have	 tried	 to	 identify	patient	characteristics	 in	 relation	 to	prognostic	
information	requirements	(Franssen	et	al.,	2009;	Hagerty	et	al.,	2004;	Jansen	et	al.,	2008).	
Attempts	 to	 link	 these	 to	 socio-demographic	 factors	 have	 not	 provided	 any	 strong	
correlations.	Fear	of	 recurrence	and	general	anxiety	appeared	to	have	an	effect	on	desire	













first	 meeting,	 such	 as	 during	 second	 opinion	 haematology	 consultations,	 establishing	 a	
rapport	 and	 demonstrating	 understanding	 of	 the	 patient’s	 problems	 immediately	 was	
essential	 (Goldman	 et	 al.,	 2009).	 Factors	 that	 helped	 establish	 good	 clinician-patient	
relationships	 included	skilled	communication	and	demonstrating	respect	and	care	towards	




Findings	 from	 a	 questionnaire	 study	 of	 physicians	 by	 Liu	 et	 al.	 (2014)	 found	 differences	
between	 individual	 clinicians’	 reported	 willingness	 to	 discuss	 prognosis	 in	 the	 advanced	
disease	 setting.	 Doctors	 with	 more	 exposure	 to	 caring	 for	 patients	 at	 the	 end	 of	 life	
appeared	to	be	more	willing	to	initiate	discussions	about	prognosis.	Interviews	studies	with	
clinicians	indicated	they	wanted	to	give	patients	honest	and	realistic	information	about	their	
condition	 (Butow	 et	 al.,	 2002;	 Mendick	 et	 al.,	 2011).	 In	 particular	 they	 wanted	 to	 give	
information	that	would	help	to	support	hope	in	their	patients.	Interview	findings	with	breast	
cancer	 surgeons	 in	 the	 study	 by	Mendick	 et	 al.	 (2013)	 indicated	 they	wanted	 patients	 to	





often	 adopt	 a	 paternalistic	 stance	 when	 deciding	 when	 and	 how	 much	 information	 to	
disclose	 about	 prognosis	 with	 patients	 in	 early	 stage	 clinical	 trials	 in	 an	 effort	 to	 help	






professionals.	Additionally,	 Step	and	Ray	 (2011)	 identified	how	meanings	might	 shift	 over	
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time	 and	 with	 changing	 clinical	 condition.	 Patients	 appeared	 to	 struggle	 to	 understand	
common	terms	used	by	medical	teams	around	prognosis,	such	as	overall	survival,	or	median	
survival	 times	 (Davey	 et	 al.,	 2003;	 Lobb,	 Butow,	 Kenny,	&	 Tattersall,	 1999).	 Thorne	 et	 al.	
(2007)	argued	that	where	there	was	a	mismatch	between	the	information	patients	felt	they	
needed	 and	 the	 manner	 and	 content	 delivered	 by	 professionals,	 patients	 frequently	
perceived	it	as	unhelpful	communication	(Thorne	et	al.,	2007).	
3.2.7 Synthesis	of	evidence	to	2014	
Across	 this	 large	body	of	 literature	 there	were	 four	key	 issues	 that	were	significant	 to	my	




clinician–patient	 relationship.	 Professionals	 differ	 in	 their	 communication	 ethos	 and	 their	
individual	willingness	to	disclose	prognostic	information	to	patients.	Some	differences	may	
be	due	to	disciplinary	role	and	clinical	experience,	especially	exposure	to	patients	receiving	
end	 of	 life	 care.	 Similarly	 patients	 have	 individual	 preferences	 for	 prognostic	 information	
and	 subject	 to	 distinct	 clinical,	 emotional	 and	 social	 situations.	 Ultimately,	 desire	 for	
prognostic	information	appears	individual	and	circumstantial.		
	
The	 third	 factor	 is	 supporting	hope.	Both	patients	 and	professionals	 appeared	 to	want	 to	
support	patients’	own	sense	of	hope.	They	attempt	to	achieve	this	by	careful	management	
of	 information	 and	 how	 it	 is	 exchanged.	 Communication	 strategies	 around	 prognosis	 are	
complex.	 Professionals	 may	 discuss	 prognostic	 information	 in	 a	 spectrum	 of	 different	
formats.	 The	 explicitness	 of	 the	 information	 can	 be	 used	 in	 varieties	 of	 ways	 to	 convey	
subtly	 different	 messages.	 Patients	 use	 numerous	 strategies	 to	 help	 them	 manage	 the	
information	they	do	receive	if	it	does	not	match	their	needs	in	terms	of	maintaining	hope.	
Examples	 include	 re-framing	 information,	 re-appraisal,	 changing	 goals,	 or	 seeking	 further	





The	 final	 and	 related	 area	 was	 managing	 uncertainty	 and	 making	 sense	 of	 likely	 future	
events.	 Undoubtedly	 many	 patients	 need	 prognostic	 information	 for	 decision-making,	
planning,	 or	 to	 help	 make	 sense	 of	 their	 situation.	 Circumstances	 and	 personality	
differences	affect	the	type	and	amount	of	information	required.	Uncertainty	and	ambiguity	












there	 had	 been	 significant	 new	 findings	 around	 prognostic	 communication	 in	 the	




new	 research	 in	 the	 field.	 I	 did	 not	 want	 to	 expand,	 or	 refine	 the	 review	 criteria.	 The	























Studies	 were	 conducted	 in	 USA,	 The	 Netherlands,	 UK	 and	 Canada.	 One	 published	 paper	
involved	a	large-scale	postal	questionnaire	study	analysed	quantitatively	(Janz	et	al.,	2017).	







Judson,	 &	 Koffman,	 2015),	 and	 one	 used	 in-depth	 interviews	with	 patients	 and	 surgeons	
(Blakely,	 Karanicolas,	 Wright,	 &	 Conn,	 2017).	 One	 study	 used	 patient	 focus	 groups	







al.,	 2017;	 Janz	 et	 al.,	 2017).	 Others	 included	 patients	 with	 surgically	 treated	 pancreatic	
cancer	(Blakely	et	al.,	2017),	head	and	neck	cancer	at	varying	disease	stages	(Dronkers	et	al.,	
2018),	advanced	stage	lung	cancer	(Singh	et	al.,	2017),	and	soft	tissue	sarcoma	being	treated	
palliatively	 (Gough	 et	 al.,	 2015).	 The	 four	 remaining	 studies	 included	 patients	 with	
heterogeneous	cancers	with	a	range	of	disease	stages	(Cartwright	et	al.,	2014;	Furber	et	al.,	
2015),	 or	 with	 advanced	 cancers	 (Chou	 et	 al.,	 2017;	 Henselmans	 et	 al.,	 2017).	 With	 the	












The	quality	of	 the	 studies	varied.	 In	 the	 focus	group	study	by	Cartwright	et	al.	 (2014)	 the	
rationale	 for	 the	 choice	of	methodology	was	not	made	clear,	 and	 the	 report	 appeared	 to	
suggest	 considerable	 norming	 of	 views	 during	 the	 focus	 groups.	 There	 was	 a	 lack	 of	
information	about	the	participants	and	their	 illness	backgrounds.	 In	the	study	by	Dronkers	
et	al.	 (2018)	analysis	of	qualitative	data	was	 limited	 in	 its	depth	and	 included	quantitative	
analysis	 of	 the	 frequency	 of	 the	 different	 forms	 of	 prognostic	 information	 used	 in	
consultations,	despite	the	small	number	of	patient	participants	suitable	for	qualitative	data	
analysis.	 Most	 studies	 were	 based	 on	 only	 a	 single	 source	 of	 data,	 such	 as	 only	 patient	
interviews,	 or	 recorded	 consultations.	 Blakely	 et	 al.	 (2017)	 used	 interviews	 with	 both	
patients	and	surgeons,	which	added	to	the	breadth	of	insight.	However,	this	was	limited	by	
a	 lack	 of	 direct	 clinical	 link	 between	 participants	 and	 no	 comparison	 to	 observed	 clinical	
practice,	which	 prevented	 a	 deeper	 analysis	 being	 presented.	 The	 studies	 by	 Singh	 et	 al.	

















between	 settings	 and	 teams.	 In	 the	 survey	 of	 breast	 cancer	 patients’	 perceptions	 of	
recurrence	risk	communication	they	had	had	with	their	doctor,	Janz	et	al.	(2017)	found	that	
most	respondents	felt	they	had	discussed	recurrence	risk,	with	the	majority	recalling	doing	
so	 using	 words	 and	 numbers.	 In	 contrast,	 studies	 of	 patients	 with	 advanced	 cancers	
suggested	 that	 doctors	 rarely	 initiated	 explicit	 discussions	 about	 prognosis.	 In-depth	










2015).	 Similarly,	 during	 observed	 consultations	with	 patients	with	 head	 and	 neck	 cancer,	
clinicians	 used	 variable	 or	 unknown	 responses	 to	 treatment	 as	 reasons	 not	 to	 talk	 about	
prognosis	 in	 detail	 (Dronkers	 et	 al.,	 2018).	 Engelhardt	 et	 al.	 (2017)	 found	 during	 initial	
consultations	 about	 adjuvant	 chemotherapy	 with	 breast	 cancer	 patients,	 oncologists	
frequently	discussed	the	inability	to	predict	an	individual’s	future	outcome	from	population	
statistics	 (aleatory	 uncertainty).	 In	 contrast	 uncertainty	 around	 the	 data	 itself	 (epistemic	
uncertainty)	was	 not	 discussed.	 Oncologists	 in	 consultations	with	 patients	with	 advanced	
common	 cancers	 often	 emphasised	 the	 uncertain	 and	 imprecise	 nature	 of	 prognostic	
statistics	(Henselmans	et	al.,	2017).	Some	patients	participating	in	focus	groups	questioned	




understand	 the	 concept	 of	 uncertainty	 in	 risk	 estimates	 and	 Englehardt	 et	 al.	 (2017)	




Evidence	 from	 these	 recent	 studies	 has	 added	 to	 the	 understanding	 of	 the	 variability	
between	 individuals	 regarding	 requirements	 for	 prognostic	 information.	 Some	 patients	
conceived	 prognosis	 as	 being	 wholly	 negative,	 associated	 with	 death,	 and	 as	 an	 “expiry	
date”	(Cartwright	et	al.,	2014;	Gough	et	al.,	2015).	Other	patients	wanted	to	have	prognostic	
information	 to	 help	 with	 planning	 and	 treatment	 decision-making	 (Blakely	 et	 al.,	 2017;	
Cartwright	et	al.,	2014;	Gough	et	al.,	2015).	However,	findings	from	an	interview	study	with	
patients	 following	 their	 initial	 consultation	 with	 an	 oncologist	 described	 a	 much	 more	
complex	 and	 ambivalent	 desire	 for	 prognostic	 information	 (Furber	 et	 al.,	 2015).	 Patients	
reported	that	they	did	not	want	information	if	it	would	increase	their	anxiety.	Nevertheless,	
they	also	wanted	 information	 if	 it	 could	help	 them	make	 informed	decisions.	The	authors	
described	 patients	 holding	 a	 tension	 between	 “wanting	 to	 know”	 and	 “not	 wanting	 to	
know”	 prognostic	 information.	 They	 argued	 that	 the	 balance	 of	 this	 tension	 would	
necessarily	 change	with	 time	and	altered	circumstances.	However,	 Furber	and	colleagues’	
study	was	a	cross	sectional	design	and	changes	over	time	remain	speculation	on	their	part.	
They	 also	 proposed	 that	 family	 members’	 information	 needs	 would	 also	 modify	 the	
dynamics	of	this	balance.		
Patient	understanding	
Furber	et	al.	 (2015)	 interpreted	patients	as	having	multiple	understandings	of	 their	 illness	
and	 prognosis	 during	 the	 same	 consultation	 and	 interview.	 The	 authors	 related	 these	
ambivalent	 and	 multiple	 understandings	 to	 the	 theoretical	 framework	 of	 awareness	










afterwards	 in	 their	 interviews.	 Information	 that	was	 felt	 to	be	overly	pessimistic	might	be	
rejected.	Patients	who	were	given	prognostic	estimates	sometimes	saw	this	as	a	challenge	
and	 frequently	 aimed	 to	 exceed	 these	 estimates	 (Furber	 et	 al.,	 2015).	 Evidence	 from	 the	
focus	group	 studies	by	Cartwright	et	al.	 (2014)	 indicated	 that	patients	who	had	exceeded	
estimates	could	take	great	pride	 in	“beating	the	odds”.	Patients	with	advanced	soft	 tissue	
sarcomas,	who	were	told	they	had	a	poor	prognosis,	but	nonetheless	felt	well,	reported	that	
they	 found	 this	 particularly	 distressing	 and	 some	 discounted	 this	 information	 entirely	
(Gough	 et	 al.,	 2015).	 Patients	 carefully	 tried	 to	 avoid	 information	 that	 challenged	 their	
positive	outlook.	A	small	number	of	patients	 in	this	study	explicitly	talked	about	this	as	an	





reported	directly	on	clinicians’	views.	During	 interviews	 for	 this	 study,	 surgeons	caring	 for	
patients	 with	 pancreatic	 cancer	 all	 emphasised	 the	 importance	 of	 maintaining	 patients’	
hope	and	providing	a	sense	of	positivity	in	their	approach.	Surgeons	characterised	hope	as	
particularly	 important	 in	 helping	 patients	 to	 undergo	 or	 to	 continue	 with	 difficult	
treatments,	 sometimes	with	marginal	 benefits.	 There	was	 a	 tension	between	maintaining	
the	 hopeful	 stance	 and	 providing	 honest	 information	when	 the	 prognosis	 was	 not	 good.	
While	 they	 wanted	 to	 maintain	 honesty,	 they	 spoke	 about	 limiting	 negative	 news	 in	 an	







Surgeons	 in	 the	 study	by	Blakely	 et	 al.	 (2017)	 spoke	 about	 recognising	 the	 challenges	 for	
patients	in	understanding	highly	complex	information	about	their	condition.	Some	surgeons	
wanted	 to	 take	 time	 to	 explain	 and	 personalise	 information	 and	 respect	 patients’	 limits,	
while	 others	 described	 themselves	 as	 needing	 to	 take	 a	 paternalistic	 approach	 to	
information	giving.	Patients	in	the	same	study	indicated	that	they	valued	professionals	who	
appeared	caring,	gave	honest,	comprehensible	messages	that	supported	hope.	Developing	
trust	 in	 the	 professionals	 was	 important	 in	 facilitating	 communication.	 Findings	 from	 the	
patient	 focus	 group	 study	 by	 Cartwright	 et	 al.	 (2014)	 indicted	 that	 clinicians	 who	 gave	
prognostic	 information	when	 it	was	not	expected,	or	not	asked	 for,	were	considered	“un-
compassionate”	 and	 not	 to	 be	 acting	 as	 champions	 for	 their	 patients	 (Cartwright	 et	 al.,	
2014).	
Shared	understanding	
Several	 studies	 indicated	 that	 patients	 were	 largely	 satisfied	 with	 their	 level	 of	
understanding	 (Cartwright	et	 al.,	 2014;	 Furber	et	 al.,	 2015;	Gough	et	al.,	 2015).	However,	
patients	reported	that	they	were	aware	that	clinicians	might	limit	discussion	of	prognosis	in	
order	to	maintain	patient	optimism	(Blakely	et	al.,	2017;	Cartwright	et	al.,	2014;	Gough	et	
al.,	 2015).	 Chou	 et	 al.	 (2017)	 analysed	 oncologists’	 language	 during	 consultations	 with	
patients	 with	 advanced	 cancer.	 Prognostic	 information	 was	 often	 discussed	 using	
ambiguous	 and	 vague	 terms,	 which	 the	 authors	 proposed	 was	 likely	 to	 impair	 patients’	
understanding	of	their	situation.	Interviews	with	patients	in	the	study	by	Furber	et	al.	(2015)	
indicated	patients	often	 felt	muddled	about	 the	 information	 they	had	been	given.	Several	
patients	described	their	condition	and	prognosis	 in	broad,	 lay	terms	during	 interviews	and	
avoided	using	explicit	language.	Many	talked	about	prognosis	in	optimistic	terms,	and	might	
give	accounts	with	differing	 levels	of	understanding	 in	 the	 course	of	 the	 interview,	which	
significantly	differed	 from	 information	 that	 they	had	been	given	during	consultations.	The	
authors	 also	 suggested	 that	 some	 patients	 might	 avoid	 directly	 engaging	 with	 the	
information	 given	 in	 consultations	 in	 order	 to	 protect	 themselves.	 Furber	 et	 al.	 (2017)	





Singh	 et	 al.	 (2017)	 used	 Conversation	 Analysis	 to	 interpret	 consultations	 between	
oncologists	 and	 patients	 with	 advanced	 lung	 cancer.	 The	 authors	 argued	 that	 the	
consultations	 were	 seen	 to	 be	 co-constructed	 by	 professionals	 and	 patients,	 but	 were	
disproportionately	controlled	by	professionals.	Most	consultations	conformed	to	a	common	
flow,	which	 the	authors	considered	to	be	 instrumental	 in	controlling	 information	delivery.	
Explicit	 discussions	 about	 prognosis,	 usually	 initiated	 by	 patients,	 took	 place	 in	 only	 a	
minority	 of	 the	 analysed	 consultations.	 Oncologists	 tended	 to	 spend	 comparatively	 little	
time	 discussing	 test	 results	 and	 to	move	 on	 quickly	 to	 talking	 about	 treatment.	 This	was	
more	pronounced	when	test	results	were	bad.	Where	prognostic	discussions	took	place	this	
usually	occurred	at	this	 transition	between	discussing	results	and	treatment.	Professionals	
used	 a	 number	 of	 linguistic	 techniques	 to	 facilitate	 this	 transition,	 which	 were	 more	
commonly	 used	 where	 the	 results	 indicated	 stable	 or	 bad	 news	 than	 in	 good	 news	
situations.	 Chou	 et	 al.	 (2017),	 in	 their	 Discourse	 Analysis	 of	 consultations	 between	
oncologists	and	patients	with	advanced	cancer,	also	found	prognostic	discussions	were	brief	
and	 moved	 quickly	 into	 discussion	 about	 the	 urgency	 and	 practicalities	 of	 treatment.	
Henselmans	 et	 al.	 (2017)	 also	 examined	 consultations	 about	 palliative	 chemotherapy.	





The	 updated	 literature	 review	 identified	 ten	 further	 papers	 that	 build	 on	 the	 knowledge	
available	at	the	inception	of	this	current	project.	The	predominance	of	qualitative	studies	in	
this	 latest	 review	 has	 helped	 to	 strengthen	 the	 idea	 that	 patients’	 requirement	 for	
prognostic	 information	 is	 not	 a	 straightforward	matter	 of	more	 information	 is	 better	 and	
has	added	to	the	understanding	of	the	complexities	of	prognostic	communication	and	the	







As	 has	 been	 demonstrated	 in	 this	 review,	 prognostic	 communication	 in	 cancer	 care	 is	 an	
area	 that	has	been	 the	subject	of	much	research	activity.	However,	 the	complexity	of	 the	
subject,	 including	the	multiple	scenarios	 in	which	such	communication	takes	place,	means	
that	 there	 remain	 many	 unanswered	 questions.	 Findings	 suggest	 that	 patients	 want	
prognostic	information	that	is	both	honest	and	presented	in	ways	that	support	hope.	Such	
aims	 at	 times	 inevitably	 can	 become	 irreconcilable.	 There	 remains	 a	 lack	 of	 evidence	
available	 to	 indicate	 how	 patients	 and	 professionals	 interact	 to	 manage	 this	 situation	 in	
practice,	and	to	what	extent	and	in	what	way	the	information	given	to	patients	 is	tailored	




with	 lung	 cancer	 and	 to	 date	 no	 studies	 have	 looked	 at	 prognostic	 communication	 with	
patients	with	 lung	 cancer	 treated	with	 surgery.	Many	 studies	have	 focused	on	prognostic	
information	practices	and	the	needs	of	patients	with	breast	cancer.	In	contrast	to	the	lung	
cancer	 setting,	 there	 is	 almost	 universal	 use	 of	 multi-modality	 treatment,	 online	 risk	




as	 well	 as	 issues	 of	 co-morbid	 disease,	 which	 may	 significantly	 alter	 patients’	 desire	 for	
prognostic	information	(Powell	et	al.,	2015).		
	
Studies	reviewed	have	 largely	adopted	a	cross	sectional	design,	aiming	to	gain	 insight	 into	
prognostic	communication	at	a	single	time	point.	One	study	specifically	designed	to	assess	
change	 in	 prognosis	 communication	 used	 a	 recall	 design,	 with	 all	 its	 methodological	
shortcomings	(Step	&	Ray,	2011).	Although	studies	have	indicated	that	patients	information	
needs	 about	 prognosis	 are	 fluid,	 there	 is	 very	 little	 research	 evidence	 that	 indicates	 how	
these	 needs	 change	 over	 time	 in	 relation	 to	 recovery,	 potential	 recurrence	 and	 life	 after	













the	 team	 wanted	 to	 understand	 what	 information	 was	 given	 to	 patients	 during	
consultations,	what	influenced	the	surgeon	regarding	information	giving,	what	information	
the	patients	wanted	to	have	and	to	explore	the	convergence	or	divergence	between	them.	
The	 findings	 were	 based	 on	 multi	 perspectival	 data	 drawn	 from	 observation	 of	
consultations,	 linked	 to	 in-depth	 interviews	with	 the	 surgeons	 and	patients	 involved.	 This	
research	was	particularly	influential	when	it	came	to	designing	my	own	research	approach,	
due	to	the	complex	multi	perspectival	and	nuanced	insights	it	provided	of	the	consultations.	
Presenting	 findings	 from	 all	 data	 sources	 linked	 to	 a	 specific	 patient	 and	 their	 surgeon	
helped	to	keep	the	context	of	 the	 interaction	visible.	Simultaneously,	having	the	ability	 to	
explore	cases	from	the	point	of	view	of	a	particular	data	type	also	gave	the	flexibility	to	give	




At	 the	 time	 of	 completing	 the	 review	 in	 2014,	 there	 was	 a	 large	 and	 complex	 literature	
about	 prognostic	 communication	 in	 both	 the	 early	 stage	 disease	 and	 advanced	 cancer	
patients	 (Hagerty,	 Butow,	 Ellis,	 Dimitry,	 &	 Tattersall,	 2005;	 Johnson,	M.	 et	 al.	 2015).	 The	
evidence	can	be	broadly	summarised:	











The	 latest	 review,	 in	 many	 ways,	 corroborates	 and	 strengthens	 most	 of	 the	 previous	
findings.	However,	further	insight	has	been	gained	around	the	complexity	of	patient	desire	


























current	knowledge	and	highlighted	areas	 for	 further	 research,	but	also	helped	 to	 indicate	
fruitful	 methodological	 approaches	 to	 studying	 prognostic	 communication	 in	 clinical	
situations.	 This	 chapter	 builds	 on	 this	 knowledge	 and	 sets	 out	 the	 methodological	






cases	 for	 the	 study.	 The	 study	method	will	 then	be	presented,	 including	ethical	 approval,	
participant	anonymity,	data	collection	and	recruitment.	Following	this	there	is	a	discussion	





Initial	 research	aims	were	 identified	at	 the	outset	of	 the	project,	which	were	 refined	and	
developed	during	the	study.		
Study	aim	
The	 aim	 of	 the	 research	 is	 to	 gain	 an	 in-depth	 understanding	 of	 the	 communication	 of	





1. To	 explore,	 using	 case	 study	 methodology,	 how	 a	 range	 of	 patients	 who	 have	




3. To	 explore	 how	 a	 range	 of	 health	 professionals	 caring	 for	 these	 patients	





5. To	 identify	 the	 nature	 and	 delivery	 of	 communication	 about	 risk	 of	 recurrence	
between	 this	 group	 of	 patients	 and	 their	 associated	 professionals	 during	 post-
operative	surgical,	oncology	and	follow-up	consultations.	








the	 world	 -	 the	 basic	 beliefs	 about	 what	 makes	 up	 reality	 (Giacomini,	 2010).	 ‘Realist	
ontology’	assumes	that	there	is	an	objective	truth	that	can	be	discovered,	and	which	exists	
independently	 of	 people’s	 beliefs	 and	 understandings.	 However,	 subtle	 realist	 ontology	
maintains	that	this	external	reality	cannot	be	directly	measured	and	understood,	except	by	








how	this	knowledge	 is	obtained.	The	approach	chosen	 is	said	to	derive	naturally	 from	the	
ontological	 assumptions	 adopted	 (Giacomini,	 2010).	 I	 have	 assumed	 a	 ‘constructionist’	
epistemology	within	 this	 research:	 an	 approach	 seen	 to	 be	 compatible	with	 subtle	 realist	




both	 time	 and	 with	 individual	 circumstances	 or	 background.	 By	 studying	 the	 social	 and	
personal	 constructions	of	meaning	around	phenomena,	 research	knowledge	 is	 generated.	
However,	 another	 key	 factor	 in	 constructionist	 epistemology	 is	 the	 recognition	 that	 the	
research	 process	 itself	 also	 has	 an	 effect	 on	 the	 participants	 and	 the	 outcomes	 of	 the	
research.	 Therefore	being	aware	of	 this	 effect	 and	explicitly	 acknowledging	 the	 impact	of	
the	 researcher	 and	 the	 research	 process	 on	 participants	 by	 incorporating	 a	 reflexive	
element	 within	 the	 final	 report,	 is	 central	 to	 this	 research	 approach	 (Ormston,	 Spencer,	
Barnard,	&	Snape,	2014).		
Axiological	approach	
The	axiological	stance	of	 the	research	relates	 to	 the	values	of	 the	researcher	 that	provide	
the	 rationale	 for	 the	 philosophical	 stance.	 Clarifying	 the	 axiological	 approach	 allows	 the	
researcher	to	explicitly	position	his	or	herself	and	make	the	assumptions	clear	relative	to	the	
research	 (Creswell,	 2013).	 The	 choice	 of	 subtle	 realist	 ontology	 and	 constructionist	
epistemology	can	be	seen	to	match	well	with	the	aims	of	this	research,	which	seeks	to	take	
a	 multi	 perspectival	 approach	 to	 gaining	 an	 in-depth	 understanding	 of	 recurrence	 risk	
communication.	No	 one	 interpretation	 is	 taken	 as	 having	 greater	 validity	 than	 any	 other.	
The	 critical	 importance	 of	 hearing	 the	 interpretations	 of	 all	 participants	 from	 their	 own	





Studies	with	 the	 greatest	 influence	 on	my	 thinking	 about	 prognostic	 communication	 and	
methodological	 approaches	 reviewed	 in	 the	 last	 chapter	 largely	 adopted	 a	 similar	
philosophical	approach	(Mendick	et	al.,	2011;	2013;	Thorne	et	al.,	2006;	2007).	In	contrast,	
studies	that	adopt	pure	realist	ontology	and	‘positivist’	epistemology	that	values	objective	
assessment	 of	 an	 external	 reality	 tend	 to	 focus	 on	 incidence	 of	 phenomena,	 rather	 than	
experience	and	meaning	(Lincoln,	Lynham,	&	Guba,	2011;	Ormston	et	al.,	2014).	Examples	
of	studies	that	take	a	more	positive	approach	include	Cox,	A.	et	al.	(2006)	and	Jenkins	et	al.	
(2001).	 Such	 a	 stance	 is	 not	 aimed	 at	 elucidating	 how	 prognostic	 communication	 comes	
about,	nor	 is	 it	able	to	help	understand	why	communication	occurs	as	 it	does.	Both	these	
factors	 are	 central	 to	 my	 research	 aims.	 Some	 researchers	 go	 as	 far	 as	 to	 argue	 that	
adopting	a	positivist	approach	to	social	 inquiry	fails	to	recognise	the	“epistemic	fallacy”	of	
equating	our	 interpretations	and	sense	 impressions	of	 the	world	with	 true	 reality	 (House,	
1991).	Nevertheless,	the	opposing	ontological	position	of	‘idealism’	argues	that	there	is	no	
external	 reality	 to	 be	 uncovered,	 only	 individual	 constructions	 and	 perceptions	 of	 the	
external	world	(Blaikie,	2007;	Giacomini,	2010).	Many	research	approaches	using	an	idealist	
perspective	have	done	so	with	the	express	aim	of	empowering	people	to	overcome	adverse	
circumstances.	 Such	 a	 stance	 did	 not	match	 with	my	 own	 research	 approach,	 due	 to	 its	
exploratory	 aims	 to	 understand	 both	 patient	 and	 professional	 perspectives	 within	 the	




the	 epistemological	 approach	 (Ormston	 et	 al.,	 2014).	 Inductive	 logic	 uses	 data	 and	
observation	 to	 generate	 knowledge	 about	 the	 world,	 whereas	 deductive	 logic	 tests	 pre-
established	 hypotheses	 or	 theories	 using	 the	 data	 collected	 (Blaikie,	 2007).	 Although	 in	
theory	 these	 reflect	 two	 opposing	 epistemological	 approaches,	 and	 researchers	 tend	 to	
favour	 one	 approach	 or	 the	 other,	 all	 studies	 tend	 to	 have	 to	 use	 both	 approaches	 to	 a	
greater	 or	 lesser	 extent.	 Inductive	 logic	 grounds	 the	 research	 findings	 in	 the	 participants’	
world	 and	 allows	 emergent	 ideas	 and	 concepts	 to	 be	 developed.	 This	 approach	 ensures	
openness	to	new	findings	and	ideas,	and	avoids	being	blinded	by	preconceived	thinking	and	
theories.	 A	 deductive	 approach,	 on	 the	 other	 hand,	 is	 reflected	 in	 the	 use	 of	 existing	
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using	 participants’	 own	 understanding	 and	 description	 of	 events	 (known	 as	 first	 order	
constructs)	 to	 develop	 a	 technical	 account	 (known	 as	 second	 order	 constructs).	 Blaikie	
argues	 that	 much	 social	 life	 is	 routine	 and	 habitual,	 and	 happens	 on	 an	 automatic	 or	
unquestioning	 level.	 This	 means	 that	 participants	 are	 often	 not	 able	 to	 reveal	 their	
motivations	 and	 meanings	 that	 underpin	 their	 interactions	 directly.	 Abstraction	 allows	 a	
deeper	 exploration	 of	 lay	 accounts	 and	 understanding.	 Professionals’	 accounts	 can	 also	
provide	an	opportunity	to	gain	an	understanding	of	tacit	knowledge	involved	in	their	skilled	
habitual	actions	(Blaikie,	2007).	Abduction	can	therefore	be	seen	as	an	essential	process	in	
moving	 findings	 beyond	 description,	 to	 a	 higher	 level	 of	 analysis,	 abstraction	 and	 theory	
development.	
4.3.2 Case	study	research	
Taking	 my	 subtle	 realist	 ontology	 and	 constructionist	 epistemology	 positions,	 combined	
with	the	findings	from	the	literature,	I	chose	to	adopt	a	qualitative	case	study	design	in	this	
research.	 I	needed	 to	understand	 the	multiple	 realities	of	both	patients	with	 lung	cancer,	
and	 the	 professionals	 involved	 when	 discussing	 possible	 cancer	 recurrence	 following	





system	 or	 department,	 rather	 than	 individual	 interactions.	 A	 grounded	 theory	 approach	




(Anthony	&	 Jack,	 2009).	 The	 research	approach	has	 resonance	with	practicing	nurses	and	
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other	 healthcare	 professionals	 who	 wish	 to	 explore	 issues	 within	 the	 context	 of	 their	








There	 were	 two	 elements	 of	 this	 definition	 that	 had	 particular	 resonance	 with	 my	
investigation.	First	was	 investigating	prognostic	communication	 in	 its	“real-world”	context,	
in	 this	 situation,	 observed	 communication	 during	 clinical	 consultations.	 Second	 was	 the	
recognition	 that	 the	 boundaries	 between	 prognostic	 communication	 and	 the	 context	 in	





The	definition	of	 case	 study	 research	offered	by	 Yin	 is	 also	 reflective	of	 Stake’s	 approach	
(Stake	2013).	Both	emphasise	using	multiple	sources	of	evidence	as	the	basis	of	the	study,	
such	 as	 interviews,	 observations,	 and	 documents	 (Creswell,	 2013).	 Stake’s	 approach	 sits	
firmly	within	constructivist	epistemology,	and	is	explicitly	qualitative	in	its	approach	(Stake,	
1995;	 Stake,	2013).	On	 the	other	hand,	Yin	 concedes	 that	much	of	his	writing	about	 case	
studies	often	takes	a	more	positivist	line.	Despite	this,	Yin	argues	his	approach	is	capable	of	
embracing	 different	 epistemological	 orientations	 (Yin,	 2018).	 Commensurate	 with	 this	
‘broad-church’	approach	to	philosophical	traditions,	Yin	is	not	prescriptive	about	the	type	of	
evidence	that	might	be	used	in	a	case	study	and	identifies	both	qualitative	and	quantitative	
methods	 as	 suitable	 for	 inclusion.	 In	 this	 sense,	 Creswell	 (2013)	 views	 Yin’s	 case	 study	
approach	as	a	research	design,	 rather	than	a	research	method.	 In	contrast,	Stake	sets	out	
extensive	and	detailed	procedures	for	undertaking	and	analysing	a	case	study	(Stake,	2013).	







take	 a	multiple-case	 design.	 Yin	 describes	 the	 logic	 of	 a	multiple-case	 study	 as	 that	 of	 a	
series	 of	 experiments,	 in	which	 the	 researcher	 is	 attempting	 to	 replicate	 findings,	 or	 see	
divergent	results	for	reasons	that	can	be	anticipated	(Yin,	2018).	Central	to	the	case	study	
research	 approach	 is	 defining	what	 constitutes	 the	 case	 and	 its	 boundaries.	A	 case	 is	 not	
necessarily	 an	 individual,	 but	might	 be	 as	 diverse	 as	 a	 neighbourhood,	 an	 institution,	 an	
event,	or	a	decision	(Stake,	2013;	Yin,	2018).	Determining	the	boundaries	to	that	case	is	an	
essential,	and	often	challenging,	step	within	case	study	research.	The	less	concrete	the	case,	






recurrence	 risk	 -	 the	 unit	 of	 analysis	 is	 about	 how	 the	 data	 is	 organised,	 analysed	 and	
viewed.	 The	unit	 of	 analysis	 for	 this	 study	was	 taken	as	 the	 individual	 patient	 and	all	 the	
collected	data	around	that	patient.	An	alternative	option	might	have	been	to	take	the	unit	
of	analysis	as	the	lung	cancer	MDT.	This	would	focus	analysis	on	prognostic	communication	
with	 patients	 within	 each	MDT	 rather	 than	 at	 the	 individual	 patient	 level.	 Such	 research	
might	 then	be	more	 interested	 in	MDT	culture	and	practice,	 rather	 than	 interactions	on	a	
level	of	 individual	 clinicians	 and	patients.	 Each	of	 these	different	ways	of	 focusing	on	 the	
research	subject	is	valid,	but	the	choice	of	the	unit	of	analysis	alters	the	focus	of	the	study.	
Having	 the	unit	of	analysis	at	 the	patient	 level	within	a	multiple	case	study	design	directs	




change	 their	 focus.	 Stake	 described	 intrinsic	 and	 instrumental	 case	 studies	 (Stake,	 1995).	
Intrinsic	 case	 studies	 aim	 to	 understand	 the	 particular	 issues	within	 a	 case	 and	 are	 often	





about	 exploratory,	 descriptive	 and	 explanatory	 case	 studies	 (Yin,	 2018).	 Exploratory	 and	
descriptive	studies	tend	to	be	focused	on	the	particular,	whereas	explanatory	case	studies	














generalizability	 of	 case	 study	 research	 findings	 to	 a	 wider	 context	 lie	 at	 the	 heart	 of	
concerns	about	the	approach	and	is	a	methodological	conundrum.	Stake	identifies	a	tension	
between	 generalization	 and	 particularisation	 in	 all	 case	 study	 research	 (Stake,	 2013).	 He	
argues	 that	 careful	 framing	of	 research	questions	 that	prioritise	 the	wider	 applicability	 of	
the	 findings	and	the	relationship	 to	 theory	are	an	 important	element	of	 the	study	design.	
Similarly	Yin	also	places	theory	development	centrally	in	the	rationale	of	case	study	design	
and	 emphasises	 the	 role	 of	 analysis	 in	 this	 process	 (Yin,	 2018).	 For	 this	 to	 occur	 analysis	
needs	 to	 take	 place	 at	 a	 higher	 conceptual	 level	 than	 simple	 descriptive	 findings	 of	 the	
original	cases,	and	it	is	this	that	can	provide	findings	that	advance	theory	with	wider	general	











The	 initial	 steps	 of	 case	 study	 design	 include	 identifying	 the	 study	 questions,	 developing	
study	propositions,	or	issues,	and	defining	and	bounding	the	case.		
4.4.1 Study	questions	
Yin	 (2018)	 suggests	 that	 identifying	 ‘study	propositions’	 help	 to	 refine	 research	questions	




a	 specialist	 nurse	 working	 with	 patients	 with	 lung	 cancer,	 my	 insider	 knowledge	 of	 the	
processes,	access	and	understanding	of	where	to	look	for	information	was	invaluable	at	this	
point.	This	very	closeness	and	understanding	of	 the	 topic,	however,	also	makes	 it	easy	 to	





• Professionals	 from	 different	 disciplines	 will	 have	 distinct	 attitudes	 and	 beliefs	
regarding	disclosure	of	recurrence	risk	information	to	patients		
• Patients’	 understanding	 of	 recurrence	 risk	 following	 surgery	 will	 develop	 over	
time	after	their	surgery	
• Patients	 who	 are	 offered	 adjuvant	 chemotherapy	 will	 be	 given	 and/or	 seek	
information	about	recurrence	risk	to	aid	treatment	decision-making	
Following	completion	of	the	literature	review	early	in	the	research	process	I	was	able	to	use	
the	 thematic	 framework	 that	 was	 developed	 to	 help	 identify	 issues	 and	 research	
propositions	 and	 generate	 a	 range	 of	 preliminary	 study	 questions	 (Johnson,	 M.,	 Collins,	
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Both	 Stake	 (2013)	 and	 Yin	 (2018)	 discuss	 the	 importance	 of	 clarifying	 the	 boundaries	 of	
what	 constitutes	 the	 case	 under	 investigation	 prior	 to	 data	 collection.	 These	 boundaries	







surgery.	 Practice	 at	 the	 surgical	 units	 in	 this	 study	was	 for	 almost	 all	 patients	 to	 be	 told	
about	 their	 surgical	 results	 and	 plans	 for	 onward	 management	 at	 the	 first	 post-surgical	
follow-up	 consultation.	 I	 therefore	 chose	 to	 start	 the	 cases	 at	 the	 point	 of	 the	 first	 post-
operative	surgical	appointment.	One	of	my	central	study	aims	was	to	understand	how	the	
issue	of	recurrence	risk	was	discussed	by	different	disciplines	and	also	how	patients	coped	
with	 the	 risk	 of	 recurrence	 over	 time.	 Therefore	 I	 needed	 to	 include	 the	 subsequent	
oncology,	 or	 surveillance	 consultation.	 Interviews	with	 the	 professionals	 present	 in	 these	
consultations	also	formed	part	of	the	case.	I	decided	to	follow-up	patients	over	the	first	six	
months	 after	 surgery	 with	 patient	 interviews.	 I	 chose	 this	 time	 period	 as	 patients	
undergoing	adjuvant	 therapy	would	have	completed	 treatment,	 and	 so	all	patients	would	
have	undergone	surveillance	scans	and	recovered	from	their	surgery.	Surrounding	the	case	
itself,	were	things	that	gave	context	to	the	case,	such	as	the	surgeon’s	operation	note,	the	









By	 choosing	 the	 boundaries	 of	 the	 case	 as	 I	 did,	 I	 wanted	 to	 avoid	 seeing	 prognosis	
disclosure	as	taking	place	at	a	single	time	point.	However,	the	limitations	of	this	are	evident.	
Patients	may	 discuss	 prognosis	 and	 outcomes	 from	 the	 point	 of	 diagnosis	 of	 lung	 cancer	
onwards.	Some	surgeons	may	include	discussion	of	recurrence	risk	and	long-term	survival	as	
part	of	 the	 surgical	 informed	consent	process.	 Some	patients	may	be	given	news	of	 their	
surgical	pathology	 results	during	 their	 in-patient	hospital	 stay.	Patients	may	also	 talk	with	
their	LCNS	separately	after	the	consultation,	which	may	cover	recurrence	concerns.	Clearly	
it	was	not	possible	as	a	researcher	to	be	present	to	observe	all	these	potential	recurrence	
risk	 discussions	 take	 place.	 Similarly	 the	 diagnosis,	 adjuvant	 treatment	 visits,	 and	
subsequent	follow-up	consultations	are	occasions	where	discussion	about	prognosis	might	
occur,	 but	 did	 not	 form	 part	 of	 the	 case	 itself.	 Information	 about	 these	 elements	 was	
gathered	through	the	patient	and	professional	interviews.	
4.4.3 Case	selection	strategy		






result	 in	 such	 large	 amounts	 of	 data	 that	 researchers	 would	 not	 be	 able	 to	 deal	 with	 it	
effectively	 (Stake,	 2013).	 I	 made	 an	 initial	 decision	 to	 recruit	 ten	 cases,	 as	 this	 number	







of	 preoperative	 clinical	 cancer	 stages.	 Amongst	 those	 patients	 who	 met	 the	 criteria	 for	
adjuvant	therapy,	 I	also	aimed	to	obtain	the	perspective	of	those	who	actually	underwent	
treatment,	 as	 well	 as	 those	 who	 did	 not.	 However,	 as	 this	 decision	 was	 made	 after	 the	




Some	 qualitative	 research	 approaches	 use	 the	 concept	 of	 ‘data	 saturation’	 to	 determine	
when	 sufficient	 participants	 have	 been	 included	 in	 a	 study.	 Data	 saturation	 is	 the	 point	
when	recruiting	further	subjects	yields	no	new	themes	during	a	study.	Some	authors	have	
even	 attempted	 to	 quantify	 the	 number	 of	 interviews	 required	 to	 achieve	 this	 (Hennink,	
Kaiser,	 &	Marconi,	 2017;	 Malterud,	 Siersma,	 &	 Guassora,	 2016).	 Case	 study	 research,	 in	
contrast,	does	not	follow	this	logic.	Rather,	the	principal	aim	is	to	generate	detailed	in-depth	
analysis	preserving	the	context	and	richness	of	the	events	under	examination	(Stake,	2013).	










epistemological	 congruity	 of	 this	 logic	 in	 social	 research,	 arguing	 that	 we	 can	 never	 fully	
know	 the	 ultimate	 true	 version	 of	 reality	 (Hammersley,	 1992).	 Others	 challenge	 the	
legitimacy	 of	 bringing	 together	 different	 qualitative	 methods	 with	 differing	 analysis	
approaches	and	assumptions	(Barbour,	R.	S.,	1998).	Nevertheless,	there	is	recognition	that	






multiple	 sources	 can	 be	 seen	 to	 be	 like	 viewing	 the	 phenomenon	 through	 “a	 variety	 of	
lenses”	 in	 order	 to	 reveal	 its	 “multiple	 facets”	 (Baxter	 &	 Jack,	 2008,	 p544).	 Such	 an	
approach,	 however,	 does	 not	 aim	 to	 validate	 or	 discount	 one	 particular	 perception	 or	
account	over	another	and	to	find	a	unified	truth.	Rather	 it	seeks	to	reflect	the	 intricacy	of	
the	different	perspectives	 and	 to	 gain	 insight	 into	 the	way	 in	which	 these	 interpretations	
come	 together	 and	 interact.	 I	 therefore	 chose	 to	 include	 in-depth	 interviews	 with	 the	
patient	cases	and	their	linked	professionals,	observation	of	the	first	two	consultations	after	











The	 following	 section	 will	 outline	 the	 processes	 and	 steps	 undertaken	 in	 setting	 up	 the	
study,	recruitment	of	participants	and	collection	of	data.	
4.5.1 Ethical	approval	
I	developed	and	 finalised	a	study	protocol	as	part	of	 the	preliminary	study	processes	 that	
included	ethical	 committee	and	 research	access	approval.	The	university	Faculty	Research	
Ethics	 committee	 approved	 the	 study	 on	 1st	 June	 2015	 (reference:	 HWB-HSC-31).	 Health	
Research	Authority	research	ethics	committee	(REC)	gave	study	approval	on	27th	July	2015	




I	 was	 given	 NHS	 Research	 and	 Development	 approval	 from	 all	 participating	 sites	 of	 the	
study.	Copies	of	approval	letters	are	available	in	appendix	6.	
4.5.2 Research	governance	and	access	
During	 the	 conduct	 of	 all	 aspects	 of	 the	 study	 I	 applied	 the	 principles	 of	 Good	 Clinical	
Practice,	 as	 described	 in	 the	Research	Governance	 Framework	 for	Health	 and	 Social	 Care	
(Department	 of	 Health,	 2005).	 As	 a	 Registered	Nurse,	 I	 also	 undertook	 all	 aspects	 of	 the	
research	 in	 accordance	 with	 the	 Nursing	 and	Midwifery	 Council	 Code	 of	 Conduct	 (NMC,	








principal	 hospital	 trust.	 I	 managed	 all	 study	 data	 in	 accordance	 with	 the	 university	 Data	
Management	 Policy,	 Research	 Data	 Management	 Policy,	 NHS	 Caldecott	 Principles	






the	surgical	pathways	followed	by	patient	participants.	The	 local	hospitals	were	 located	 in	
socio-demographically	 and	 geographically	 diverse	 areas.	 LMDT	 1	 was	 at	 a	 hospital	 in	 a	









treatment.	These	were	both	based	 in	 tertiary	hospitals.	 Surgical	unit	1	was	 in	a	 suburban	
area.	Surgical	unit	2	was	a	city	centre	location.	Following	surgery,	patients	were	discussed	in	
their	 local	 referring	 LMDT	meeting	 to	 ascertain	 if	 they	would	 be	 offered	 an	 appointment	
with	 an	 oncologist	 to	 discuss	 adjuvant	 treatment,	 or	 commence	 long-term	 follow-up.	







alphabetically	allocated	according	 to	 recruitment	 timings	 (Audrey,	Barbara,	Cathy,	Denise,	
Edward,	Fiona,	Glennis,	Henry,	Jane,	Kamal,	Len	and	Maggie).	References	to	particular	place	
names	were	removed.	Where	specific	details	of	a	patient’s	case	might	be	 likely	 to	 lead	to	







precautions,	 I	 recognised	 that	 identification	was	 still	 possible.	 A	 review	 by	 Allmark	 et	 al.	
(2009)	highlighted	the	limitations	to	confidentiality,	particularly	in	studies	using	interviews.	




Inclusion	 and	 exclusion	 criteria	were	 developed.	 The	 target	 group	of	 patients	were	 those	
with	 lung	 cancer	undergoing	potentially	 curative	 surgery.	Although	 some	patients	did	not	
have	histologically	confirmed	diagnosis	of	lung	cancer	prior	to	surgery,	patients	were	aware	
that	lung	cancer	was	a	likely	diagnosis.	Patients	who	later	were	confirmed	not	to	have	a	lung	
cancer	 would	 be	 discontinued	 from	 the	 study,	 although	 this	 situation	 did	 not	 arise	 post	
recruitment.	No	restriction	was	placed	on	the	stage	of	lung	cancer,	although	patients	where	
the	surgeon	did	not	resect	all	visible	tumour,	a	so-called	“open	and	close”	procedure,	were	
excluded.	 Due	 to	 the	 qualitative	 nature	 of	 the	 study	 and	 reliance	 on	 interviews	 and	
observations	of	consultations,	I	chose	to	include	only	patients	able	to	speak	fluent	English.	
There	was	no	facility	for	translation	services.	The	need	for	translation	was	also	felt	to	be	a	
significant	barrier	 to	 in-depth	understanding	of	meaning	and	 language	use,	 central	 to	 the	
methodological	 approach.	 Another	 major	 consideration	 was	 to	 avoid	 causing	 patients	
unnecessary	 distress,	 or	 exacerbating	 existing	 psychological	 or	 psychiatric	 conditions	 by	
taking	part	in	the	study.	Therefore	patients	who	were	experiencing	unusually	high	levels	of	
psychological	distress	were	excluded	from	the	study.	The	judgement	about	this	matter	was	













• Patient	 has	 had	 a	 surgical	 resection	
for	primary	lung	cancer	
• Patient	 is	 aware	 they	 have	 or	 are	
likely	to	have	lung	cancer		
• Patient	 has	 not	 yet	 been	 seen	 in	 the	
first	follow-up	clinic		




• Patients	 who	 do	 not	 meet	 the	
inclusion	criteria	
• Patients	under	18	years	of	age	
• Patients	 unable	 to	 give	 informed	
consent	to	participation	in	the	study	
• Patients	 undergoing	 surgery	 where	





• Patients	 with	 a	 diagnosis	 of	
mesothelioma	
• Patients	judged	by	the	clinical	team	to	









and	 recruitment.	 The	 LCNS	 approached	 suitable	 patients	 and	 gave	 them	 an	 information	
sheet	 (PIS)	 about	 the	 study.	 They	 then	 asked	 patients	 for	 permission	 for	me	 to	 come	 to	
discuss	 the	study	 further	with	 them.	 I	approached	willing	patients,	 spoke	about	 the	study	
and	answered	any	questions.	Interested	patients	were	given	at	least	24	hours	to	think	about	
participation	before	signing	a	written	 informed	consent	 form	(ICF).	 In	practice,	 this	meant	
written	consent	was	usually	taken	just	prior	to	the	post-surgical	consultation.	Patients	were	
usually	 aware	 of	 my	 clinical	 role	 and	 I	 recognised	 the	 potentially	 coercive	 influence	 this	












Prior	 to	 commencing	 the	 study	 I	 approached	 members	 of	 the	 LMDT	 at	 the	 referring	




























details	 and	 reasons	 for	 not	 including	 patients	 in	 the	 study	 are	 given	 in	 table	 4.2.	 Five	
patients	 declined	 to	 take	 part	 in	 the	 study.	 Three	 patients	 did	 not	 meet	 the	 inclusion	 /	
exclusion	 criteria	 once	 their	 history	 was	 explored	 in	more	 detail.	 Two	 patients	 were	 not	
included	due	to	problems	with	my	attendance	at	their	consultation	appointment	and	one	as	
the	 study	 site	 was	 not	 yet	 open.	 One	 patient	 was	 excluded	 as	 they	 did	 not	 meet	 the	















































eight	 surgeons,	 six	 LCNS,	 four	 oncologists	 and	 two	 chest	 physicians.	 Two	 additional	
professionals	 consented	 to	 take	part	 in	 the	 study	 (Surgeon	7	and	LCNS	5),	but	 in	 the	end	














































Each	 of	 the	 12	 cases	 centred	 on	 a	 single	 patient	 participant	 and	 was	 associated	 with	
between	two	and	four	professional	participants	during	the	study.	Many	of	the	professionals	








Data	 collection	 commenced	 once	 written	 patient	 consent	 had	 been	 obtained.	 Multiple	




Case	 Record	 Form	 (CRF).	 This	 covered	 biographical	 information	 about	 the	 patient	 and	





















back	 to	during	 the	subsequent	 interviews	with	participants.	These	notes	were	essential	 in	









I	 undertook	 this	 myself,	 so	 I	 could	 recall	 the	 events	 clearly	 and	 ensure	 I	 was	 aware	 of	
individual	 speaker’s	 contributions.	 Transcriptions	 were	 verbatim,	 whilst	 remaining	
congruent	with	the	purpose	of	the	data.	This	meant	including	non-verbal	vocalisation,	such	
as	 sighs,	 laughs,	 repetitions	 and	 strong	 emphasis.	 I	 was	 able	 to	 record	 interruptions	 of	
speech	 or	 where	 more	 than	 one	 speaker	 was	 speaking	 at	 the	 same	 time.	 Pauses	 and	








quiet,	 non-clinical	 environment.	 However,	 the	 only	 opportunity	 to	 interview	 one	 surgeon	
was	 in	 theatre	 between	 cases	 (Surgeon	 3	 about	 Henry).	 Distractions	 and	 time	 pressure	
meant	this	was	the	shortest	of	all	interviews	and	yielded	little	useful	data.		
	
Interviews	 followed	 a	 topic	 guide	 and	 were	 conversational	 in	 nature	 (Tod,	 2015).	 Topic	
guides	 are	 available	 in	 appendix	 11.	Guides	were	 developed	 from	 the	 research	 questions	









I	used	a	commercial	 transcription	service	 to	 transcribe	 the	 interviews.	 I	 checked	these	 for	
accuracy	 against	 the	 audio	 recordings	 and	 updated	 for	 omissions,	 misheard	 words,	
significant	non-verbal	points,	 as	well	 as	ensuring	 that	 the	 final	 text	was	anonymised.	 This	
process	also	assisted	me	to	become	fully	immersed	in	the	data.		
4.7.4 Interviews	with	patient	participants	
After	 the	 surgical	 consultation,	 if	 the	 patient	 had	 a	 planned	 appointment	with	 either	 the	
oncologist,	 or	 with	 the	 respiratory	 team	 within	 a	 window	 of	 three	 weeks,	 I	 arranged	 to	
interview	the	patient	after	the	second	consultation.	If	there	was	no	immanent	appointment,	
the	 initial	 patient	 interview	 took	place	after	 the	post-surgical	 visit.	 Scheduling	of	 this	was	




Eleven	 of	 the	 12	 patient	 participants	 completed	 an	 initial	 interview.	 One	 patient	 (Jane)	
declined	 to	 be	 interviewed	 and	 did	 not	 undertake	 any	 interviews	 for	 the	 study.	 She	 felt	
overwhelmed	by	her	situation,	both	relating	to	her	cancer	treatment	and	also	due	to	wider	
social	issues,	and	did	not	feel	able	to	undergo	this	aspect	of	the	study.	Average	length	of	the	
first	 interview	was	51	minutes	 (range	26	to	83	minutes).	Eight	 interviews	were	conducted	
face-to-face	 in	 the	 hospital	 environment.	 Three	 patient	 participants	 elected	 to	 have	 a	
telephone	 interview.	 Interview	 field	 notes	 were	 completed	 about	 each	 interview	 and	
entered	into	the	research	diary.	
	
I	 had	 not	 planned	 to	 involve	 partners	 in	 the	 interviews.	However,	 excluding	 partners	 felt	
awkward	 and	 challenging	 for	 participants,	 especially	 when	 a	 family	 member	 had	 been	
closely	involved	during	the	preceding	consultation.	On	four	occasions	the	patient’s	partner	
was	 present	 during	 the	 interviews.	 With	 the	 first	 patient	 I	 interviewed,	 Barbara,	 her	
husband	assumed	he	would	be	 included	and	came	 into	the	 interview	room	before	 I	could	
stop	him.	In	this	circumstance	I	did	not	feel	able	to	ask	him	to	leave	the	room.	This	interview	
did	 give	 some	 insights	 that	 might	 not	 have	 occurred	 without	 her	 husband	 there.	
Subsequently,	 where	 a	 family	 member	 expressed	 a	 wish	 to	 be	 present,	 they	 joined	 the	
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Patients’	 first	 interviews	 were	 completed	 within	 three	 weeks	 of	 the	 post-surgical	
consultation	with	two	exceptions.	One	patient	(Len)	completed	their	interview	31	days	after	
the	surgical	consultation,	due	to	delays	during	the	respiratory	follow-up	consultation.	In	the	









only	 completed	 the	 first	 interview	 and	 Jane	 declined	 to	 take	 part	 in	 any	 interviews.	 This	
resulted	in	a	total	of	31	patient	interviews	within	the	study.	(See	appendix	11	for	topic	guide	
for	 the	second	and	third	 interviews).	Attempts	were	made	to	complete	 these	 longitudinal	
interviews	 at	 three	 and	 six	months	 after	 the	 surgery.	 In	 practice,	 time	 scales	 slipped	 for	






second	 interviews	 were	 conducted	 face-to-face;	 five	 were	 by	 phone	 and	 one	 via	 Skype.	




Seven	 were	 conducted	 face-to-face,	 two	 by	 phone	 and	 one	 via	 Skype.	 The	 wives	 of	 the	
patients	Henry	and	Kamal	were	present	during	their	final	interviews.	Transcription	of	all	the	





approach	 to	 data	 analysis	 also	 evolved.	 I	 will	 outline	 my	 initial	 analytic	 strategy	 of	
Framework,	and	identify	some	of	its	limitations.	These	limitations	then	led	me	to	adopting	





of	 the	overall	 analysis	process.	 The	goal	of	 analysis	 is	 to	 retain	 the	 integrity	of	 the	entire	
case,	which	 then	enables	 subsequent	analysis	between	cases	 (Yin,	2018).	This	meant	 that	
‘the	 case’	 became	 central	 to	 the	 analysis,	 with	 a	 need	 to	 maintain	 the	 origin	 of	 each	
element	of	data	throughout	the	process	of	managing	the	data,	analysis,	and	writing	up.	 In	
order	 to	maintain	 the	 integrity	 of	 the	 cases	 I	 adopted	 a	 number	 of	 strategies.	 Data	 from	
each	case	were	kept	together.	The	case	was	visible	at	each	step	of	the	analysis	process	to	
avoid	losing	sight	of	it.	Individual	case	summaries	were	constructed,	allowing	prominence	to	




An	 early	 decision	 in	 the	 study	 was	 to	 use	 a	 computer-assisted	 qualitative	 data	 analysis	
software	 program	 (CAQDAS)	 to	 manage	 and	 organise	 the	 large	 quantities	 of	 data	 from	
multiple	 sources	 (Silver	&	Lewins,	2014).	NVivo	11	 for	Windows	 (QSR	 International,	2016)	
was	chosen	for	this	project	largely	as	it	contained	a	feature	that	facilitated	the	development	






Framework	 is	 a	 method	 of	 analysis	 particularly	 associated	 with	 applied	 social	 research	
(Pope,	Zeibland,	&	Mays,	2000;	Spencer,	Ritchie,	O'Connor,	Ormston,	&	Barnard,	2014).	 It	
shares	many	 of	 the	 keys	 steps	 with	 other	 qualitative	 analysis	 methods.	 However,	 it	 also	
incorporates	an	additional	step	of	generating	‘thematic	matrices’.	These	matrices	provide	a	
way	of	visualising	the	data	by	generating	summaries	of	themes	for	each	case	and	data	type.	
In	 this	 way	 data	 can	 be	 visualised	 flexibly,	 with	 the	 aim	 of	 detecting	 relationships	 and	
patterns	 in	 the	 data.	 Attitudes	 to	 the	 Framework	 approach	 differ	 amongst	 researchers.	
Some	view	 it	 as	 a	 very	 rigorous	and	auditable	process	of	 analysis	 (Gale,	Heath,	Cameron,	
Rashid,	&	Redwood,	2013).	Others	regard	it	as	laborious	and	time	consuming	to	undertake	
(Ward,	Furber,	Tierney,	&	Swallow,	2013).	Some	authors,	such	as	Braun	and	Clarke	(2006),	





The	 structure	 of	 Framework	 consists	 of	 five	 initial	 data	 management	 phases	 that	 are	
employed	 iteratively.	 These	 are	 ‘data	 familiarisation’,	 development	 of	 a	 ‘thematic	
framework’,	a	process	of	‘indexing	and	sorting’,	‘reviewing	extracts’,	and	‘data	summary	and	
display’	 (see	 figure	 4.7).	 Much	 of	 these	 initial	 phases	 of	 Framework	 produce	 descriptive	
analysis	of	the	research	topic	and	it	is	only	the	final	phase	of	abstraction	and	interpretation	







Used with permission of SAGE Publications Ltd, from Ritchie et al., (2014); permission conveyed through 
Copyright Clearance Center, Inc. 
Data	familiarisation	
Becoming	fully	familiar	with	all	the	data	is	emphasised	in	the	Framework	approach,	possibly	
because	 it	 is	often	used	 in	 the	context	of	 teams	of	 researchers,	whose	members	may	not	
have	been	involved	in	data	collection.	As	a	singlehanded	researcher,	I	had	collected	all	the	




The	thematic	 framework	was	developed	so	 that	 it	could	be	applied	 to	 the	whole	data	set	
later	in	analysis.	In	order	to	keep	the	thematic	framework	grounded	in	the	data,	descriptive	
codes	were	applied	by	hand	to	the	data	from	the	first	three	patient	participants	(Saldaña,	
2016).	Members	of	 the	 supervisory	 team	 independently	 reviewed	 three	coded	 transcripts	
and	 suggested	 modifications	 and	 possible	 different	 approaches.	 Codes	 from	 these	 initial	
data	were	grouped	 into	broad	descriptive	 themes	 that	were	developed	 into	a	preliminary	
framework.	 A	 process	 of	 trying	 out	 the	 thematic	 framework	 on	 subsequent	 data	 allowed	
development	and	refinement	of	the	framework.	Emergent	issues	and	new	lines	of	thinking	
were	subsequently	incorporated	in	to	the	framework.	This	thematic	framework	underwent	





Once	 the	 thematic	 framework	 was	 developed	 to	 a	 level	 that	 incorporated	 all	 initial	
descriptive	codes,	data	were	uploaded	to	NVivo	and	the	framework	trialled	by	applying	it	to	
further	case	data	series.	Spencer	et	al.	(2014)	refer	to	applying	the	thematic	framework	to	
the	 data	 as	 ‘indexing	 and	 sorting’,	 in	 a	 similar	 way	 as	 others	 might	 talk	 about	 ‘coding’.	
Additional	 identification	 of	 in	 vivo	 codes	within	 the	 data,	 such	 as	words	 or	 short	 phrases	
that	encapsulated	a	particular	idea	or	point	of	view,	helped	to	keep	the	analysis	grounded	in	
the	data.	 In	 vivo	 codes	were	added	 to	existing	elements	of	 the	 thematic	 framework,	or	 if	
there	was	 no	match,	 used	 to	 help	 identify	 emergent	 themes.	 Extensive	 use	 of	 functions,	
such	 as	 notes	 and	 memos	 within	 NVivo,	 enabled	 me	 to	 capture	 ideas	 and	 analytical	
thoughts	 during	 the	 indexing	 and	 sorting	 process.	 An	 example	 of	 coding	 using	 NVivo	 is	
included	 in	 appendix	14.	Once	 the	process	of	 indexing	and	 sorting	were	 complete,	 it	was	
easy	to	generate	displays	from	NVivo	of	data	coded	to	one	theme.	The	process	of	reviewing	
these	 data	 extracts	 allowed	 a	 check	 for	 consistency	 and	 a	 view	 of	whether	 the	 thematic	






of	 the	 data	 was	 written.	 The	 challenge	 of	 writing	 these	 summaries	 was	 to	 summarise	
enough	so	the	information	was	manageable,	but	not	to	lose	the	essence	of	the	material,	or	
its	 grounding	 in	 the	 data.	 To	 achieve	 this,	 I	 included	 direct	 quotations	 and	 used	 original	










At	the	end	of	 these	processes	 the	 findings	remained	at	a	descriptive	 level.	The	process	of	
abstraction	 of	 data	 is	 complex	 and	 more	 difficult	 to	 describe.	 The	 Framework	 approach	










Thematic	 analysis	 is	 often	 seen	 as	 a	 straightforward	 and	 accessible	 technique	 for	 novice	
researchers	(Pope,	Zeibland,	&	Mays,	2006).	Braun	and	Clarke	(2012)	describe	the	process	
of	Thematic	Analysis	and	identify	six	steps.	These	are,	‘familiarisation’	and	‘generating	initial	
codes’,	 ‘searching	 for	 themes’,	 ‘reviewing	 themes’,	 ‘defining	 and	 naming	 themes’	 and	
‘report	 writing’.	 Despite	 differences	 in	 nomenclature,	 the	 initial	 two	 steps	 have	 some	
similarity	 with	 those	 of	 ‘data	 management’	 used	 in	 Framework.	 However,	 the	 two	
approaches	have	quite	different	 terminology.	 In	Thematic	Analysis	a	 theme	 is	a	“coherent	
and	meaningful	pattern	in	the	data	relevant	to	the	research	question”	(Clarke,	V.	&	Braun,	
2013,	p120).	In	this	sense,	themes	in	Thematic	Analysis	are	not	the	same	as	the	themes	of	




Braun	 and	 Clarke	 (2012)	 identify	 the	 creative	 processes	 involved	 in	 developing	 a	 clear	
thematic	analysis,	and	suggest	that	it	is	a	process	that	sometimes	defies	clear	explanation.	






explore	 the	 inner	hidden	processes	and	conceptualisations	about	what	 is	occurring	 in	 the	




As	 a	 result	 of	 the	 use	 of	 Framework,	 data	 had	 largely	 been	 coded	 using	 a	 theoretical,	
deductive	approach,	although	significant	 inductive	coding	was	also	 incorporated.	As	Braun	
and	 Clarke	 (2012)	 acknowledge,	 in	 reality	 both	 approaches	 are	 almost	 inevitable.	 This	
flexibility	 in	 the	 application	 of	 Thematic	 Analysis	 was	 important	 when	 considering	 my	
philosophical	underpinning	for	the	research,	which	was	one	of	subtle	realist	ontology,	and	a	
constructionist	 epistemology.	 I	 did	 not	 re-code	 the	 data	 at	 this	 stage,	 but	 took	 time	 to	
explore	the	data	again	and	to	re-group	existing	codes	to	identify	new	linkages	and	patterns.	
In	order	to	help	identify	themes	I	also	made	extensive	use	of	charts	and	mind-maps	to	help	
focus	 thought	around	analysis	 (Pope,	et	al.,	2006).	Examples	are	 included	 in	appendix	16.	
This	 strategy	 helped	 to	 identify	 relevant	 linkages	 in	 the	 data	 between	 different	 elements	
(Nowell	et	al.,	2017).	 I	was	able	to	then	group	coded	data	together	 into	more	meaningful	









they	 remained	 congruent	with	 the	 research	 aims.	 Each	 theme	 needed	 to	 be	 distinct	 and	
focused,	 whilst	 interlinking	 with	 the	 other	 themes,	 allowing	 me	 to	 build	 and	 develop	 a	
logical	 argument	 about	 the	 data	 collected.	 The	 process	 remained	 highly	 iterative,	 with	
writing	forming	a	core	part	of	the	process	of	analysis,	whilst	moving	between	this	and	the	




theme.	 The	 process	 of	 writing	 helped	 to	 crystallise	 my	 thinking	 around	 each	 theme,	
ensuring	 that	 it	 had	 sufficient	 robustness	 to	 stand	up:	 linked,	 but	 still	 distinct	 from	other	






How	 to	 judge	 the	quality	 of	 qualitative	 research	has	 been	 the	 subject	 of	much	 argument	
(Mays	&	Pope,	2006;	Ritchie	&	Ormston,	2014).	Whether	qualitative	research	can	be	judged	
on	the	same	basis	as	quantitative	studies	is	at	the	heart	of	this	debate.	Traditional	measures	
of	 research	 quality	 have	 tended	 to	 use	 concepts	 such	 as	 reliability,	 validity	 and	




dependability,	 confirmability,	 transferability)	 and	 authenticity	 of	 the	 research	 have	 been	
proposed.	 However,	 such	 terminology	 can	 be	 closely	 mapped	 to	 the	 more	 conventional	
ones	 and	 some	 researchers	 feel	 that	 the	 use	 of	 specific	 language	 relating	 to	 qualitative	




philosophical	 assumptions	 underpinning	 qualitative	 methodologies	 mean	 that	 external	
quality	measures	cannot	be	 imposed,	and	studies	 should	be	solely	 judged	on	a	 subjective	
assessment	of	their	own	merits	(Rolfe,	2006).	Nevertheless,	there	is	consensus	from	many	
health	service	and	applied	research	fields	that	there	needs	to	be	some	criteria	with	which	to	
make	 judgements	 (Lewis	 et	 al.,	 2014).	 Guidelines	 have	 been	 produced	 to	 facilitate	
assessment	 of	 qualitative	 research,	 such	 as	 the	 consolidated	 criteria	 for	 reporting	













































































In	 this	 study	 I	 have	 thought	 about	 quality	 and	 research	 rigour	 using	 the	 terms	 validity,	
reliability	 and	 generalizability,	 adapted	 to	 match	 the	 ontological	 and	 epistemological	
approach	that	 I	have	adopted.	The	way	these	terms	have	been	applied	are	summarised	in	





impact	 of	 the	 researcher	 on	 participants,	 data	 collection	 and	 analysis	 (Seale,	 2007).	 This	
latter	 point	 is	 described	 as	 the	 ‘researcher’s	 position’	 and	 includes	 factors	 such	 as	
demographic	 profile,	 professional	 role,	 power,	 as	 well	 as	 personal	 characteristics	 and	
standpoint	(Berger,	R.,	2015).	Throughout	this	current	study	I	have	tried	to	adopt	a	reflexive	













&	 Treharne,	 2016).	 I	 described	 my	 research	 role	 within	 the	 observed	 consultations	 as	
‘observer-as-participant’.	 I	 made	 a	 choice	 to	 be	 present	 during	 the	 consultations	 in	 the	
knowledge	that	 it	might	have	more	 impact	than	 just	audio	recording	the	 interaction	and	 I	




points	during	 the	 interaction	 the	professional	and	patient	became	obviously	aware	of	 the	
digital	recorder,	being	guarded	about	saying	certain	things,	or	conversely	making	comments	
aimed	 specifically	 at	 the	 recorder;	 essentially	 ‘breaking	 the	 fourth	 wall’	 of	 their	
‘performance’.	 In	 other	 consultations	 comments	 were	 sometimes	 made	 referencing	 the	
recorder,	 often	 in	 response	 to	 expressions	 of	 thanks	 made	 by	 patients	 to	 professionals.	
Some	 participants	 made	 comments	 afterwards	 regarding	 their	 awareness	 of	 my	 writing	
observation	 notes.	 	 One	 professional	 specifically	 asked	me	 to	 feedback	 on	 the	 quality	 of	
their	consultation.	In	this	situation	I	declined	to	do	this,	explaining	that	it	was	not	part	of	the	
research	objectives,	but	I	did	share	the	transcript	of	the	consultation.	Such	issues	underline	
the	 impossibility	 of	 completely	 ‘fading	 into	 the	 background’	 as	 a	 researcher.	 For	 some	
professionals	there	was	an	apparent	sense	of	being	judged	during	the	observations,	a	factor	
that	 was	 well	 described	 by	 Kirkham	 (1989)	 in	 a	 study	 on	 midwifery.	 Especially	 when	 a	
researcher	 has	 extended	 periods	 being	 ‘embedded’	 within	 a	 research	 environment	
participants	 seem	 to	 quickly	 adapt	 to	 the	 observation.	 Behaviour	 appears	 to	 change	 in	
superficial	ways	rather	than	altering	core	behaviours	and	communication	(Kirkham,	1989).	





My	 clinical	 role	 was	 known	 by	 both	 professional	 and	 patient	 participants	 and	was	made	
explicit	in	the	participant	information.	While	I	attempted	to	adopt	the	researcher	role,	there	
were	examples	where	 I	 also	had	 to	be	a	 clinician.	 In	one	 consultation	where	 the	 surgeon	
was	 unfamiliar	with	 the	 arrangements	 at	 the	 local	 hospital	 I	 was	 drawn	 directly	 into	 the	





In	 interviews	 with	 patients	 there	 were	 also	 occasions	 where	 these	 roles	 clashed.	 For	





to	 ignore	 significant	 misinterpretations.	 In	 the	 end	 I	 decided	 to	 contact	 the	 patient’s	
specialist	 nurse	 to	 ask	 them	 to	 pick	 up	 the	 issues	where	 I	 felt	 that	 there	were	 areas	 the	
patients	 had	 not	 fully	 understood.	 The	 nature	 of	 the	 interviews	 themselves	 can	 also	 be	
influenced	 by	 the	 perception	 of	 the	 participants,	 vis-à-vis	 research	 and	 professional	 roles	










clinical	 situation	underpinned	much	of	my	 initial	 conceptions	of	a	 ‘good	consultation’.	My	
initial	 view	 of	 published	 population	 outcome	 data	 as	 an	 objective	 measure	 of	 patient	
prognosis	also	 influenced	the	 initial	direction	of	 the	study.	Much	of	 the	early	analysis	was	
spent	 on	 identifying	 the	 mechanisms	 of	 giving	 recurrence	 risk	 information,	 rather	 than	
looking	 at	 the	 interaction	 in	 much	 more	 broad	 terms.	 The	 challenge	 was	 to	 stop	 these	
personal	and	professional	meanings	crowding	out	the	broader	interpretations	that	emerged	
from	within	the	data	(Sword,	1999).	Openly	disclosing	the	inherent	nature	of	the	enmeshed	




In	 this	 chapter	 I	 have	 set	 out	 the	methodology	 and	 study	 processes	 that	 I	 followed.	 This	
research	aimed	to	gain	an	in-depth	understanding	of	the	communication	around	recurrence	
risk	following	potentially	curative	lung	cancer	surgery	using	a	multi	perspective	approach.	I	
adopted	 subtle	 realist	 ontology	 and	 constructionist	 epistemology	 to	 undertake	 a	multiple	
qualitative	 instrumental	 case	 study.	Each	 ‘case’	 centred	on	a	patient	participant	 following	
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lung	 cancer	 surgery	 and	 included	 the	 associated	 professionals	 involved	 during	 the	 post-






evidence,	observation	of	 consultations	 involving	participants,	 interviews	with	participating	
professionals	and	 longitudinal	 interviews	with	patients	at	 three	 time	points.	 	 I	 recruited	a	
total	 of	 12	 cases,	 each	 centring	 on	 an	 individual	 patient	 participant	 and	 involved	 20	
professional	participants	across	the	cases.	Audio-recorded	data	were	transcribed	verbatim	
and	 field	 notes	 maintained.	 I	 used	 the	 software	 NVivo	 to	 help	 manage	 the	 data.	 Initial	
analysis	was	undertaken	using	the	Framework	approach.	Later	I	adopted	Thematic	Analysis	









of	 the	data.	 In	 this	 current	 chapter	 I	will	present	details	of	each	of	 the	 study	cases.	After	
their	 surgery,	 patient	 participants	 followed	 two	 distinct	 pathways	 for	 their	 onward	
management,	 either	 entering	 a	 period	 of	 clinical	 follow-up,	 or	 being	 referred	 to	 see	 an	
oncologist	to	discuss	possible	adjuvant	therapy.	I	will	use	these	two	pathways	to	group	the	
cases,	beginning	with	those	who	went	straight	into	long-term	follow-up.	For	each	case	I	will	





table	5.1.	Pre-operative	 lung	 cancer	 clinical	 stage	 ranged	 from	 IA	 to	 IIIB.	One	patient	was	
referred	for	surgery	without	a	recorded	clinical	stage.	Educational	backgrounds	varied	from	
leaving	school	with	no	formal	qualifications,	to	having	postgraduate	education.	Eight	of	the	
participants	were	 retired.	Previous	and	 current	employment	 varied	 from	unskilled	 jobs	 to	
professional	 roles.	 Smoking	 history	 ranged	 from	 negligible	 to	 recently	 stopped.	 Patient	
participants	all	had	significant	co-morbid	illnesses,	with	the	exception	of	Fiona.	Of	particular	
note	 was	 the	 fact	 that	 half	 of	 the	 participants	 had	 had	 a	 previous	 or	 concurrent	 cancer	
diagnosis,	 other	 than	 lung	 cancer.	 This	 was	 higher	 than	might	 have	 been	 anticipated.	 In	
several	 cases,	 tests	 and	 investigations	 for	 the	 other	 cancer	 directly	 led	 to	 the	 incidental	









































































































































Patient	 participants	 followed	 two	 different	 post-surgical	management	 pathways.	 None	 of	




these	 consultations,	 three	 went	 on	 to	 receive	 adjuvant	 chemotherapy,	 radiotherapy,	 or	
both.	 The	 remaining	 three	 did	 not	 receive	 adjuvant	 treatment;	 although	 one	went	 on	 to	
receive	 radical	 radiotherapy	 to	 treat	 a	 separate,	 synchronous	 lung	 lesion	 in	 the	 opposite	















networks	 lived	away.	She	did	not	 rely	on	her	husband	and	sons	 for	 support,	but	valued	a	
circle	 of	 close	 female	 friends.	 Cathy	 had	worked	 full-time	 as	 a	 catering	manager	 until	 six	




Cathy	 first	 went	 to	 the	 doctor	 with	 pains	 in	 her	 stomach.	 Investigations	 showed	 an	
abnormality	 in	her	blood	 tests	and	she	 said	 she	knew	straight	away	 there	was	 something	
seriously	wrong	with	her.	She	was	diagnosed	with	chronic	 leukaemia,	which,	although	not	
curable,	 only	 required	 monitoring	 and	 no	 immediate	 treatment.	 However,	 during	
investigation	 for	 this,	 a	 lesion	was	 revealed	on	her	 lung.	 She	 instantly	 knew	 that	 this	was	










questions	 about	 what	 had	 gone	 wrong	 during	 the	 surgery	 and	 why	 problems	 were	 not	
detected	until	after	her	cardiac	arrest.	They	were	unable	 to	see	Cathy’s	consultant	during	










































































































to	 reduce	 her	 chance	 of	 breast	 cancer	 recurrence	 in	 the	 future.	 She	was	 still	 undergoing	
medical	 follow-up	 for	 her	 breast	 cancer	 at	 the	 time	 she	was	 diagnosed	with	 lung	 cancer.	
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consultation	where	 she	was	 told	 that	 this	was	an	adenocarcinoma	of	 the	 lung.	 The	other	
lesion	was	too	small	to	biopsy	and	she	was	told	that	this	would	be	monitored	for	any	further	
changes.	 Denise	 was	 very	 upset	 to	 find	 out	 that	 the	 larger	 lesion	 on	 her	 lung	 had	 been	
visible	on	scans	she	had	been	given	when	first	diagnosed	with	breast	cancer,	but	no	one	had	





time	 she	 came	 back	 to	 the	 post-surgical	 clinic,	 four	 weeks	 after	 her	 surgery.	 A	 registrar	








































































































However,	 she	 found	 receiving	 different	 management	 possibilities	 for	 this	 second	 lesion	
unsettling	due	to	the	confusion	it	created	in	her	mind.	Although	subsequent	scans	showed	
no	growth	in	the	lesion,	Denise	saw	further	surgery	as	inevitable	at	some	point	in	the	future.	











it	 was	 a	 lung	 cancer	 straight	 away,	 but	 it	 was	 not	 confirmed	 until	 she	 had	 a	 biopsy.	
Investigations	revealed	that	the	cancer	had	spread	to	a	lymph	node	in	her	neck,	so	surgery	
and	radiotherapy	were	ruled	out.	She	said,	"You're	thinking	all	 the	time,	 it's	getting	worse	











worried	 what	 would	 happen	 if	 she	 had	 to	 stop	 treatment.	 Fiona	 built	 up	 a	 strong	 and	
trusting	 relationship	 with	 her	 consultant,	 Oncologist	 2.	 She	 also	 attended	 the	 local	 lung	
cancer	support	group	and	through	this	she	cemented	a	supportive	relationship	with	LCNS	4.	
At	 the	 group	 she	met	 others	 in	 similar	 situations	 and	 became	 a	 reluctant	 role	model	 for	
some.	 Gradually	 she	 began	 to	 see	 herself	 as	 an	 ambassador	 for	 lung	 cancer	 patients.	
Following	a	PET	scan,	Fiona	recalled	her	oncologist	ringing	her	at	home	and	telling	her	that	







scarring.	 There	 was	 an	 elated	 atmosphere,	 but	 Fiona	 struggled	 to	 take	 this	 momentous	
news	in	fully.	Fiona	was	then	referred	back	to	her	oncologist	for	long-term	follow-up.		
	
Oncologist	 2	 saw	 Fiona	 and	 her	 husband	 about	 two	weeks	 later.	 This	 consultation	 had	 a	
similarly	 elated	 feeling.	 The	 strong	 relationship	 between	 Fiona	 and	 her	 oncologist	 was	










































































































































Fiona	continued	 to	make	a	good	physical	 recovery.	Emotionally,	 she	struggled	 to	come	to	
terms	with	the	changes	in	her	prognosis	following	her	surgery.	In	particular	she	knew	that	




Glennis	 was	 59	 when	 she	 was	 diagnosed	 with	 lung	 cancer.	 She	 had	 worked	 in	 an	



















After	 her	 surgery	Glennis	was	 very	worried	 about	 coming	 to	 the	 surgical	 clinic	 to	 get	 the	
results.	This	was	particularly	focused	on	whether	she	would	require	further	treatment,	such	
as	chemotherapy.	She	attended	clinic	with	her	partner	two	weeks	after	discharge	and	was	
seen	 by	 a	 surgical	 registrar,	 Surgeon	 5,	 with	 whom	 she	 had	 developed	 a	 very	 good	
relationship	 during	 her	 admission.	 LCNS	 1	was	 also	 present,	 but	 they	 had	 not	 previously	
met.	Glennis	took	a	strong	role	in	the	consultation,	insisting	she	was	told	her	surgical	results	
right	at	the	beginning,	by	saying	to	Surgeon	5,	“just	cut	to	the	chase”.	Glennis	was	referred	






























































































number	 of	 chest	 infections.	During	 these	 times	 she	 tended	 to	 search	 for	more	 and	more	










and	was	under	 the	care	of	 several	different	 teams	at	his	 local	hospital.	Some	of	his	other	











morbidities.	He	 and	his	wife	were	 still	 keen	 for	 him	 to	have	 the	operation,	 as	 he	did	not	







during	 his	 admission.	 Kamal’s	 wife	 asked	 the	 majority	 of	 questions	 in	 the	 consultation.	












































































































nodes”	 in	his	chest.	He	expressed	 frustration	 that	he	was	not	 told	about	what	was	wrong	




Len	 was	 73	 when	 he	 underwent	 his	 lung	 cancer	 surgery.	 He	 had	 left	 school	 at	 16	 after	
completing	his	exams.	He	had	worked	as	a	mechanic	and,	before	retirement,	as	a	foreman.	






he	 felt	 his	memory	was	not	 as	 good	as	 it	 used	 to	be,	 but	 also	 as	he	 felt	 that	 there	were	












seen	 until	 about	 eight	 weeks	 after	 his	 surgery.	 Len	 was	 seen	 by	 Surgeon	 8,	 who	 had	








and	 interruption	by	a	pre-assessment	nurse	 in	relation	to	his	 forthcoming	bladder	surgery	








































































































Len	 recovered	well	 from	his	 lung	 surgery,	 but	 there	were	 further	 delays	with	 his	 bladder	









be	 considered	 divergent	 in	 relation	 to	 this	 pathway:	 Fiona’s	 case	 due	 to	 her	 initial	
chemotherapy	 given	 with	 palliative	 intent,	 and	 Kamal’s	 case,	 where	 his	 final	 pathology	
report	indicated	a	stage	IIA	lung	cancer,	due	to	having	lymph	node	involvement.		
	
The	 only	 case	 on	 this	 pathway,	 and	 also	 across	 the	whole	 study,	 where	 the	 patient	 was	
given	a	numerical	estimate	of	 recurrence	 risk	without	 first	asking	 for	 it	was	 in	 Len’s	 case.	
However,	in	each	of	the	other	cases	on	this	pathway,	patients	all	initiated	questions	to	their	










about	 risk	 of	 recurrence,	 in	 what	 seemed	 to	 be	 a	 bid	 to	 ‘test’	 the	 information	 they	 had	
already	been	told.	Neither	was	offered	a	numerical	probability	of	risk	of	recurrence.	In	the	
other	 cases,	 there	was	 no	more	 discussion	 of	 the	 risk	 of	 cancer	 recurrence.	 None	 of	 the	
professionals	 explicitly	 raised	 the	 subject	 of	 recurrence	 risk	 during	 the	 follow-up	
consultation	with	any	of	 the	patients.	Only	 Len’s	 surgeon	and	 the	 chest	physician	 looking	
after	 Kamal	 discussed	 symptoms	 to	 be	 aware	 of	 that	 might	 indicate	 the	 early	 signs	 of	









and	had	worked	 in	 several	 roles	 including	 shop	work	 and	 catering.	 She	was	divorced	and	
lived	alone,	and	her	main	support	was	from	her	son	who	lived	close	by.	He	attended	all	the	
hospital	 appointments	with	her.	 Personal	 experience	of	 cancer	before	 she	was	diagnosed	
herself	was	through	her	sister	who	was	diagnosed	with	breast	cancer.	Soon	after	completing	




with	 lung	 cancer.	 Repeated	 chest	 x-rays	 did	 not	 reveal	 any	 problems,	 until	 finally	 she	
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coughed	up	blood.	 The	number	and	 speed	of	 the	 subsequent	 tests	made	her	 realise	 that	
something	was	seriously	wrong.	Nonetheless	she	recalled	the	shock	and	devastation	she	felt	
when	she	was	told	it	was	a	lung	cancer.	She	met	her	Macmillan	community	support	nurse	at	
the	 time	 of	 her	 diagnosis	 and	 this	 became	 someone	 she	 went	 to	 for	 reassurance	 and	
information.	 She	 generally	 avoided	 telling	 friends	 and	 acquaintances	 about	 her	 diagnosis	
until	after	all	her	treatment	was	complete.	
	
Audrey’s	 surgical	 consultant	 (Surgeon	 1)	 told	 her	 that	 her	 best	 option	would	 be	 to	 have	
surgery,	but	she	was	initially	worried	about	Audrey’s	breathing.	Her	surgeon	made	her	climb	
two	 flights	 of	 stairs	 to	 test	 her	 breathing	 and	 her	 surgeon	 felt	 it	 was	 her	 “sheer	
determination	 to	 have	 the	 surgery”	 that	 she	 managed	 it.	 Although	 Audrey	 expected	 her	
operation	would	be	to	have	removal	of	one	lobe	of	her	lung,	due	to	the	size	and	position	of	
the	tumour	she	ended	up	having	her	whole	left	lung	removed.	During	her	investigations	in	






saw	 Surgeon	 1	 in	 the	 post-surgical	 consultation,	 four	 weeks	 after	 surgery.	 Issues	 around	






the	 end	 her	 oncologist	 did	 not	 recommend	 chemotherapy,	 due	 to	 her	 overall	 health.	
However,	he	did	arrange	to	treat	the	lesion	in	the	other	lung	with	radiotherapy.	She	and	her	

















































































































While	 Audrey	 was	 undergoing	 radiotherapy	 she	 developed	 back	 pain,	 initially	 putting	 it	
down	 to	 the	 hard	 treatment	 couch.	 However,	 this	 got	 worse	 and	 she	 was	 eventually	
admitted	to	hospital	as	an	emergency.	She	was	very	anxious	that	the	cancer	had	spread	to	








Barbara	 was	 68	 at	 the	 time	 she	was	 diagnosed	with	 lung	 cancer.	 Barbara	 had	 grown-up	
children	who	lived	nearby,	but	it	was	her	husband	who	was	her	main	support.	Their	strong,	
enmeshed	relationship	was	evident	in	the	observed	consultations	and	in	the	first	interview.	






Barbara	 had	 developed	 a	 cough,	 which	 was	 interfering	 with	 her	 ability	 to	 have	 her	
rheumatoid	 arthritis	 treatment	 and	 she	was	 sent	 for	 an	 x-ray.	 She	otherwise	 felt	well,	 so	
when	a	“mass”	was	seen	on	the	x-ray	it	did	not	feel	real	to	her.	But	as	she	had	also	smoked	
for	 all	 of	 her	 adult	 life,	 she	 immediately	 concluded	 it	 was	 a	 lung	 cancer	 and	 found	 it	












The	 consultation	 was	 positive	 and	 upbeat.	 Her	 surgeon	 told	 her	 that	 she	 would	 refer	
Barbara	to	see	an	oncologist	to	discuss	adjuvant	chemotherapy.		
	
A	 week	 later	 Barbara	 and	 her	 husband	 attended	 the	 oncology	 clinic.	 They	 were	 more	
nervous	about	seeing	Oncologist	1	than	the	surgical	consultation.	She	was	not	keen	to	have	
chemotherapy,	as	her	priority	was	to	re-start	her	arthritis	treatment.	The	arthritis	was	still	a	
day-to-day	 reality,	while	 the	 lung	 cancer	 remained	abstract	 to	her.	However,	 if	 there	had	
















































































































Emotionally	 she	 liked	 to	 keep	 her	 feelings	 private	 and	 described	 holding	 “everybody	 out	
with	 a	 bubble.”	 Three	 months	 after	 her	 surgery	 Barbara	 was	 admitted	 to	 hospital	 with	
pneumonia.	A	CT	scan	revealed	that	she	had	widespread	secondary	lung	cancer.	She	tried	to	
remain	positive	about	the	future	and	hoped	the	chemotherapy	she	had	started	would	keep	










had	been	a	driver	 for	most	of	his	working	 life.	However,	most	 important	 to	him	were	his	









a	 CT	 scan,	which	 revealed	 a	 lung	 lesion.	 He	 saw	 this	 as	 lucky	 as	 it	 led	 to	 an	 earlier	 lung	
cancer	diagnosis.	He	was	referred	for	lung	surgery	and	immediately	felt	great	confidence	in	














Edward	 felt	 more	 reassured	 about	 his	 lung	 cancer,	 and	 had	 also	 been	 able	 to	 clarify	














































































































After	 his	 consultation	with	 the	 oncologist	 he	was	 referred	 on	 to	 the	 chest	 physicians	 for	
long-term	follow-up.	Edward’s	main	goal	was	 to	get	back	 to	being	physically	active,	 riding	









close	 couple.	 She	 continued	 to	 work	 from	 home.	 Henry	 had	 always	 been	 a	 fit	 man	 and	
played	rugby	into	his	forties	and	was	proud	of	only	having	three	days’	sick	leave	during	his	
working	 career.	 He	 avoided	 seeking	 information	 about	 his	 health.	 This	 attitude	 stemmed	
from	his	 experience	when	his	mother	was	 diagnosed	with	 cancer.	He	 and	 the	 family	 had	
kept	 his	 mother’s	 diagnosis	 from	 her	 for	 about	 a	 year.	 One	 day	 a	 doctor	 told	 her	 the	
diagnosis	and	details	about	her	cancer.	Henry	felt	that	she	deteriorated	from	that	moment	
and	she	died	within	3	months.	Since	then	he	avoided	looking	for	information	and	worrying	













They	 were	 not	 able	 to	 see	 the	 surgeon	 in	 whom	 they	 had	 such	 faith,	 but	 saw	 someone	
different,	 Surgeon	 3,	 who	 they	 had	 never	 met	 before.	 They	 found	 the	 consultation	






Henry	 and	 his	 wife	 were	 seen	 by	 Oncologist	 1	 about	 two	 weeks	 later.	 The	 oncologist	
presented	 the	 rationale	 for	 offering	 adjuvant	 chemotherapy	 and	 possibly	 radiotherapy.	
Henry	 felt	 he	 was	 given	 a	 large	 volume	 of	 information	 about	 the	 side	 effects	 and	
practicalities	 of	 the	 treatment,	 which	 he	 described	 as	 “overwhelming”.	 Despite	 having	
worked	 in	 a	medically	 related	 field,	 he	 did	 not	 feel	 that	 he	 had	 a	 good	understanding	 of	





5 	Positive	 resection	 margins	 indicated	 that	 the	 tissue	 removed	 during	 surgery	 showed	
microscopic	 evidence	 of	 cancer	 cells	 at	 the	 cut	 edge	 of	 the	 specimen.	 This	 means	 that	























































































































still	 had	 family	 living	 in	her	home	country.	Her	main	 social	 support	was	a	 strong	 circle	of	
friends.	Jane	had	been	treated	for	thyroid	cancer	about	25	years	previously.	
Diagnosis	and	treatment	







in	getting	her	diagnosis	and	 treatment.	 She	was	 referred	 for	 surgery	and	was	 told	 that	 in	
addition	to	the	usual	surgical	risks,	the	surgeon	might	not	be	able	to	completely	remove	the	
tumour	 and	 that	 there	 was	 a	 risk	 of	 arm	 paralysis.	 Jane	 went	 ahead	 with	 the	 surgery.	
Although	 the	 tumour	 was	 removed	 there	 was	 a	 positive	 posterior	 resection	margin.	 She	
recovered	well	from	the	surgery,	with	considerable	improvement	in	her	shoulder	pain.		
Consultations	
Jane	 was	 seen	 in	 the	 post-surgical	 consultation	 about	 two	 weeks	 after	 her	 surgery.	 She	
attended	with	a	friend	for	support.	Her	consultant	briefly	saw	her	initially	to	explain	about	
the	 positive	margin	 and	 need	 for	 radiotherapy,	 but	 this	was	 not	 observed	 as	 part	 of	 the	
study.	A	registrar,	Surgeon	5,	who	had	not	previously	met	with	Jane,	then	saw	her	and	this	
consultation	 was	 recorded.	 Her	 pre-operative	 pain	 had	 improved	 dramatically	 and	 this	
consultation	was	up	beat	and	positive.	
	
Her	 subsequent	 oncology	 consultation	 took	 place	 with	 Oncologist	 3,	 whom	 she	 had	met	
during	her	diagnostic	phase.	She	brought	a	different	friend	to	this	consultation.	Emotionally	
she	 found	 this	 consultation	more	 difficult	 for	 a	 number	 of	 reasons,	 some	 related	 to	 her	
health	and	some	external	reasons.	She	described	it	as	“Not	a	good	day”.	Her	focus	regarding	
information	appeared	to	be	on	practical	 issues	of	her	treatment,	although	she	did	enquire	








the	 lung,	 often	 involving	 infiltration	 of	 local	 structures,	 such	 as	 the	 chest	 wall,	 brachial	


















































































































job	 in	 local	 government	 and	 was	 looking	 forward	 to	 spending	 time	 with	 her	 family	 and	
travelling.	Her	husband	was	her	main	support.	She	had	several	adult	children	living	close	by	




















Maggie	 attended	 the	 post-surgical	 consultation	with	 her	 husband	 about	 four	weeks	 after	
her	 surgery.	 She	 was	 experiencing	 heart	 rhythm	 problems	 which	 were	 making	 her	 very	
breathless.	 Her	 consultant,	 Surgeon	 9,	 focused	 discussion	 on	 her	 heart	 problem,	 post-





Maggie’s	appointment	 to	see	 the	oncologist	happened	only	 four	days	 later.	However,	 she	
was	much	more	anxious	on	 this	occasion.	 She	attended	with	her	husband	again.	 She	was	
seen	 by	 Oncologist	 4	 and	 also	 LCNS	 7,	 both	 of	 whom	 she	 had	 not	 previously	 met.	 The	
oncologist	explained	the	rationale	behind	adjuvant	chemotherapy,	and	left	the	final	decision	




7	A	sleeve	 lobectomy	 involves	 resection	of	a	segment	of	bronchus	along	with	 the	affected	

































































































Maggie	 commenced	 chemotherapy,	 but	 found	 it	 very	 difficult	 to	 tolerate	 due	 to	 the	 side	
effects.	She	wanted	to	complete	the	treatment,	as	she	sought	peace	of	mind	about	future	




The	 cases	 that	 followed	 this	 second	 pathway	 were	 all	 referred	 to	 see	 an	 oncologist	 to	






Information	 given	 by	 the	 surgeons	 about	 possible	 future	 recurrence	 for	 this	 group	 of	
patients	 tended	 to	 be	 limited	 in	 nature.	Maggie	 and	 her	 surgeon	 did	 not	 discuss	 surgical	









During	 the	 oncology	 consultations	 oncologists	 had	 an	 inherent	 need	 to	 discuss	 the	
possibility	 of	 recurrence,	 at	 least	 in	 terms	 of	 the	 role	 of	 adjuvant	 treatment.	 However,	
oncologists	like	the	surgeons,	framed	recurrence	in	terms	of	a	future	possibility,	rather	than	
using	numerical	probabilities.	None	of	 the	oncologists	gave	patients	estimates	of	absolute	
risk	 of	 recurrence,	 or	 overall	 survival.	 Some	 oncologists	 used	 comparative	 statements	 to	
give	a	sense	of	degree	of	risk	for	patients	when	considering	adjuvant	treatment.	Oncologists	
mostly	explained	 the	potential	benefit	of	undergoing	chemotherapy	 to	patients	by	 talking	
about	the	numbers	of	extra	patients	who	might	not	experience	cancer	recurrence,	or	who	
might	 survive,	 compared	 to	 those	 treated	 with	 surgery	 alone.	 In	 one	 case	 no	 numerical	
estimate	 of	 benefit	 of	 adjuvant	 treatment	 was	 given	 (Henry)	 and	 in	 another	 case	 the	















some	cases	this	was	 instrumental	 in	the	patient’s	early	 lung	cancer	diagnosis	and	surgery.	
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Fiona’s	 case	 was	 atypical	 amongst	 those	 in	 the	 study	 due	 to	 her	 diagnosis	 two	 years	
previously	and	initial	chemotherapy	treatment	prior	to	surgery.		
	
Patients	 followed	 two	 distinct	 pathways	 after	 surgery,	 either	 referred	 on	 to	 long-term	
follow-up	 (Pathway	 A),	 or	 referred	 to	 see	 an	 oncologist	 to	 talk	 about	 adjuvant	 therapy	
(Pathway	B).	Patients	on	Pathway	A	were	 told	by	 their	 surgeon	that	no	 further	 treatment	
was	required	after	surgery.	Patients	then	asked	about	their	risk	of	recurrence.	For	patients	
with	 stage	 I	 cancer	 in	 this	 group,	 professionals	 emphasised	 the	 early	 cancer	 stage.	 For	
patients	on	Pathway	B,	professionals	did	 initiate	discussion	of	 recurrence,	but	 these	were	
generally	vague	and	often	at	the	level	of	possibility	rather	than	probability.		The	benefits	of	
adjuvant	 treatment	were	usually	discussed	 in	 terms	of	 the	extra	number	of	patients	who	
might	 survive	 or	 avoid	 recurrence,	 rather	 than	 discussing	 absolute	 risks.	 Across	 all	 of	 the	
observed	consultations	professionals	were	reluctant	to	enter	into	detailed	discussion	about	




















caring	 for	 them	 conceived	 the	 long-term	 outcome	 in	 relation	 to	 lung	 cancer.	 The	 theme	
covers	what	participants	foresaw	for	the	patients,	as	well	as	what	information	they	drew	on	






The	 chapter	 will	 be	 organised	 around	 the	 three	 main	 subthemes.	 In	 the	 first,	
‘Prognostication’,	 I	 will	 explore	 how	 professional	 participants	 conceived	 the	 long-term	
outcomes	for	patients	following	lung	cancer	surgery,	based	on	available	published	data	and	
clinical	 experience.	 The	 second	 subtheme,	 ‘Will	 it	 come	 back?’	 will	 look	 at	 the	 patient	
participants’	conceptions	of	 their	 long-term	outcomes,	which	were	 largely	concerned	with	
whether	 the	 lung	 cancer	 would	 recur.	 In	 the	 last	 subtheme,	 ‘If	 it	 were	 to	 come	 back’,	 I	
contrast	 the	 largely	 positive	 patient	 narratives	 around	 treating	 a	 recurrence	 if	 it	 were	 to	
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published	 International	Association	 for	 the	Study	of	Lung	Cancer	 (IASLC)	survival	data,	are	
provided	in	table	6.1.	The	answers	that	professionals	gave	to	this	line	of	questioning	ranged	
from	 very	 specific	 numerical	 estimates	 of	 prognosis	 to	 qualitative	 evaluations.	 Some	
professionals	declined	to	give	answers	to	these	questions,	either	because	they	did	not	feel	






data.	 However,	 the	 purpose	 of	 presenting	 the	 population	 data	was	 not	 to	 establish	 how	
















































































































































sometimes	 appeared	 that	 the	 two	 concepts	 were	 indistinct.	 In	 order	 to	 talk	 about	








surgeon	 about	 the	 estimate	 he	 gave	 Glennis	 during	 her	 consultation	 of	 “85%	 chance	 of	







long-term	outcome	 for	patients	with	early	 stage	 lung	cancer,	 than	 for	patients	with	more	
advanced	disease.	One	explanation	for	this	could	simply	be	that	statistics	around	early	stage	
cancer	were	relatively	easily	recalled.	However,	many	of	the	patients	with	more	advanced	
cancer	 also	 had	 more	 complex	 clinical	 scenarios.	 As	 complexity	 of	 individual	 scenarios	




Familiarity	with	and	access	 to	 the	 relevant	data	appeared	 to	be	 important	 factors	 in	both	
professionals’	use	of	these	statistics	in	practice	and	the	answers	they	gave	in	the	interviews.	
Some	professionals	 talked	about	 seeking	 relevant	 information	 in	 relation	 to	patients	 they	
were	due	to	see.	An	example	was	Kamal’s	Chest	Physician,	who	said:	“I'd	probably	try	and	




survival	 data	 for	 the	 individual	 patient	 “well	 before	 any	 kind	 of	 appointment”	 before	
embarking	on	a	discussion	about	treatment,	“because	I'm	not	great	at	keeping	figures	in	my	





Other	 professional	 participants	 did	 not	 appear	 to	 see	 prognostic	 information	 as	 so	
important	 in	 relation	 to	 their	 clinical	 practice.	 Several	 declined	 to	 give	 a	 numerical	




the	 staging	 report8	suggested	 a	 lack	 of	 familiarity	with	 the	 staging	 system.	 This	may	 then	






Some	LCNS	participants	were	more	explicit	 in	their	 lack	of	 familiarity	with	prognostic	data	
and	did	not	feel	able	to	answer	these	questions.	Maggie’s	surgical	LCNS	felt	that	she	lacked	
the	knowledge	and	experience	of	discussing	issues	around	treatment	outcome,	“because	my	
















other	 situations	 to	 place	 the	 risk	 in	 some	 form	 of	 context,	 while	 avoiding	 a	 numerical	
estimate	of	outcome.	Barbara’s	surgeon	viewed	her	risk	of	recurrence	as	being	higher	than	
other	surgical	patients,	due	to	cancer	spread	to	local	lymph	nodes.	Although	she	identified	
Barbara	 as	 being	 at	 “significant”	 risk	 of	 recurrence,	 despite	 further	 questioning,	 she	was	








as	a	 verbal	description,	as	 shown	 in	 table	6.1.	Although	 some	 replies	 intuitively	appeared	
congruent,	 such	 as	 the	 answer	 provide	 by	 Cathy’s	 surgeon,	 others,	 such	 as	 Maggie’s	
surgeon,	 underlined	 the	 contextual	 and	 idiosyncratic	 nature	 of	 these	 verbal	 estimates	 of	
outcome.	The	 surgeon	estimated	Maggie’s	 chance	of	 survival	 at	 five	years	as	35	–	40	per	
cent:	 somewhat	 lower	 than	 the	 population	 data	 for	 Maggie’s	 stage.	 Nevertheless,	 he	





There	 was	 a	 range	 of	 views	 amongst	 professional	 participants	 about	 the	 applicability	 of	









as	 limiting	 the	 usefulness	 of	 population-based	 data	when	 thinking	 about	 the	 outcome	 of	
individual	patients.	These	included	the	meaning	of	average	outcomes,	the	binary	nature	of	











more	 likely	 to	 fall	on	one	side	or	 the	other.	Do	better	 than	expected	or	worse	than	
expected.	(Chest	physician	1:	Kamal)	
	
Another	 basic	 concern	 about	 the	 usefulness	 of	 population	 data	 when	 dealing	 with	
individuals	 was	 the	 binary	 nature	 of	 the	 outcomes	 in	 question.	 Although	 several	
professionals	acknowledged	the	existence	of	“good	population	statistics”	(Oncologist	1),	the	
relevance	 to	 the	 individual	 patient	 cases	 was	 less	 clear.	 Jane’s	 Oncologist	 made	 a	 point	
about	the	binary	nature	of	recurrence	during	their	consultation,	saying,	“either	it	is	going	to	
come	back,	or	it	is	not”.	Several	professionals	felt	that	making	predictions	about	whether	an	
















inherent	 in	 cancer	 recurrence.	 Professional	 participants	 appeared	 to	 characterise	 lung	
cancer	patients	as	being	particularly	prone	to	surprising	outcomes,	at	odds	with	the	outlook	
suggested	 by	 the	 available	 statistics.	 Maggie’s	 surgical	 LCNS	 spoke	 about	 seeing	 patients	
with	recurrence	where	you	“wouldn’t	have	expected”	it.	Glennis’s	LCNS	saw	“no	rhyme	and	
reason”	 regarding	 which	 patients	 would	 relapse,	 especially	 for	 those	 diagnosed	 with	
adenocarcinomas.	Edward’s	LCNS	spoke	about	patients	she	had	cared	for	with	early	stage	
cancer	who	had	relapsed	unexpectedly,	highlighting	the	gap	between	available	population	
data	 and	 the	 complexities	 and	 uncertainties	 of	 individual	 patients’	 situations.	 These	
experiences	 led	 her	 to	 conclude	 that	 attempting	 to	 predict	 outcomes	 for	 an	 individual	
patient	was	not	useful.		
[…]	 as	 we	 have	 proven	 so	 often,	 statistics	 are	 actually	 not	 of	 any	 help	 anyway,	
because	things	just	don’t	fit	in	the	boxes,	do	they?	(LCNS	3:	Edward)	
Individual	differences	
Where	 professionals	 drew	 on	 average	 population	 data	 to	 make	 predictions,	 some	 used	
specific	 histology	 and	 pathological	 features	 to	 reflect	 a	 more	 individual	 estimate	 of	
outcome,	 such	 as	 the	 oncologists	 caring	 for	 Jane	 and	 Maggie	 (see	 table	 6.1).	 Maggie’s	
oncologist	spoke	about	aspects	of	the	pathology	report	that	could	negatively	influence	her	
prognosis,	 such	as	 tumour	 invasion	 into	 the	pleura	and	necrosis	of	 the	 tumour.	However,	







Other	 aspects	 of	 the	 pathology	 report	 appeared	 to	 be	 given	 less	 importance.	 Several	
professionals	characterised	adenocarcinomas	as	less	aggressive	than	other	cancer	types.	For	
example,	LCNS	2	said	that	“the	adenocarcinomas	 in	general	tend	to	be	slow	growing”	and	
Surgeon	 2	 described	 Denise’s	 adenocarcinoma	 as	 “not	 a	 particularly	 aggressive	 type	 of	
cancer”.	 But	 beyond	 this,	 none	of	 the	professionals	 identified	histological	 sub-type	 in	 the	
pathology	report	as	indicating	a	better	or	worse	prognosis,	despite	some	available	evidence	
on	 the	 effect	 of	 adenocarcinoma	 subtype	 on	 prognosis.	 Audrey’s	 oncologist	 commented	
that	his	primary	focus	was	to	decide	about	whether	or	not	to	offer	adjuvant	chemotherapy.	
Histological	subtype	had	little	bearing	on	this	decision,	and	was	therefore	largely	incidental.	
It’s	 really	 the	 stage	 of	 the	 disease	 and	 the	 patients’	 health	 that	 drives	 sort	 of	
adjuvant	chemo	decisions.	(Oncologist	1:	Audrey)	
	
Another	 factor	 that	 limited	 the	 reliance	 professional	 participant’s	 placed	 on	 the	 available	
evidence	was	the	impact	of	co-morbidities	on	a	patient’s	overall	prognosis.	Such	individual	
complexities	meant	that	the	available	population	data	became	increasingly	unrelated	to	the	
clinical	 estimates	 for	 outcome.	 Audrey’s	 oncologist	 raised	 concerns	 about	 the	 long-term	
effect	of	having	a	pneumonectomy,	alongside	her	other	co-morbidities.	His	estimate	for	her	
prognosis	included	the	effect	of	cancer	stage	as	well	as	her	underlying	health.	However,	the	




For	 some	patients,	 professionals	 saw	other	health	 conditions	as	 important	 as	 lung	 cancer	
stage	in	predicting	survival,	such	as	Kamal’s	Chest	physician.		






Another	 situation	 that	 presented	 a	 significant	 challenge	 to	 professionals	 when	 using	 the	
available	evidence	to	predict	long-term	outcomes	was	for	patients	who	had	microscopically	
incomplete	 resections	 (denoted	 as	 R1).	 Table	 6.1	 outlines	 the	 estimates	 for	 long-term	
outcome	for	Henry	and	Jane.	The	estimate	given	by	Henry’s	surgeon	for	risk	of	recurrence	
was	unusual	in	providing	a	definitive	estimate.	However,	the	answer	appeared	to	be	based	






oncologist.	 The	 oncologist	 particularly	 highlighted	 the	 unknown	 significance	 of	 the	
microscopically	 positive	margin	 finding	on	 survival.	 The	 limited	evidence	base	meant	 that	
this	estimate	was	apparently	an	educated	guess.		
The	 difficulty	we	 have	with	 this	 one	 is	 that	 nobody	 really	 knows	what	 impact	 the	
















[…]	 most	 of	 the	 evidence	 is	 based	 around	 those	 patients	 who	 have	 got	 nodal	
positivity,	in	terms	of	the	actual	values	and	figures	and	numerical	values.	And	I	think	
where	you	have	got	R1	and	where	you've	got	PL39	that	makes	it	much	more	difficult	
to	 be	 able	 to	 extrapolate	 those	 patients	 out	who	 have	 got	 node-negative	 disease.	
(Oncologist	3:	Jane)	
	
Fiona’s	 case	 was	 a	 particularly	 vivid	 example	 of	 a	 patient	 who	 had	 followed	 an	 unusual	
pathway	to	surgery,	having	initially	been	treated	with	chemotherapy	with	palliative	intent.	
The	uniqueness	of	Fiona’s	case	meant	that	there	was	not	a	population	of	other	patients	on	




happen	 in	 the	 future”	 (Fiona’s	 surgeon).	 Fiona’s	 oncologist	 summed	 up	 the	 particular	
challenges	in	predicting	her	future	outcome.		
So	she's	not	completely	risk-free,	but	what	the	percentage	is...	Because	this	is	such	an	
unusual	case.	 I	mean,	 in	 […]	the	many	years	 I	worked	[…]	treating	 lung	cancer,	 I've	
never	seen	 this.	We	 just	have	 to	watch	and	see.	 I	 can't	put	a	 figure	on	 it	at	all	 I'm	
afraid.	(Oncologist	2:	Fiona)	
	
Whether	 or	 not	 professionals	 were	 willing	 or	 able	 to	 offer	 prognostic	 estimates	 for	 the	
individual	patient	 cases,	 the	way	 in	which	 they	 spoke	about	and	conceptualised	 the	 long-
term	outlook	drew	on	the	available	evidence	and	on	their	clinical	knowledge	and	experience	











In	 this	 second	 subtheme	 I	will	 focus	 on	 how	 the	 patient	 participants	 conceived	 the	 long-
term	future	and	what	 information	 they	used	 to	 form	their	understanding.	The	 title	of	 the	
subtheme,	 ‘Will	 it	come	back?’,	 reflects	the	concern	 in	patients’	narratives	about	whether	




































think	 that	 is	 probably	 the	most	 sensible	 approach.	 I'll	 try	 and	 think	 positively	 and	
hope	that	this	is,	you	know,	it.	(Denise	1st	interview)	
By	emphasising	her	individuality	and	by	invoking	a	game	of	chance,	Denise	appeared	to	be	
taking	 away	 prediction	 based	 on	 populations	 and	 focused	more	 on	 randomness	 and	 the	
potential	 effect	 on	 her	 as	 an	 individual.	 Her	 position	 resonated	 with	 that	 of	 the	
professionals	discussed	previously	who	were	sceptical	about	the	applicability	of	population	
statistics	 to	 individuals.	 Unlike	 Glennis,	 here	 Denise	 was	 consciously	 trying	 to	 accept	 the	
uncertainty	of	her	position	and	to	use	this	as	a	positive	force	in	coping	with	it.		
	







expectancy.	 She	 recalled,	 “…	 he	 said	 something	 about	 five	 years,	 so	 I	 think	 I’ve	 got	 five	
years.”	 Other	 patients	 also	 appeared	 not	 to	 fully	 retain	 the	 information	 that	 they	 were	
given.	 When	 Len	 was	 asked	 about	 the	 recurrence	 risk	 information	 given	 during	 the	





that	 giving	patients	 information	may	not	 result	 in	 retention,	or	 accurate	 interpretation	of	
what	professionals	think	they	have	conveyed.		
Other	indicators	
Patient	 participants	 frequently	 used	 much	 broader	 sources	 of	 information	 to	 form	 their	
understanding	 of	 their	 long-term	 outlook	 beyond	 the	 direct	 recurrence	 risk	 or	 survival	
information	given	by	professionals.	This	might	include	information	about	the	nature	of	the	
surgical	operation,	plans	for	onward	management,	the	emotional	tone	of	the	consultation,	
as	 well	 as	 factors	 from	 the	 wider	 healthcare	 setting,	 such	 as	 knowledge	 of	 how	 other	




completely	 remove	 the	 cancer	 was	 often	 central	 to	 patients’	 positive	 outlook	 about	 the	
future.	An	example	of	this	was	Cathy,	who	was	able	to	recall	the	surgical	outcome	and	plan.		
They'd	taken	out	the	cancer.	And	they'd	had	a	good	chunk	around	and	they'd	made	
sure	 they'd	 got	 it.	 So	 there	 was	 no	 cancer,	 so	 I	 needed	 no	 treatment.	 (Cathy	 1st	
interview)	
She	also	spoke	about	the	rationale	for	the	planned	follow-up.		
I	 suppose	 she's	 keeping	 an	 eye	 that	 they	 don't	 come	 back,	 hopefully.	 (Cathy	 1st	
interview)	
Although	she	acknowledged	an	 inherent	 risk,	albeit	minimal,	 she	 remained	positive	about	
the	outlook	 in	 relation	 to	her	 cancer.	 She	described	her	own	 sense	of	 agency	 that	would	
help	to	minimise	this	risk	to	a	negligible	level,	which	included	a	combination	of	hope,	prayer	
and	life-style	changes.	Describing	her	perceived	risk	of	recurrence,	she	said:	
Hopefully,	zero.	 I	hope	and	I	pray.	 I	don't	smoke	any	more.	 I	eat	healthy.	(Cathy	1st	
interview)	
	
Other	 patients	 appeared	 to	 take	 the	 general	 tone	 of	 the	 consultation	 and	 the	 overall	
message	about	onward	management	as	an	 indication	of	 their	outlook.	A	clear	example	of	
this	 was	 Len’s	 consultation	 with	 is	 surgeon.	 Although	 he	 was	 not	 able	 to	 recall	 specific	
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details	 of	 the	 information	 given	 during	 his	 consultation,	 he	 took	 the	 surgeon’s	 confident	
attitude	as	evidence	of	a	good	outlook.	He	acknowledged	the	possibility	for	recurrence,	but	
this	 understanding	 came	 from	 the	 discussion	 about	 long-term	 follow-up,	 rather	 than	 the	
specific	discussions	about	recurrence	risk.		
I	 presumed	 there’d	 be	 something	 like	 that	 [risk	 of	 recurrence]	 because	 otherwise	
there	wouldn’t	be	no	reason	to	follow	up.	(Len	1st	interview)	
	
Several	 of	 the	 participants	who	were	 referred	 for	 an	 opinion	 regarding	 adjuvant	 therapy	
(those	 on	 pathway	 B)	 explicitly	 acknowledged	 that	 this	 referral	 indicated	 a	 higher	 risk	 of	
cancer	 recurrence.	However,	 none	of	 the	patients	 gave	 any	 indication	of	 the	 level	 of	 this	
risk,	or	any	desire	to	know.	Henry	was	an	example	of	this.	In	his	interview	he	explained:	
And	 now	 there	 is	 the	 possibility	 of	 a	 recurrence,	 so	 therefore	 further	 treatment	 is	
recommended.	(Henry,	1st	interview)	
However,	 his	 perception	 of	 the	 high	 cost	 of	 the	 treatment	 he	was	 receiving	was	 in	 itself	
taken	to	indicate	that	there	was	still	a	good	chance	of	a	good	outcome.	




















view	of	 their	 long-term	outcome.	 Such	understanding	 came	 from	general	 knowledge,	 the	
media,	 as	well	 as	 the	 experiences	 of	 family	members,	 friends	 and	 acquaintances.	 Several	
participants,	 such	 as	 Audrey,	 Kamal	 and	Maggie,	 spoke	 about	 their	 view	 that	 cancer	was	
equated	with	 death.	 A	 lay	 understanding	 also	 often	 informed	participants’	 beliefs	 of	why	




he	 spoke	 about	 “getting	 rid”	 of	 his	 lung	 cancer,	 he	 viewed	 the	 presence	 of	 asbestos	
“lurking”	in	his	body	as	giving	him	a	higher	risk	of	future	cancers.	
So	now	we've	got	rid	of	this	bit	[the	lung	cancer].	And	this	crept	up	on	us.	So	maybe	







And	 have	 I	 got	 a	 predisposition	 to	 both	 [breast	 cancer	 and	 lung	 cancer]?	 I'm	 still	
living	in	the	same	[area].	Is	it	environmental?	(Denise	1st	interview)	
Although	she	raised	her	concern	about	the	environment,	she	went	on	to	talk	about	how	she	

























Fiona	 was	 another	 participant	 who	 saw	 her	 body	 as	 being	 more	 vulnerable	 to	 future	















Patient	participants	developed	multiple	narratives	 regarding	 their	 future	after	 lung	cancer	
surgery.	These	accounts	were	seen	to	change	and	different	ones	given	greater	prominence	











During	 the	 longitudinal	 element	 of	 the	 study	 patients’	 understanding	 of	 their	 long-term	
outlook	 appeared	 to	 alter	 principally	 in	 relation	 to	 changes	 in	 circumstances.	 This	 was	
particularly	true	where	patients	experienced	concerning	symptoms.	Audrey’s	case	provided	
a	 clear	 example	 of	 this,	 when	 her	 bodily	 symptoms	 led	 to	 a	 crisis	 point	 regarding	 the	
possibility	of	cancer	recurrence.	After	she	completed	her	radiotherapy	to	her	synchronous	
nodule,	she	developed	severe	back	pain.	She	initially	told	herself	 it	was	treatment	related,	























































































































































Eventually	 Audrey	 was	 reassured	 that	 it	 was	 due	 to	 osteoporosis	 and	 not	 cancer,	 and	
gradually	her	fears	of	widespread	metastatic	cancer	diminished.	The	old	recurrence	worries	
still	 returned	 at	 times,	 such	 as	 worsening	 back	 pain,	 or	 prior	 to	 scans	 and	 clinic	
appointments.		
I	think	if	anybody	that	has	got	cancer	has	to	go	and	see	the	specialist	for	their	next	
appointment,	must	get	 the	same	as	me,	you’re	anxious	as	 to	what	 they’re	actually	
going	to	say.	(Audrey,	3rd	interview)	
	












her	 growing	 anxiety	 about	 her	 respiratory	 symptoms.	 Checking	 for	 symptoms	 became	 a	
quotidian	reality	for	Glennis.		
I	wake	up	and	I	feel	like	as	if	I’ve	got	a	pressure	headache,	every	morning,	and	then	it	
goes	when	 I’m	 in	 the	 shower	 and	 doing	 things.	 And	 I	 do	 think,	 have	 I	 got	 a	 brain	
tumour?	And	it	doesn’t	really	leave	you,	to	be	honest.	(Glennis	2nd	interview)	























the	 reality	 of	 potential	 recurrence,	 where	 the	 event	 either	 does	 or	 does	 not	 happen,	
Kamal’s	 alternative	 narratives	 did	 not	 incorporate	 probability,	 but	 was	 capable	 of	




Some	participants,	 such	 as	 Cathy’s	 approach	 discussed	 earlier,	wanted	 to	 emphasise	 that	




The	 comment	 served	 to	 underline	 how	 he	wished	 to	 convey	 his	 level	 of	 concern	 at	 that	
time:	 simple,	non-threatening	and	 finished.	Nonetheless,	Edward	was	cautious	 in	 the	way	




They	 said	 that	 they	 didn't	 think	 that	 I	 would	 benefit	 from	 chemo,	 which	 is	 a	 lot	




from	 the	 oncology	 referral	 was	 of	 a	 greater	 risk	 of	 recurrence	 in	 his	 mind.	 Edward	
recognised	 the	 inherent	 risk	 of	 cancer	 in	 the	 future,	 but	 he	 consistently	 denied	worrying	
about	 possible	 cancer	 recurrence.	 He	 described	 his	 approach	 as	 “San	 Fairy	 Ann” 10 ,	
conveying	a	dismissive	attitude	to	any	worry.	
	
Exploring	 and	 acknowledging	 the	 potential	 for	 a	 feared	 outcome	 appeared	 to	 be	 an	
important	way	 of	 dealing	with	 difficult	 ideas	 for	 some	of	 the	 participants.	While	 patients	
frequently	 maintained	 their	 positive	 narratives	 that	 emphasised	 their	 belief	 that	 things	





size’,	 and	 to	 see	how	 they	would	manage	 them.	Denise	wanted	 to	 acknowledge	 that	 she	
could	need	further	lung	surgery	if	the	nodule	identified	were	to	grow.	
So	 I	 think	 I'll	be	more	realistic	 thinking	 it's	probably	going	to	need	[…]	surgery,	and	





or	 evolving	 evidence	 became	 available	 to	 the	 participants.	 Information	 given	 by	
professionals	 directly	 about	 long-term	 outlook	 seemed	 to	 only	 make	 up	 a	 small,	 albeit	
																																																						
10 	Jocular	 form	 representing	 French	ça	 ne	 fait	 rien	‘it	 does	 not	 matter’,	 said	 to	 have	








This	 final	 subtheme	will	 explore	 how	 patient	 and	 professional	 participants	 conceived	 the	
implications	and	likely	treatment	options	available	if	they	were	to	experience	a	recurrence	
of	cancer.	I	will	start	by	examining	the	largely	positive	narratives	patients	used	to	talk	about	
treating	 any	 potential	 future	 recurrence.	 I	 will	 then	 examine	 the	 contrasting	 ways	
professional	 participants	 spoke	 about	 treating	 recurrence,	 reflecting	 a	much	 less	 positive	
vision	of	what	it	is	to	manage	patients	with	recurrent	lung	cancer.	
6.4.1 If	such	a	thing	should	happen	–	patients’	views	































In	a	 similar	way,	Barbara	 constructed	a	narrative	around	what	 things	would	be	 like	 if	 she	
were	to	later	relapse.	In	her	first	interview	she	spoke	about	how	important	it	was	to	her	not	
to	 go	 ahead	 with	 adjuvant	 chemotherapy	 in	 order	 to	 give	 priority	 to	 her	 rheumatoid	
arthritis	 treatment.	 However,	 she	 stressed	 that	 she	 would	 go	 ahead	 with	 chemotherapy	
later	if	a	recurrence	were	detected	during	her	follow-up.		
If	 such	 a	 thing	 should	 happen	…,	 I	wouldn't	 hesitate	 to	 have	 the	 chemo.	 But	 as	 it	
stands	at	the	moment,	and	being	that	I'm	going	to	be	looked	after	so	well,	at	the	first	
sign	of	any	problems,	that's	where	I	go.	(Barbara	1st	interview)	
The	 phrasing	 “If	 such	 a	 thing	 should	 happen”	 suggested	 something	 remote	 and	 probably	




Although	Maggie	did	commence	adjuvant	 treatment,	 she	was	unable	 to	complete	 the	 full	
course.	 She	 was	 able	 to	 acknowledge	 recurrence	 was	 a	 possibility	 and	 explain	 her	
contingency	if	she	were	to	relapse.		
And	the	other	thing	is,	OK,	you	know,	touch	wood	and	whistle,	it	won't	come	back.	It	
could	 come	 back	 anyway	with	my	 body,	 couldn’t	 it?	 I'll	 cope	with	 that	when	 that	
happens	and	then,	you	know.	And	what	they	said	is	that	is	a	different	chemo	anyway.	
[…]	It	would	be	different	and	I	would	do	it	[…].	(Maggie	3rd	interview)	
Maggie’s	 narrative	 distanced	 the	 eventuality	 by	 saying,	 “I’ll	 cope	 with	 that	 when	 that	




also	 never	 acknowledged	 the	 change	 of	 treatment	 aims	 inherent	 in	 chemotherapy	
treatment	after	relapse.	
	




for	 further	 information	 on	 the	 Internet	 but	 the	 findings	 were	 not	 reassuring	 to	 her.	 Her	
initial	 assumptions	 that	 if	 she	 had	 a	 recurrence	 of	 the	 cancer	 she	would	 be	 able	 to	 have	
further	surgery	became	increasingly	eroded	by	her	concerns	over	her	respiratory	symptoms.		













Some	 professional	 participants	 emphasised	 the	 importance	 of	 post-operative	 surveillance	
during	long-term	follow-up	in	order	to	detect	recurrence	early	and	offer	further	treatment	
aimed	at	cure.	Len’s	surgeon	stood	out	as	being	the	most	interventionist	and	positive	about	
detecting	 and	 treating	 future	 recurrence.	 He	 stressed	 the	 importance	 of	 detecting	
















Professionals	distinguished	the	biology	of	 lung	cancer	 from	other	 types	of	cancer,	 such	as	
colorectal	 cancers,	 where	 isolated	 sites	 of	 metastatic	 cancer	 were	 more	 common.	





Only	 patients	 with	 localised	 disease	 would	 be	 suitable	 for	 curative	 intervention	 and	
consequently	 treatment	 after	 relapse	 was	 usually	 palliative.	While	 he	 would	 be	 open	 to	
offering	 radical	 treatment	 if	 the	 patient	were	 suitable,	 his	 experience	 suggested	 this	was	
unlikely.	









However,	 she	 also	 recognised	 that	 the	 development	 of	 new,	 targeted	 radiotherapy	
techniques,	had	opened	up	treatment	possibilities	for	patients	who	relapsed	with	only	very	
limited	 disease,	 but	 she	 continued	 to	 be	 cautious	 about	 the	 treatment	 of	 isolated	 lung	





on	 to	 relapse,	 treatment	 was	 primarily	 offered	 to	 help	 manage	 symptoms	 rather	 than	
aiming	at	cure.	Nevertheless,	professionals	still	emphasised	the	importance	of	following	up	
patients	 regularly	 to	 identify	 signs	 of	 recurrence	 early.	 The	 purpose	 was	 portrayed	
principally	as	a	supportive	intervention	for	patients	and	families,	rather	than	contributing	to	
curing	patients.	Findings	suggested	that	new	approaches	to	treatment	might	be	beginning	
to	 influence	 attitudes	 to	 detecting	 and	 treating	 recurrence,	 professional	 participants	
generally	remained	pessimistic	about	the	outcome	if	a	patient	was	to	experience	a	relapse	
following	surgery.		
[…]	 it’s	 more	 about	 trying	 to	 pick	 up	 things	 before	 they	 present	 too	 much	 of	 a	
symptom	burden	to	him	so	we	can	intervene	at	an	earlier	stage.	(Chest	physician	1:	
Kamal)	






significant	differences	 in	 the	way	 that	patients	 and	professionals	 thought	 about	 the	 long-
term	 outcome	 for	 individual	 patients.	 The	 subtheme	 ‘Prognostication’	 discussed	 the	
professionals’	 numerical	 and	 verbal	 estimations	 of	 patients’	 chance	 of	 survival	 or	 risk	 of	









on	 whether	 the	 cancer	 might	 recur	 after	 surgery.	 Patients	 used	 multiple	 sources	 of	
information	to	construct	their	views	of	the	future,	with	specific	prognostic	information	given	
to	 them	 by	 professionals	 only	 making	 up	 a	 small	 part	 of	 their	 understanding.	 Patients’	
narratives	about	their	likely	future	were	not	static,	but	changed	over	time,	and	adapted	to	
interpret	 evolving	 events	 and	 emotions.	 Patients	 were	 capable	 of	 holding	 multiple,	
sometimes	conflicting	narratives	concurrently.	
	
The	 final	 subtheme	 examined	 the	 way	 patients	 and	 professionals	 thought	 about	 the	
implications	and	management	of	a	potential	future	lung	cancer	recurrence.	Several	patients	
maintained	positive	narratives	 about	 treating	 their	 cancer	 if	 it	 recurred	and	 talking	 about	
this	may	have	formed	part	of	the	way	patients	coped	with	the	uncertainty	of	recurrence.	In	







In	 this	 chapter	 I	will	 present	 the	 cross	 case	 theme	 ‘Maintaining	Hope’.	 This	 explores	how	
patient	and	professional	participants	made	active	 choices	about	 the	 information	 that	was	
disclosed	and	sought	about	long-term	outcomes	with	the	aim	of	supporting	patients’	hope.	
Findings	 will	 be	 presented	 using	 four	 subthemes:	 ‘Hope	 for	 normality’,	 ‘Information	 as	






The	 subtheme	 of	 ‘Hope	 for	 normality’	 will	 characterise	 the	 nature	 of	 hope	 as	 viewed	 by	
both	patients	and	professionals	and	focuses	on	the	shared	aim	of	patients	regaining	a	sense	
of	normality.	The	second	subtheme,	‘Information	as	threat’,	explores	how	professionals	and	
patients	 characterised	 cancer	 related	 information	 as	 potentially	 threatening	 to	 patients’	
sense	 of	 hope	 which	 impacted	 on	 both	 emotions	 and	 physical	 recovery.	 Numerical	 risk	
information	 was	 conceived	 to	 pose	 a	 particular	 danger	 to	 patients.	 The	 third	 subtheme	
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‘Painting	 an	 information	 picture’	 considers	 the	 choices	 professionals	 made	 in	 the	
information	they	provided	and	patients’	choices	regarding	the	information	they	sought.	The	
final	subtheme	‘Pivoting	the	cancer	gaze’	explores	how	patients	and	professionals	wanted	




This	 subtheme	 explores	 how	 patients	 and	 professional	 participants	 shared	 a	 goal	 of	
achieving	a	sense	of	normality	in	patients’	disrupted	lives	following	lung	cancer	surgery.	In	
the	 short-term	 hope	 was	 centred	 on	 resumption	 of	 usual	 activities	 and	 the	 emotional	
stability	that	patients	had	prior	to	their	lung	cancer	diagnosis.	Shared	hope	in	the	long-term	
was	for	cancer	fading	into	the	background	of	life	and	no	longer	having	an	immediate	impact	





















loaded	 term	 that	 promised	 more	 than	 was	 actually	 being	 offered.	 Nevertheless,	
professionals	saw	patients	as	wanting	the	certainty	of	being	told	they	had	been	cured.	




not	 to	 indicate	 to	 patients	 that	 they	were	 cured	 following	 surgery.	 These	 concerns	were	
particularly	evident	for	patients	with	more	advanced	stage	lung	cancer.		
[…]	 I’d	 hope	 I'd	 never	 say	 to	 her	 that	 we	 think	 we've	 cured	 you,	 because	 that's	
completely	unreal…	(Surgeon	1:	Barbara)	
Other	surgeons,	 like	those	seeing	Glennis	and	Len,	 included	other	terms	they	were	careful	
of	 using,	 such	 as	 “cancer	 clear”	 or	 “it’s	 all	 been	 resected”.	 This	 was	 especially	 so	 when	







was	 a	 highly	 significant	 life	 event,	 as	 was	 evident	 in	 the	 case	 presentations.	 In	 the	 last	
chapter	I	demonstrated	how	patients	talked	about	a	future	where	the	cancer	did	not	return	
and	no	further	treatment	was	required.	Most	patients	wanted	to	put	the	diagnosis	of	lung	






















I	 still	 feel	 as	 if	 I’m	 in	 sort	 of	 mourning	 for	 how	 I	 was	 beforehand.	 (Glennis	 2nd	
interview)	





For	 some	 patient	 participants,	 surgery	was	 seen	 as	 offering	 an	 end	 to	 the	 uncertainty	 of	
being	 diagnosed	 with	 lung	 cancer.	 This	 was	 especially	 true	 for	 Fiona.	 During	 her	 initial	
treatment	 with	 chemotherapy	 she	 had	 understood	 her	 cancer	 to	 be	 “terminal”	 and	 she	
worried	what	would	happen	if	she	stopped	treatment:	“as	far	as	I	knew	it	was	just	holding	
the	cancer”.	 It	was	apparent	 that	 she	had	hoped	surgery	would	 remove	her	uncertainties	
about	 her	 long-term	 future.	 After	 surgery	 she	wanted	 to	 be	 told	 that	 she	 no	 longer	 had	








cancer,	 two	 of	 the	 patients	 also	 recognised	 another	 side	 to	 hope.	 Len	 and	 Fiona	 both	 at	
times	 identified	hope	as	being	too	flimsy	and	weak	against	cancer,	and	wanted	to	rely	on	








[…]	 Because	 hope	means	 you	 hope	 it’s	 going	 to	 happen,	 but	 I'm	more	 positive	 it’s	




This	 subtheme	 examines	 how	 patients	 and	 professionals	 both	 characterised	 much	
information,	 particularly	 about	 outcome,	 as	 potentially	 threatening	 to	 patients’	 sense	 of	
hope.	 Whilst	 some	 information	 about	 diagnosis	 and	 treatment	 was	 acknowledged	 as	




The	 impact	 of	 information	 on	 patients’	 psyche,	 especially	 on	 factors	 such	 as,	 optimism,	
depression	and	maintaining	hope,	was	the	principal	concern.	For	some	patients	feeling	that	
cancer	was	equivalent	 to	 “death”	had	been	particularly	difficult	 to	deal	with.	Often	 these	








do	about	 it?	How	are	you	going	to	do	that?	And	am	I	better?	 [...]	 I	don't	want	any	
finer	details.	(Maggie	1st	interview)	
Maggie	described	herself	as	a	natural	worrier.	 Information	about	her	cancer	appeared	too	




This	 strategy	 was	 inherently	 problematic.	 Patients	 often	 had	 no	 control	 over	 the	
information	 they	 received.	 This	 was	 particularly	 so	 when	 information	 was	 delivered	
unexpectedly,	or	at	times	of	particular	vulnerability.	Maggie	referred	to	an	incident	where	
she	 was	 given	 unexpected	 information	 just	 prior	 to	 going	 for	 surgery.	 She	 described	 it	












to	contemplate.	She	said,	“I	don’t	want	 to	know	 if	 it’s	got	a	 life	sentence”,	 indicating	 that	
she	did	not	want	to	be	told	she	was	not	curable.	The	potential	for	this	sort	of	information	to	
damage	her	psychologically	was	clear.	Her	strategy	became	to	avoid	asking	any	questions,	










personal	 agency	 seen	 in	 the	 patient	 interviews	 in	 terms	 of	 actively	 blocking	 out	 negative	










belief	 about	 his	 Mother’s	 death	 after	 learning	 about	 her	 own	 cancer	 diagnosis.	 This	
experience	led	to	him	not	wanting	any	information	that	might	expose	him	to	facts	capable	
of	damaging	his	hope.		
I	 have	 a	 fairly	 positive	 attitude	 to	 most	 things	 and	 I	 don’t	 want	 to	 start	 reading	
things,	which	are	going	to	give	me	a	negative	attitude.	(Henry	1st	interview)	
Henry	felt	most	information	he	was	given	lacked	a	practical	value	that	might	enable	him	to	










Other	participants	had	a	quasi-magical	belief	 that	 thinking	about	cancer	 recurrence	might	
make	it	more	likely	to	happen.		
I'm	 a	 great	 believer	 in	 positive	 energy	 and	 if	 you're	 negative	 about	 something,	 oh	
God,	I	might	get	cancer	in	my	toe.	You	might	well	get	cancer	in	your	toe.	(Maggie	3rd	
interview)	







Many	 of	 the	 professional	 participants	 expressed	 similar	 views	 to	 the	 patients	 about	 the	
inherent	threat	to	patients’	sense	of	hope	posed	by	recurrence	risk	 information.	Although	
often	 couched	 in	more	 scientific	 terms	 than	 the	 views	of	 the	patients,	many	professional	
participants	 linked	 information	 that	 was	 a	 threat	 to	 patients’	 hope	 as	 having	 a	 direct	
negative	impact	on	their	chance	of	survival.	When	characterising	the	threat	that	recurrence	





Professionals	 were	 concerned	 about	 how	 negative	 information	 about	 recurrence	 and	
survival	 would	 “impact	 [the	 patient’s]	 psychology”	 (Kamal’s	 surgeon)	 and	 levels	 of	
hopefulness.	A	sense	of	hopelessness	and	depression	was	felt	to	affect	the	immune	system,	
which	some	linked	to	greater	risk	of	recurrence.	
[…],	 I	 believe	 that	 [with]	 the	 cancer	 fight,	 people	 immunosuppress	 due	 to	 their	













“opening	a	 can	of	worms”	 (Kamal’s	Chest	Physician).	 Some	professionals	were	 reticent	 to	
talk	about	long-term	outcome	statistics	with	patients	even	with	early	stage	cancers,	where	
statistics	 were	 viewed	 as	 being	 more	 favourable.	 Professionals	 were	 reluctant	 to	 “say	
numbers”	 (Cathy’s	Surgeon)	 to	patients,	and	saw	 it	as	being	“unfair”	 (Kamal’s	Surgeon)	 to	
burden	 patients	 with	 this	 type	 of	 information.	 Survival	 statistics	 were	 characterised	 as	




Numerical	 information	was	seen	 to	be	 too	stark,	and	 therefore	unhelpful	 to	patients.	The	
bleak	 way	 the	 surgeon	 framed	 her	 comment	 underscored	 her	 negative	 attitude	 to	
numerical	 information.	Others	were	more	 vivid	 in	 the	 language	 they	used	 about	 the	way	
patients	could	misuse	the	figures	professionals	gave	them.		






















I	 don't	 think	 [knowing]	 the	 exact	 percentage	 is	 going	 to	make	much	 difference	 to	
how	you	deal	with	it,	but	some	patients	need	the	exact	number.	(Surgeon	5:	Glennis)	
Others	understood	patients’	need	 to	have	 this	 information	and	saw	 their	 role	as	not	only	
providing	this,	but	also	in	guiding	patients	to	be	able	to	understand	its	limitations.	Kamal’s	
chest	 physician	 wanted	 to	 make	 patients	 clear	 about	 the	 uncertainty	 inherent	 in	 the	
available	 data.	 Denise’s	 surgical	 LCNS	 recognised	 the	 plethora	 of	 prognostic	 information	
available	 to	 patients	 and	 their	 need	 for	 guidance	 in	 negotiating	 this.	 If	 help	 was	 not	
forthcoming,	 patients	 might	 unwittingly	 seek	 information	 from	 incorrect	 or	 from	 poor	
sources,	 which	 she	 felt	 could	 be	 more	 dangerous	 for	 patients	 than	 having	 accurate	
information.	




This	 subtheme	 explores	 how	 participants,	 principally	 professionals,	 aimed	 to	 achieve	 the	
right	 balance	 in	 the	 information	 patients	 received.	 How	 professionals	 interpreted	 and	
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presented	 the	 available	 information	 for	 patients	 can	 be	 seen	 as	 analogous	 to	 an	 artist	
painting	a	picture	to	give	a	particular	view	of	a	scene,	choosing	an	angle	to	present,	placing	
certain	objects	 in	 the	 foreground,	and	determining	the	 level	of	detail	and	the	 lightness	or	
darkness	of	the	overall	scene.		
	




there	was	an	 inevitable	selectivity	 in	what	patients	were	told.	Professionals	varied	 in	their	






training	 had	 placed	 emphasis	 on	 patients	 controlling	 and	 initiating	 discussions	 about	
prognosis.	
[…]	 the	 oncology	 training	 is	 towards	 the	 patient	 as	 an	 individual	 requesting	
information,	and	being	given	 the	 information	at	 the	pace	 they	want	 it,	at	 the	 time	
they	want	it.	(Oncologist	4:	Maggie)	
In	 contrast,	 two	 surgical	 registrars	 spoke	 about	 the	 lack	 of	 training	 and	 preparation	 for	
giving	 this	 sort	 of	 information.	 Kamal’s	 surgeon	 said,	 “we	 haven’t	 been	 trained	 to	 do	 it”.	











patients.	 One	 where	 the	 balance	 was	 weighted	 strongly	 towards	 providing	 objective	
scientific	 facts	 (a	 scientific	 picture),	 one	where	 it	 was	much	more	 focused	 on	 supporting	
hope	 (a	 hopeful	 picture)	 and	 one	 aimed	 at	 both	 helping	 patients	 find	 hope,	 but	
acknowledging	risks	as	well	(a	balanced	picture).	
7.4.1 A	scientific	picture	
One	 of	 professionals’	 first	 concerns	 was	 getting	 information	 that	 patients	 were	 able	 to	
understand.	 Several	 professionals	 highlighted	 links	 with	 smoking	 and	 an	 increased	 co-
morbid	 disease	 burden	 that	 might	 influence	 information	 requirements.	 Others	
characterised	the	general	population	of	people	with	lung	cancer	as	a	group	that	tended	to	










Len’s	 surgeon	 was	 unusual	 amongst	 the	 professional	 participants	 in	 this	 study	 in	 his	



























Regardless	 of	 a	 patient’s	 background,	 however,	 there	 remained	 challenges	 in	 conveying	
complex	 biomedical	 information	 to	 people	 who	 had	 no	 medical	 knowledge	 before	 they	
became	ill.		
The	patients	are	very	accepting	of	all	the	information	because	they	are	new	to	this.	








(Barbara’s	 surgeon)	 and	only	 give	what	was	 necessary	 to	 patients	 in	 order	 to “give	 some	









Reflecting	 a	 different	 philosophy,	 several	 professionals	 prioritised	 painting	 positive	















Professional	 participants	 saw	patients	who	had	a	 surgical	 resection	as	 the	 fortunate	ones	




Fiona’s	 surgeon	 wanted	 to	 make	 a	 clear	 link	 to	 the	 available	 biomedical	 information	 to	
emphasise	to	the	good	news	of	the	situation.	
Then	I	make	that	very	clear	in	the	consultation,	and	I’ll	often	sort	of	say,	you	know,	






for	patients	where	 the	prognosis	was	not	 so	good.	These	professionals	aimed	 to	 turn	 the	
bad	news	of	a	diagnosis	of	lung	cancer	into	something	that	might	be	seen	as	good	news	by	

































chest	X-ray's	all	 right.	The	wound	 is	well	healed.	These	kinds	of	 things.	 (Surgeon	3:	
Edward)	
	
The	minimum	 level	 of	 information	 about	 potential	 cancer	 recurrence	 some	 professionals	
felt	was	necessary	to	give	patients	was	to	ensure	patients	were	aware	that	it	was	possible.		
	[…]	 my	 own	 feeling	 is	 that	 so	 long	 as	 they’ve	 got	 that	 [the	 understanding	 that	
relapse	was	a	possibility],	so	long	as	if	they	do	relapse	it’s	not	a	complete	surprise	to	
them.	And	I	think	that’s	probably	all	anyone	needs	to	know.	(Oncologist	1:	Edward)	
Such	 an	 approach	 allowed	 professionals	 to	 provide	 a	 picture	 that	 did	 not	 focus	 on	 the	
negative	 aspects	 of	 risk	 and	 the	 consequences	 of	 recurrent	 cancer.	 However,	 oncologists	
who	 saw	 patients	 to	 discuss	 adjuvant	 treatment	 inherently	 needed	 to	 talk	 openly	 about	
possible	recurrence.	As	a	way	of	counterbalancing	damage	to	hope	from	raising	the	subject	
of	 potential	 recurrence,	 professionals	 also	 wanted	 to	 stress	 to	 patients	 the	 benefits	 of	
having	 already	 undergone	 surgery	 and	 the	 potential	 to	 have	 already	 affected	 a	 cure.	














I	 mean	 it	 is	 very	 easy	 to	 give	 good	 news	 all	 the	 time.	 I	 don’t	 think	 it’s	 always	
appropriate.	(Surgeon	5:	Glennis)	









uncertain	 prognosis.	 This	 distinction	 broadly	 reflected	 the	 differences	 between	 patient	
participants	following	the	two	pathways	discussed	in	chapter	5.	Patients	following	pathway	
B	could	be	viewed	as	having	an	intermediate	prognosis,	somewhere	between	good	or	bad	
news.	Nevertheless	he	viewed	patients	with	stage	 II	or	 III	 cancer	as	distinct	 from	patients	
with	advanced,	metastatic	cancer	who	had	an	unvaryingly	bleak	prognosis	and	where	cure	
was	 no	 longer	 a	 realistic	 possibility.	 This	 underlined	 the	 challenges	 that	 professionals	 felt	




you’re	 not	 dealing	 with	 good	 numbers	 or	 terrible	 numbers,	 it’s	 somewhere	 in	
between.	(Surgeon	5:	Glennis)	
	
Several	 professionals	made	 a	 distinction	 between	 fostering	 “hope”	 and	 “false	 hope”,	 and	
characterised	 the	 latter	as	 something	 to	be	avoided.	Several	professionals	commented	on	
times	 where	 they	 had	 seen	 colleagues	 being	 overly	 positive	 about	 a	 situation	 and	 had	
painted	a	picture	that	was	unrealistic	for	patients.		
I'm	careful	not	 to	over	 reassure	and	 careful	not	 to	give	 false	hope.	Because	 I	 have	
observed	that	in	other	clinicians,	in	a	very	well-meaning	way,	trying	to	give	the	best	




By	 talking	 about	 putting	 “the	 best	 spin”	 on	 something,	 Kamal’s	 physician	 suggested	 that	
although	significant	information	might	not	be	withheld,	the	implications	and	consequences	
of	 information	might	be	painted	 in	a	way	that	could	be	considered	overly	positive.	Where	
professionals	 saw	 the	need	 to	 give	more	negative	 information	 to	prevent	patients	having	
falsely	positive	expectations,	this	was	something	that	required	sensitivity.		
[…]	 I	 think	 one	 of	 our	 roles	 is	 actually	 being	 honest	 without	 being	 brutal	 and	 to	
manage	expectations	and	then	those	of	relatives.	(Chest	physician	1:	Kamal)	
Managing	 expectations	 in	 this	 sense	 was	 about	 signalling	 the	 potential	 for	 negative	
outcomes	 amongst	 the	hoped	 for	 positive	outcome.	 Some	 LCNS	participants	 felt	 that	 the	
consequence	 of	 some	 medical	 colleagues	 being	 “a	 bit	 too	 optimistic”	 was	 that	 patients	









Many	 of	 the	 patient	 participants	 appeared	 to	 value	 professionals	who	 gave	 an	 optimistic	
picture	of	their	condition,	often	mirroring	the	views	of	their	professionals.	Fiona	had	known	










































However,	 she	 also	 recognised	 that	 this	 approach	would	 not	 suit	 everyone	 and	 using	 too	
blunt	 a	 style	 might	 be	 problematic	 for	 some	 patients.	 Importantly,	 despite	 wanting	 the	
professional	 to	 help	 build	 hope	 for	 them,	 no	 one	 wanted	 to	 feel	 that	 they	 were	 being	
deceived	 if	 there	was	 a	material	 change	 in	 their	 situation.	Other	 participants	 also	 took	 a	
pragmatic	approach	to	difficult	 information.	Edward	spoke	about	dealing	with	 information	
that	 might	 be	 considered	 difficult	 in	 a	 calm,	 non-emotional	 way,	 focusing	 on	 problem	
solving	to	bolster	his	sense	of	hope.	He	tried	to	identify	practical	steps	that	could	be	taken	
to	address	the	issues	raised	in	the	information	given.	This	approach	mirrored	his	self-image	
as	 someone	 who	 rolled	 with	 challenges	 in	 life	 and	 his	 ability	 to	 cope	 with	 threatening	
situations.	 In	 this	 way	 it	 appeared	 that	 he	 was	 able	 to	 sustain	 hope	 even	 in	 the	 face	 of	
potentially	negative	information.	




In	 this	 final	 subtheme	 I	 use	 the	metaphor	 of	 ‘Pivoting	 the	 cancer	 gaze’	 to	 consider	 how	






As	 discussed	 at	 the	 beginning	 of	 this	 chapter,	 the	 overall	 aim	 for	 both	 patients	 and	
professionals	was	to	get	life	back	to	normal	following	the	disruption	of	the	cancer	diagnosis	
and	 surgery.	 The	majority	of	 the	patient	participants	 talked	during	 their	 interviews	about	
consciously	 trying	 to	 remain	 upbeat	 and	 actively	 avoid	 thinking	 about	 their	 cancer	 by	
pivoting	 the	 focus	 of	 their	 attention	 away	 from	 their	 cancer.	 Some	 participants	 faced	
significant	 issues	other	 than	 their	 lung	cancer	 that	demanded	attention.	After	her	surgery	
Barbara’s	 main	 concerns	 were	 about	 her	 rheumatoid	 arthritis	 and	 the	 recovery	 from	
surgery.	 Her	 gaze	 was	 focused	 on	 dealing	 with	 the	 immediate	 problems	 she	 faced.	 By	
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Many	 patient	 participants	 conveyed	 a	 strong	 sense	 of	 personal	 agency	 in	 the	 way	 they	





















use.	 The	 Internet	 was	 seen	 as	 a	 threatening	 and	 risky	 place,	 especially	 in	 relation	 to	
prognosis,	or	recurrence	risk	information.	Kamal	said	that	what	he	saw	on	the	Internet	did	
not	make	him	 feel	 “good	or	happy”	and	 that	“it’s	all	disturbing”.	Denise	 talked	about	her	
experiences	 of	 searching	 the	 Internet	 during	 her	 earlier	 breast	 cancer	 treatment.	 She	
recalled	 a	 sense	 of	 relief	when	 her	 breast	 surgeon	 absolved	 her	 of	 responsibility	 to	 seek	
information	on	line.	












The	 views	 of	 professional	 participants	 regarding	 patients	 using	 the	 Internet	 were	
remarkably	similar	to	those	of	the	patients	described	above.	Professionals	wanted	to	steer	
patients	 away	 from	 searching	 the	 Internet	 indiscriminately.	 In	 particular	 they	 were	




Others,	 such	 as	Audrey’s	 surgeon,	 felt	 that	 even	web	 sites	 aimed	 specifically	 at	 a	 patient	
audience	could	be	“doom	and	gloom”	 in	 the	content	 they	offered.	What	was	common	to	
these	concerns	was	the	fear	 that	 the	 Internet	gave	access	to	 information	that	risked	both	
being	 misunderstood,	 or	 overwhelming	 patients.	 Professionals	 appeared	 to	 want	 to	
maintain	 control	 over	 the	 information	 that	 patients	 received,	with	 the	 aim	 of	 preventing	
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sense	 of	 hope	 and	 cope	 with	 their	 situation.	 Professionals,	 such	 as	 Barbara’s	 oncologist,	
viewed	patients	who	could	pivot	their	gaze	and	put	cancer	out	of	their	mind	and	move	on	as	
the	ones	who	were	most	likely	to	cope	best	with	their	situation	following	surgery.		










Barbara’s	 oncologist	wanted	 patients	 to	 simply	 “focus	 forward”,	 away	 from	 the	 diagnosis	
and	what	 they	had	been	 through,	 and	 to	 try	 to	 get	 “back	 to	a	more	normal	way	of	 life”.	
Other	professionals	saw	patients	that	focused	unduly	on	their	cancer	after	treatment	ended	
up	 wasting	 precious	 time	 that	 might	 prevent	 them	 doing	 meaningful	 things	 after	 their	






















One	 approach	 used	 by	 several	 professionals	 was	 to	 provide	 a	 focus	 on	 the	 end	 point	 of	
follow-up.	 By	 explicitly	 discussing	 the	 five-year	 follow-up	 period	 and	 emphasising	 an	 end	
point,	 Jane’s	 oncologist	 wanted	 to	 focus	 patients	 on	 the	 long-term	 future	 and	 help	 to	
construct	hope.		
[…]	one	of	 the	 things	 I	 think	 it	 [cancer]	 steals	 the	most	 is	 the	ability	 […]	 to	assume	
there	is	a	future.	So	if	you’re	able	to	build	something	into	someone's	calendar	that	is	
a	 fixed	 point	 in	 time	where	 you	 say	 you’re	 going	 to	 be	 around	 for	 that,	 then	 that	
helps.	(Oncologist	3:	Jane)	
	
Many	 professional	 participants	 wanted	 to	 avoid	 opening	 up	 discussions	 about	 possible	
recurrence	 as	 a	 way	 of	 helping	 patients	 pivot	 their	 gaze	 away	 from	 their	 cancer.	 This	
involved	avoiding	discussion	of	not	only	recurrence	risk,	but	also	information	about	possible	
signs	and	symptoms	of	recurrence	as	well.	Cathy’s	LCNS	felt	putting	too	much	emphasis	on	





Some	professionals	 indicated	 that	 they	 saw	patients	 as	being	especially	 vulnerable	 to	 the	





about	 possible	 recurrence	 too	 much	 during	 their	 initial	 consultation	 after	 surgery	 could	
“bring	things	down”	in	what	was	a	“good	news”	discussion.	Denise’s	surgical	LCNS	felt	there	















about	 every	 new	 pain	 or	 cough	 and	 emphasised	 that	 it	 was	 the	 “duration	 of	 symptoms	
that’s	 the	 concern”	 (Edward’s	 oncologist),	 or	 things	 that	 lasted	 “more	 than	 two	 weeks”	
(Maggie’s	oncologist).		
	
In	 contrast,	 two	 professional	 participants	 explicitly	 wanted	 to	 provide	 specific	 signs	 and	
symptoms	 of	 recurrence	 to	 patients,	 as	 part	 of	 their	 on-going	 surveillance.	 For	 these	
professionals,	focusing	patients’	attention	onto	their	cancer	was	seen	to	offer	benefits	that	
outweighed	 the	 risks	of	patients	becoming	over	 focused	on	 their	condition.	Kamal’s	chest	
physician	explained	he	routinely	gave	patients	this	information.		
I	 normally	 signpost	 them	 to	 some	 specific	 symptoms	 […].	 So	 I	 mention	 things	 like	
cough,	 breathlessness,	 haemoptysis	 and	 anything	 out	 of	 the	 ordinary.	 (Chest	
Physician	1:	Kamal)	









Recognising	 symptoms	 of	 potential	 recurrence	 was	 something	 that	 many	 patient	





to	 return	would	 it	 still	 be	 lung	 cancer	 or	 could	 it	 be	 somewhere	 else?	 […]	And	 the	
other	 thing	 is	how	will	 they,	 if	 the	 cancer	 returns,	what	will	 be	 the	 symptoms	of	 it	
returning?	(Henry	3rd	interview)	
Despite	 these	 uncertainties,	 it	 was	 apparent	 that	 he,	 in	 common	 with	 others,	 had	 not	
actually	 asked	 these	 questions	 of	 his	 cancer	 team	 and	 he	 was	 unsure	 whether	 this	 was	
something	he	would	want	to	know.	Edward	commented	that	he	would	not	mind	being	told	
symptoms	to	look	out	for,	but	was	concerned	about	the	effect	on	his	wife.		
I	wouldn’t	worry	 about	 it,	 but	 then	 [my	wife]	might.	 […]	 she	worries	 enough	 now.	
(Edward,	3rd	interview)	
	
While	professional	participants	 recognised	 these	potential	 sources	of	anxiety	 for	patients,	




[…]	part	about	 that	 is	 I	 think	that	projecting	that	 it’s	normal	 to	be	uncertain	about	
the	future.	It’s	normal	to	be	unsure	sometimes	about	the	future.	Everybody	has	those	
uncertainties.	(Oncologist	4:	Maggie)	





about	 it,	 it’s	 not	 going	 to	make	 the	 relapse	 any	more	 or	 less	 likely.	 (Oncologist	 1:	
Edward)	
Denise’s	 surgical	 LCNS	 recognised	 the	 importance	 of	 identifying	 those	 patients	who	were	
struggling	with	these	issues	and	to	refer	on	to	other	services,	such	as	psychological	support,	
where	 necessary.	 She	 also	 recognised	 the	 role	 of	 other	 activities	 like	 yoga,	 Pilates,	 or	
relaxation	 that	 have	 a	 physical	 benefit,	 "but	 also	 have	 a	 positive	 impact	 on	 the	 mind".	








sense	 of	 life	 returning	 to	 normal	 that	 was	 shared	 by	 both	 patients	 and	 professionals.	
Although	 it	was	apparent	that	professionals	and	patients’	also	shared	the	goal	of	ultimate	
cure,	there	was	reluctance	and	caution	in	explicitly	discussing	cure	during	consultations.	The	
subtheme	 ‘Information	 as	 threat’	 explored	 how	 patients	 and	 professionals	 shared	 a	 view	
that	information	about	cancer,	and	particularly	regarding	outcomes,	was	viewed	as	posing	a	




the	 right	 balance	 of	 information	 to	 meet	 the	 needs	 of	 patients.	 The	 personal	
communication	ethos	of	the	professionals	appeared	to	be	fundamental	to	the	information	
they	 disclosed	 to	 patients.	 Some	wished	 to	 present	 detailed	 scientific	 information,	 while	






with	 the	aim	of	 supporting	hope	 for	 the	 future.	However,	 there	were	 times	when	turning	
the	 gaze	 towards	 cancer	was	 necessary	 or	 unavoidable.	 This	 included	where	 there	was	 a	












from	 the	 consultations	 to	 explore	 the	 process	 of	 information	 exchange	 and	 to	 illustrate	
these	exchanges.	Extracts	from	associated	patient	and	professional	interviews	will	be	used	















to	Different	Tunes’	provides	 insight	 into	a	divergent	case,	where	participants	appeared	 to	
want	 different	 things	 from	 the	 communication	 dance.	 Space	 does	 not	 permit	 a	 detailed	





and	 the	 patient	 or	 their	 family	member.	 This	 dyadic	 form	 suggested	 a	 dance	 involving	 a	
couple.	The	terms	‘Lead’	and	‘Follow’	are	sometimes	used	as	a	gender-neutral	description	of	
dancing	 roles	 and	 serve	 to	 clarify	 the	nature	of	 the	 interactions	 in	 the	 consultations.	 The	
observed	consultations	conformed	to	a	norm	of	the	professional	taking	a	clear	Lead	and	the	
patients	 taking	 the	 Follow	 role.	 A	 feature	 of	 all	 the	 interactions	 was	 a	 sense	 of	 power	
imbalance,	where	power	lay	primarily	with	the	professional	by	virtue	of	the	knowledge	and	
information	they	possessed.	This	allowed	professionals	to	give	the	information	they	felt	was	
appropriate	 for	 the	 patient.	 Patients	 varied	 in	 the	 extent	 to	 which	 they	 interacted	 or	
remained	passive	during	the	consultations.		
	
These	 dances	 adhered	 to	 the	 unwritten	 rules	 of	 doctor/patient	 interactions	 in	 terms	 of	
structure,	turn	taking,	and	roles	within	the	consultation.	In	all	of	the	observed	consultations	
professionals	 began	 by	 attempting	 to	make	 an	 assessment	 of	 patients’	 current	 health,	 in	
terms	of	 recovery	 from	 surgery,	 or	 fitness	 for	 chemotherapy.	During	most	 of	 the	 surgical	
consultations	the	results	from	the	lung	cancer	operation	were	discussed	in	the	second	half	
of	 the	 encounter.	 This	 was	 then	 followed	 by	 discussing	 plans	 for	 follow-up	 or	 further	




I	 will	 use	 two	 observed	 consultations,	 first	 Barbara’s	 surgical	 consultation,	 followed	 by	








Surgeon	1	 that	was	 very	 upbeat.	 Bright	 and	positive	 in	 tone.	 Barbara	appeared	 to	
take	a	lot	of	the	information	in	and	to	understand	it.	(Research	field	notes)		
In	common	with	all	the	other	observed	consultations,	there	was	no	explicit	enquiry	into	the	
level	 of	 information	 that	 Barbara	 required.	 The	 only	 time	 that	 Barbara	 and	 her	 husband	







this,	 the	surgeon	began	 to	discuss	 the	surgical	 findings.	This	 section	of	 the	consultation	 is	
shown	 in	box	8.1.	 Information	given	 that	 related	 to	 the	 surgical	procedure,	diagnosis	and	




















The	 interaction	 is	 continued	 in	 Box	 8.2.	 Here	 Barbara’s	 surgeon	 uses	 the	 biomedical	
information	 she	 had	 already	 given	 to	 lead	 the	 dance	 into	 the	 outcome	 from	 the	 MDT	
meeting	and	the	plan	to	refer	her	to	see	an	oncologist	(lines	25	–	27).	Her	explanation	about	
the	rationale	for	chemotherapy	was	limited	and	extended	to	only	suggesting	there	might	be	
an	 unnamed	 benefit	 (line	 29).	 By	 using	 the	 phrase	 “some	 advantage”	 Barbara’s	 surgeon	
avoided	discussing	potential	recurrence	at	this	point	in	the	consultation.	She	then	indicated	
that	 Barbara’s	 oncologist	 would	 explain	 the	 treatment	 in	 more	 detail,	 with	 the	 ultimate	
treatment	decision	being	a	joint	one	(lines	31	–	36).	It	was	striking	how	little	information	or	
rationale	 she	offered	her	about	 the	 referral	 for	 chemotherapy.	 In	her	 interview	Barbara’s	
surgeon	 later	 explained	 that	 she	 wanted	 to	 give	 a	 simple	 message	 about	 the	 onward	
management	plan,	but	not	to	make	it	overly	complicated.		





























































































































During	 Barbara’s	 interview	 she	 was	 able	 to	 confirm	 that	 she	 had	 understood	 and	
remembered	most	of	 the	 information	she	had	been	given	by	her	surgeon.	She	also	 found	
the	information	reassuring	and	helped	her	feel	more	in	control	of	her	situation.		
Yeah,	she	said	 it	had	all	gone.	 […]	That	was	 important	 to	me.	Because	 I	know	that	
one	[lymph	gland]	was	showing	the	signs	of,	wasn't	too	good.	[…]	so	anything	that	
was	on	 that	 side	has	 gone	now.	 […]	 Yeah,	 that	 felt	 reassuring	 to	me.	 (Barbara	 1st	
interview)	












Throughout	 this	 consultation	 Barbara’s	 surgeon	 was	 able	 to	 lead	 the	 dance	 and	 Barbara	
appeared	happy	to	follow.	The	Follow	role	involved	indicating	that	she	had	understood	the	
information	that	was	being	given	and	reacting	appropriately	to	it.	The	Lead	ensured	that	the	
discussion	 remained	 hopeful	 by	 curtailing,	 or	 avoiding	 discussion	 focusing	 on	 negative	






she	 directed	 Barbara’s	 gaze	 towards	 positive	 aspects	 of	 her	 situation,	 such	 as	 the	 non-





Another	 consultation	 that	 followed	 the	 Lead	 and	 Follow	 model	 was	 Maggie’s	 oncology	
consultation.	Although	superficially	similar	 in	that	the	professional	gave	a	 large	amount	of	





consultation,	 later	 noted	 in	 my	 research	 diary.	 In	 her	 interview	 she	 spoke	 about	 how	
worried	 she	 was	 regarding	 the	 appointment.	 Not	 only	 was	 she	 concerned	 that	 her	
















adjuvant	 chemotherapy.	 She	 began	 this	 by	 talking	 about	 the	 proportion	 of	 people	 who	
























a	 type	 of	 a	 non-small	 cell	 lung	 cancer.	 But	 that	 one	 of	 the	 lymph	 glands	
<close>	to	the	cancer	was	involved	with	the	cancer.	
Maggie	 >Right<	
Onc	4	 So	 you	 have	 a	 spread	 to	 that	 local	 lymph	 gland	 within	 the	 lung,	 but	 not	
outside	of	the	lung,	either	in	the	centre	of	the	chest	or	anywhere	else.	So	as	
far	as	we	are	aware	you	have	got,	the	cancer	has	been	completely	got	rid	of	
for	 you.	 However,	 we	 know	 that	 looking	 at	 thousands	 and	 thousands	 of	
people	 that	 isn't	 always	 the	 case.	And	we	 know	 that	 if	we	 give	people	 like	
yourself	 chemotherapy,	 if	 I	 give	 a	 hundred	 people	 like	 you	 chemotherapy,	
five	extra	people	would	be	cured	of	the	cancer	in	addition	to	the	surgery.	
Maggie	 >Right<	

















it	could	be	considered	that	Maggie’s	oncologist	was	taking	the	 lead	 from	Maggie’s	 lack	of	
questions,	in	reality	the	professional	remained	in	control	of	the	information	and	how	much	
was	disclosed.	Following	this	extract	Maggie’s	oncologist	then	moved	the	discussion	on	to	






With	her	 she	was	nodding	and	shaking	her	head	 in	 the	 right	places.	 […]	So	when	 I	
was	saying	stuff	 that	was,	you	might	die	sort	of	 thing,	she	kind	of	did	do	the	good	




herself	 in	 the	circumstances.	The	next	extract	 from	 the	consultation	presented	 in	Box	8.4	
indicates	the	way	in	which	her	oncologist	dealt	with	this	query.	In	response	to	Maggie	(line	
B1),	her	oncologist	asked	her	a	further	question	in	return	(lines	B4	–	B6).	The	oncologist	can	
be	 seen	 to	engage	Maggie	 in	 the	dance	by	graphically	placing	Maggie	 into	a	hypothetical	
“worst-case	 scenario”	 and	 asking	 her	 how	 she	 would	 feel.	 This	 question,	 apparently	
unconsciously,	emotively	used	Maggie’s	hope	to	see	her	grandchildren	grow	up	as	a	way	of	
getting	Maggie	 to	make	a	decision	about	her	 treatment	 (lines	B14	–	B20).	Her	oncologist	














































Onc	4	 Not	 everybody,	 but	 a	 fair	 few.	 Er	 I	 think	 I	 think	 the	 answer	 is	 that	 I	 am	 a	
different	person	to	you,	and	what	I	view	as	important	is	different	...	probably,	to	
you.	What	I,	one	of	the	things	to	think	about	is,	in	the	worst-case	scenario,	say	




























Despite	 the	 oncologist’s	 attempts	 to	 present	 the	 small	 but	 realistic	 benefit	 of	
chemotherapy,	Maggie	eventually	interpreted	the	message	in	a	way	that	supported	her	own	
hope.	 It	 was	 likely	 that	 Maggie’s	 interpretation	 was	 much	 more	 optimistic	 than	 her	
oncologist	 had	 intended	 it.	 Maggie	 seemed	 to	 understand	 that	 chemotherapy	 would	
guarantee	 the	 cancer	 would	 not	 recur	 and	 therefore	 remove	 any	 uncertainty	 about	 her	
future.		
I’m	hoping	that,	if	I	manage	to	do	the	whole	course,	that	there	won’t	be	any	cancer	
cells	 in	my	body	at	all.	So	 I	won’t	have	to	 live	 in	 fear	every	time	 I	get	an	ache	or	a	





seeing	 that	 accepting	 this	 treatment	 as	 offering	 a	 guarantee	 against	 recurrence,	 Maggie	
then	was	able	to	estimate	her	chance	of	not	having	a	recurrence	with	surgery	alone	as	95%.		
You	 know,	 this	 gives	 you,	 not	much	…	 higher	 chance	 of	 survival,	 or	 it	 not	 coming	
back.	But	5%	is	5%,	isn't	it?	So	then	I	started	to	look	at	it	the	other	way:	well,	it's	only	
5%,	so	I've	still	got	95%.	(Maggie	3rd	interview)	
Such	 an	 optimistic	 reading	 of	 the	 information	 she	 was	 given	 about	 the	 role	 of	 adjuvant	
treatment	could	be	seen	as	a	form	of	‘false	hope’,	or	denial.	On	the	other	hand,	this	strategy	





hope.	 This	 included	 emphasising	 having	 had	 “good”	 surgery	 as	 being	 the	most	 important	






what	 information	 she	 took	 on	 board	 about	 her	 situation.	 When	 faced	 with	 potentially	





There	 were	 numerous	 variations	 on	 the	 Lead	 and	 Follow	 dance	 within	 the	 observed	
consultations.	The	subtheme	‘Back	Leading’	explores	how	patients	or	family	members	could	
influence	 discussions	 in	 complex	 and	 often	 subtle	 ways.	 The	 term	 is	 used	 in	 dancing	
whereby	the	person	in	the	Follow	role	can	indicate	opportunities,	such	as	potential	space	on	




without	 directly	 challenging	 the	 role	 of	 the	 Lead.	 I	will	 use	 two	 contrasting	 consultations	
from	the	case	studies	to	illustrate	how	Back	Leading	might	be	used.		
Denise	and	Surgeon	2	
Denise	 had	 been	 very	 anxious	 to	 know	 the	 surgical	 findings	 following	 her	 operation.	 Her	
anxiety	had	built	over	the	four	weeks	between	discharge	and	the	consultation.	Although	she	
had	numerous	concerns	about	her	surgical	recovery,	her	chief	aim	was	to	know	whether	she	
was	 going	 to	 need	 chemotherapy.	 In	 the	 run	 up	 to	 the	 appointment	 she	 had	 convinced	
herself	that	the	surgeon	would	tell	her	she	did	require	further	treatment.		
And	 they're	 probably	 going	 to	 say	 to	 me	 I'm	 afraid	 you've	 got,	 it's	 positive,	 has	
spread	and	afraid	you're	going	to	have	to	have	chemotherapy.	(Denise	1st	interview)	
This	 anxiety	 was	 evident	 during	 her	 surgical	 consultation,	 which	 felt	 tense	 and	 slightly	
confrontational	as	an	observer.		
[Denise]	 appeared	 anxious	 and	 'brittle'	 throughout	 the	 consultation,	 although	






















to	absorb	 that.	And	yes	 it's	all	okay.	So	 that	was	 reassuring.	 I	 thought	yes,	at	 last.	
(Denise	1st	interview)	








In	 the	 second	 half	 of	 her	 surgical	 consultation	 Denise	 asked	 another	 question,	 this	 time	
about	 possible	 recurrence.	 An	 extract	 of	 the	 consultation	 covering	 this	 discussion	 is	
presented	 in	 Box	 8.5.	 Denise	 began	 by	 asking	 if	 the	 cancer	 could	 recur.	 However,	 she	
immediately	followed	this	with	comments	that	appeared	to	relate	to	causation,	rather	than	
recurrence	 (line	 2).	 The	 answer	 the	 surgeon	 gave	 digressed	 from	 the	 information	 that	
Denise	was	 looking	 for.	Eventually	Denise	 interrupted	 the	surgeon’s	answer	 to	 repeat	her	
original	 question	more	 explicitly	 (line	 18).	On	 this	 occasion	Denise	 received	 an	 answer	 in	
terms	of	 a	 verbal	description	of	possibility	 (Line	23,	 ‘It	 is	unlikely’).	 Immediately	 after	 she	








































































After	 the	consultation	Denise	spoke	about	 the	 information	 that	she	was	 looking	 for	when	
she	asked	about	recurrence.	
[…]	 it	was	whether	 in	her	experience	with	 this	particular	 type	of	cancer,	whether	 it	
recurs	or	not.	[…]	But	I	just	wondered	if	it	had	a	…,	you	know,	if	this	was	a	common	
cancer	that	did	reoccur.	(Denise	1st	interview)	
Asked	whether	 she	 had	 been	 looking	 for	 statistical	 data	 around	 risk	 of	 recurrence	when	
asking	her	question,	she	replied:	
Probably	not,	because	that	would	be	equal	to	me	looking	it	up	on	the	Internet.	And	




Denise	had	apparently	 taken	a	 risk	 in	asking	 the	question	about	 recurrence.	Back	Leading	
the	conversation	in	the	way	that	she	did	allowed	her	to	move	herself	out	of	danger	as	soon	
as	 she	 had	 heard	 the	 information	 she	 wanted,	 and	 avoided	 hearing	 things	 that	 might	
threaten	her	sense	of	hope.	Despite	her	anxiety,	Denise	continued	attempting	to	back	lead	
the	consultation	until	she	had	received	the	information	that	she	wanted.	Her	surgeon	had	













Another	 case	where	 Back	 Leading	was	 an	 important	 factor	 in	 the	 interaction	was	 that	 of	
Kamal’s	surgical	consultation.	In	this	case	it	was	Kamal’s	wife	who	used	Back	Leading	most	
to	try	and	achieve	the	level	of	information	she	wanted	from	the	consultation.	Box	8.6	gives	
an	extract	of	 the	consultation	where	most	of	 the	 information	about	 the	surgical	outcome	
was	given.	Kamal’s	surgeon	explained	the	surgical	 results	and	the	MDT	decision	regarding	
adjuvant	chemotherapy,	initially	portraying	these	results	in	a	positive	light	(lines	A10	–	A13).	
Kamal’s	wife	 actively	 responded	 to	 this	 information	 by	 seeking	 clarification	 that	 this	was	
really	“good	news”	(line	A14).	Rather	than	just	acknowledging	the	information,	she	queried	
it	on	behalf	of	her	husband	in	a	way	that	can	be	seen	as	Back	Leading.	The	surgeon	initially	






































































































This	 further	 Back	 Leading	 by	 Kamal’s	 wife	 appeared	 to	 lead	 the	 surgeon	 to	 clarify	 the	
information	 that	he	had	already	given.	 In	 lines	A18	–	A22	 the	 surgeon	explained	 to	 them	
that	 rather	 than	not	 requiring	adjuvant	 treatment,	 it	was	actually	Kamal’s	overall	 level	of	
fitness	that	meant	offering	chemotherapy	would	probably	be	of	no	benefit.	However,	in	his	
answers,	 the	 surgeon	 remained	 careful	 not	 to	 offer	 too	much	 information	 regarding	 the	
implications	 of	 the	 lymph	 node	 status.	 It	 was	 evident	 that	 Kamal’s	 wife	 had	 not	 fully	
understood,	as	she	continued	Back	Leading	the	discussion	(line	A23)	and	the	surgeon	was	
forced	to	clarify	 the	situation.	Kamal’s	 surgeon	avoided	making	direct	 reference	 to	cancer	
recurrence	and	reiterated	that	everything	was	resected	(line	A37).	Kamal’s	wife	concluded	








any	 further	 treatment’,	 I	 think	 that	 was	 well	 embedded	 in	 their	 memory	 […].	
(Surgeon	6:	Kamal)		
Kamal’s	 surgeon	 emphasised	 the	 importance	 of	 presenting	 the	 information	 in	 a	 positive	
light	 in	 order	 to	 maintain	 hope	 and	 ultimately	 support	 Kamal’s	 continued	 recovery.	 This	
meant	 making	 choices	 about	 the	 information	 he	 gave	 about	 the	 decision	 not	 to	 offer	









voice	 to	 his	 understanding	 that	 cancer	 is	 never	 actually	 curable	 (line	 B2),	 previously	
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discussed	 in	 chapter	 6	 (Predicting	 the	 Future).	 It	 was	 apparent	 that	 doubts	 remained	 in	
Kamal’s	 mind	 about	 the	 long-term	 outcome	 following	 surgery.	 Kamal’s	 surgeon	 avoided	
directly	answering	Kamal’s	query	by	initially	confirming	that	all	visible	cancer	was	removed	
(line	B3	 –	B5).	 In	 line	B5	Kamal’s	 surgeon	 started	 talking	 about	 cancer	 stage,	 but	 did	 not	
elucidate	 further	how	 this	might	 apply	 to	Kamal’s	 situation.	 The	apparent	attempt	 to	use	
Back	 Leading	 to	 get	 further	 clarity	 by	 Kamal’s	wife	 appeared	 to	 be	 ignored	 (line	B6).	 The	
surgeon	 immediately	went	on	 to	acknowledge	 the	possibility	of	 future	cancer	 recurrence,	










































































how	 do	 you	 think	 it’s	 going	 to	 impact	 his	 psychology?	 He	 was	 when	 he	 came,	 I	
remember	 him	 when	 he	 went	 home,	 he	 was	 more	 depressed	 and	 unwell	 looking.	
Now	when	he	came	he	said	I’m	feeling	good.	And	that	keeps	you	alive.	 (Surgeon	6:	
Kamal)	
From	 Kamal’s	 point	 of	 view	 the	 information	 that	 he	 had	 been	 given	 in	 the	 consultation	
made	him	view	his	situation	more	optimistically	and	challenged	his	lay	beliefs	about	cancer,	
as	was	evident	from	his	later	interview.		
My	 opinion	 is	 different	 now.	 […]	 Now	 the	 way	 he	 said,	 it’s	 done.	 Operation	 has	
cleared	everything.	[…]	I	don’t	believe	that	it	will	come	back.	(Kamal	1st	interview)	
By	 offering	 the	 explanation	 he	 did,	 Kamal’s	 surgeon	 appeared	 to	match	 closely	 with	 the	
level	of	detail	and	 the	degree	of	hopefulness	 in	 the	message	 that	Kamal	and	his	wife	had	
wanted.	
	
Kamal’s	 surgeon	 stayed	 within	 the	 Lead	 and	 Follow	model	 of	 consultation,	 remaining	 in	
control	of	 the	 information	 that	was	disclosed.	Kamal’s	wife	 strongly	 influenced	 the	dance	
within	the	consultation	by	Back	Leading	to	gain	clarity	in	her	mind,	and	to	satisfy	herself	that	
he	 was	 not	 missing	 out	 on	 necessary	 treatment.	 She	 later	 facilitated	 an	 opportunity	 for	
Kamal	 to	ask	his	own	question	about	 recurrence.	However,	his	 surgeon	wanted	to	ensure	
that	the	message	that	he	gave	to	the	couple	was	one	that	could	support	their	hope	for	the	






Another	 variation	 on	 the	 Lead	 and	 Follow	 dance	 is	 described	 using	 the	 subtheme	 ‘An	
Ensemble	Piece’.	This	explores	how	multiple	participants	may	use	Leading	and	Back	Leading	







role	 in	how	and	what	 information	was	disclosed.	However,	 Fiona’s	 surgical	 and	 follow-up	
consultations	seemed	to	function	in	a	slightly	different	manner	and	provided	an	example	of	












Fiona’s	 surgeon	 explained	 the	 surgical	 results	 to	 Fiona	 and	 her	 family	 early	 in	 the	




Overall,	 the	 feeling	was	of	Fiona’s	 shock	and	positive	 surprise	at	 the	news	of	 there	
being	no	cancer	present	in	the	samples.	(Research	field	notes)	
This	 shock	can	be	understood	 in	 terms	of	 the	process	of	mental	adjustment	between	her	
initial	bleak	diagnosis	and	prognosis	and	the	new	post-surgical	situation.	
	
An	 extract	 from	 the	 consultation	 is	 displayed	 in	 box	 8.8.	 Fiona’s	 initial	 response	 after	




underline	 that	 Fiona’s	 lung	 cancer	pathway	was	not	 a	normal	one	and	 that	 there	was	no	
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clear	protocol	 to	 follow	 (lines	6	–	11).	 In	her	 interview	 following	 the	consultation,	 Fiona’s	
LCNS	 spoke	 about	 why	 she	 wanted	 to	 take	 the	 Lead	 at	 that	 point	 in	 the	 consultation.	
Knowing	 both	 Fiona	 and	 her	 oncologist	 well,	 the	 LCNS	 wanted	 to	 ensure	 a	 consistent	
message	was	given	in	both	consultations.	Fiona’s	LCNS	attempted	to	pre-empt	any	potential	
threat	 to	 Fiona’s	 hope	 that	 might	 occur	 when	 she	 saw	 her	 oncologist	 in	 the	 follow-up	
consultation,	by	ensuring	 there	was	an	appropriate	balance	 in	 the	 language	used	and	she	
was	realistic	about	the	next	steps.	
I	wanted	to	pre-warn	that	discussion	because	I	think	that	is	the	sort	of	language	that	
[her	 oncologist]	might	 use.	 You	 know,	 you're	 not	 standard.	 You	don't	 fit	 things,	 so	
actually,	we	don't	really	know. (LCNS	4:	Fiona)	
	
Fiona’s	 LCNS	 continued	 to	 take	 the	 Lead	 and	 to	 give	 an	 outline	 of	 what	 the	 long-term	
follow-up	would	 involve	 (lines	13	–	21),	before	 the	 surgeon	began	 to	 take	back	 the	 Lead,	
beginning	at	line	18.	Fiona	then	went	on	to	ask	an	explicit	question	about	the	potential	for	
recurrence;	 “Is	 it	 liable	 to	 pop	 up	 again”	 (line	 27).	 The	 surgeon	 began	 by	 reiterating	 the	
unusual	 nature	 of	 Fiona’s	 situation	 (lines	 28	 –	 34),	 which	 echoed	 back	 to	 the	 previous	
comments	by	her	LCNS.	While	she	highlighted	the	positive	features	of	the	surgical	findings,	
ultimately	 she	 was	 not	 able	 to	 provide	 a	 definite	 answer	 for	 Fiona	 (lines	 34	 –	 37).	 She	
concluded	by	trying	to	keep	a	balance	 in	her	answer	by	saying,	“the	signs	are	good	at	the	
moment,	 but	 we	 will	 want	 to	 be	 keeping	 a	 close	 eye	 on	 things”	 (Lines	 37	 –	 38).	 Fiona’s	



















































































































encounter	 by	 talking	 about	 the	 “absolutely	 fantastic	 news”	 of	 the	 surgical	 results.	 These	
positive	statements	were	reinforced	a	number	of	times.	Fiona’s	oncologist	told	her,	“So	it	is	
really,	 really,	 <really>	 good	 news.	 I	 can't,	 I	 can't	 over	 emphasise	 that.”	 The	 oncologist	






Fiona’s	 oncologist	 went	 on	 to	 talk	 about	 her	 future	 management.	 This	 section	 of	 the	
consultation	 is	 reproduced	 in	box	8.9.	Her	oncologist	began	by	explaining	 that	no	 further	
chemotherapy	was	indicated	(lines	1	–	6).	Fiona	appeared	to	use	Back	Leading	to	raise	her	
concerns	about	the	lymph	node	in	her	neck,	which	had	not	been	operated	on	(line	7).	Their	



















































































a	 period	of	 five	 years	 (lines	 23	 –	 31).	 The	oncologist’s	 comment	 “all	 being	well”	 (line	 34)	
served	to	underline	a	sense	of	balance	and	remind	everyone	that	there	was	still	a	possibility	
of	 the	 cancer	 returning	 in	 the	 future.	 The	 tone	 of	 guarded	 optimism	 set	 in	 the	 surgical	




We're	 optimistic,	 but	 still	 there's	 a	 bit	 of	 realism	 there	 isn't	 there?	 (Oncologist	 2:	
Fiona)	
The	question	that	was	first	asked	by	her	daughter	 in	the	surgical	consultation	about	being	
considered	 “cancer	 free”	 appeared	 to	 have	 remained	 at	 the	 forefront	 of	 Fiona’s	 mind.	
Towards	 the	 end	 of	 the	 follow-up	 consultation	 with	 her	 oncologist,	 Fiona	 raised	 the	

















The	 final	 subtheme	will	 use	 the	metaphor	 of	 participants	 ‘Dancing	 to	Different	 Tunes’	 to	
examine	the	example	of	Len’s	surgical	consultation.	The	two	participants	appeared	to	have	
different	ideas	of	what	they	wanted	the	consultation	to	be	about,	which	they	enacted	with	
little	 ostensible	 coordination	with	 the	 other	 dancer’s	 steps.	 Superficially	 the	 consultation	






Several	 aspects	 of	 Len’s	 case	highlight	 it	 as	 being	 slightly	 atypical.	 Some	of	 these	 aspects	
have	 been	 identified	 in	 the	 preceding	 findings	 chapters.	 The	 surgeon’s	 attitudes	 to	 the	
utility	of	 lung	 cancer	outcome	data	and	his	 approach	 to	providing	and	educating	patients	






An	 extract	 from	 Len’s	 surgical	 consultation,	 where	 results	 and	 their	 implications	 were	
discussed,	is	displayed	in	Box	8.10.	The	consultation	was	short,	but	upbeat	and	positive	from	






























































































































was	 early”	 for	 the	 third	 time.	 He	 then	 used	 this	 to	 segue	 into	 information	 about	 risk	 of	
recurrence.	He	used	phrases	such	as,	“we	removed	it	in	time”	and	the	“chances	of	it	coming	
back	is	very	small”,	likely	to	engender	an	optimistic	view	of	the	future.	He	followed	this	with	




form	 of	 a	 joke,	 but	 also	may	 have	 signalled	 his	 lack	 of	 interest	 in	 engaging	 in	 the	 dance	





initiating	discussion	of	 the	early	warning	 signs	of	 recurrence	 that	 Len	 should	be	aware	of	
(lines	50	–	53).	Despite	this,	Len	was	not	able	to	recall	the	details	of	this	information	that	he	





from	 when	 I	 first	 met	 him,	 acted	 like	 there	 was	 no	 problems.	 Whatever	 was	




the	 indication	 that	 Len	 might	 not	 be	 listening	 to	 all	 the	 details	 being	 given	 during	 the	
consultation,	 Len’s	 surgeon	 had	 continued	 to	 give	 the	 information	 he	 had	 planned	 to	
anyway.	 Despite	 this,	 during	 his	 subsequent	 interview	 Len’s	 surgeon	 did	 appear	 to	
acknowledge	the	limited	nature	of	the	information	that	Len	actually	required.		
This	 gentleman	 was	 more	 than	 happy	 to	 hear	 that	 he	 had	 the	 well-intended	
operation	and	the	well-intended	outcome,	so	he	stopped	at	that	point.	[…]	But	he	is	
already	happy	because	 I	 had	given	 the	 information	 that	 he	wanted.	He	wanted	 to	
move	on.	(Surgeon	8:	Len)	
	
This	 subtheme	 particularly	 illustrated	 how,	 despite	 the	 intentions	 and	 the	 information	











The	 theme	 ‘Hope	 Dances’	 has	 been	 used	 to	 illustrate	 how	 professional	 and	 patient	
participants	 interacted	 to	 influence	 the	 information	about	 surgical	outcome	and	potential	
for	 future	 cancer	 recurrence	 during	 a	 number	 of	 selected	 consultations.	 None	 of	 the	
observed	 consultations	 included	 professionals	 asking	 patients	 explicitly	 what	 level	 of	
information	 they	 required.	 Nevertheless,	 it	 was	 remarkable	 how	well	 professionals	 often	
appeared	to	meet	patient	participants’	information	needs.	One	of	the	key	drivers	as	to	how	
information	 disclosure	 was	 determined	 appeared	 to	 be	 maintaining	 and	 supporting	 a	
suitable	 level	of	patient	hope.	There	was	 some	evidence	 that	patients	often	 retained	and	









interact	 to	 influence	 the	 information	 disclosed,	 with	 this	 effect	 felt	 even	 across	 clinical	
encounters.	 The	 final	 subtheme,	 ‘Dancing	 to	 Different	 Tunes’	 explored	 an	 unusual	









In	 this	 chapter	 I	will	 begin	by	briefly	 revisiting	 the	 research	aims	and	objectives	and	 then	








The	overall	 aim	of	 this	multiple	 case	 study	was	 to	 gain	 an	 in-depth	 understanding	 of	 the	




surgical	 treatment	 for	 lung	 cancer	 conceptualise	 their	 long-term	 risk	 of	 cancer	
recurrence,	and	how	these	change	over	time.	


























Cases	 provided	 a	 diverse	 range	 of	 both	 patient	 and	 professional	 perspectives.	 Cases	
followed	two	distinct	pathways.	Patients	who	followed	Pathway	A	were	referred	from	their	
post-surgical	 consultation	 straight	 into	 long-term	 follow-up.	 Pathway	 B	 patients	 were	
















• Professionals	 used	 verbal	 and	 numerical	 estimations	 of	 chance	 of	 survival	 or	 risk	 of	
recurrence	when	asked	in	interviews.		































• Participants	 appeared	 to	 share	 a	 tacit	 goal	 of	 treatment	 being	 curative,	 but	 explicit	
discussion	of	‘cure’	was	rare	during	consultations	and	the	term	used	with	great	caution.		
Information	as	threat	

















• Professionals	spoke	about	pivoting	patients’	attention	away	 from	cancer	at	 the	end	of	
their	treatment,	with	the	aim	of	supporting	hope	for	the	future.		
• Professionals	 specifically	 wanted	 to	 avoid	 talk	 about	 possible	 recurrence	 in	 order	 to	
prevent	patients	focusing	on	their	cancer	too	much.	














patients	 around	 long-term	 outlook	 following	 lung	 cancer	 surgery.	 How	 communication	
about	 recurrence	 risk	 is	 influenced	 by	 these	 different	 worldviews	 and	 the	 imperative	 to	
maintain	 patient	 hope	 regarding	 the	 future	 will	 then	 be	 examined.	 This	 will	 then	 be	
followed	 by	 looking	 at	 the	 processes	 by	 which	 professionals	 and	 patients	 attempted	 to	
control	 the	 flow	 of	 information	 during	 the	 observed	 consultations,	 aimed	 at	 managing	
patient	 hope.	 I	 will	 conclude	 this	 section	 by	 examining	 the	 implications	 of	 the	 study	 in	
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relation	 to	 the	 Living	With	 and	Beyond	Cancer	 agenda	 and	 the	 particular	 issue	of	 fear	 of	
cancer	recurrence.	
9.4.1 Recurrence	risk	communication	across	divergent	worldviews	
Findings	 presented	 using	 the	 theme	 ‘Predicting	 the	 Future’	 indicated	 that	 there	 were	
significant	 differences	 in	 the	way	professionals	 and	patients	 thought	 about	 the	 long-term	
outlook	 following	 lung	 cancer	 surgery	 that	 reflected	 their	 broadly	 medical	 and	 lay	
perspectives.	 These	different	 views	have	 implications	 for	how	 risk	of	 cancer	 recurrence	 is	
discussed	at	the	end	of	initial	lung	cancer	treatment.	
Professionals’	conception	of	prognosis	
Imprecision	 and	 uncertainty	 are	 at	 the	 heart	 of	 prognostication	 (Smith,	White,	&	 Arnold,	
2013).	Mackillop	 (2006)	described	making	 a	prognosis	 as	being	multifactorial	 and	a	much	
more	 subjective	 process	 than	making	 a	 diagnosis.	Most	 published	 studies	 on	 accuracy	 of	




accurate	 (Mackillop	&	Quirt,	 1997).	 However,	 in	 the	 context	 of	 curative	 treatment,	 there	
appears	 to	 be	 relatively	 little	 published	 regarding	 professionals’	 attitudes	 to	 making	
prognoses	and	the	utility	of	population	data	in	relation	to	individual	patients.	Findings	from	
the	current	 study	provide	an	 insight	 into	 the	attitudes	 to	prognostication	of	professionals	
working	with	patients	with	 lung	cancer	undergoing	curative	 treatment.	Professional	views	
around	long-term	outcomes	for	study	patients	were	unsurprisingly	characterised	by	detailed	





took	 these	 at	 face	 value	 and	 assumed	 they	 were	 made	 in	 the	 light	 of	 the	 full	 clinical	
information	available	to	the	professional	participants.	Many	of	the	professionals	discussed	
their	 reasons	 for	 the	 variation	between	 their	prognostic	 estimates	and	 the	 corresponding	
published	 population	 survival	 data.	 From	 this	 I	 was	 able	 to	 gain	 unique	 insights	 into	
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professionals’	 attitudes	 towards	 prognostic	 information	 for	 patients	with	 early	 stage	 lung	
cancer.	As	 identified	 in	 the	 subtheme	 ‘A	 Limited	Evidence	Base’,	 Professional	 participants	
varied	in	how	important	population	statistics	were	to	them	when	considering	an	individual’s	




a	 lack	 of	 relevant	 data	 on	 which	 to	 form	 a	 prognostic	 estimate	 (epistemic	 uncertainty).	
Differences	 between	 average	 characteristics	 of	 the	 population	 sample	 and	 those	 of	 the	
specific	 individual	patient	 (stochastic	uncertainty)	also	 limited	professionals’	willingness	 to	
make	 a	 numerical	 estimate	 of	 prognosis.	 Professional	 participants	 also	 spoke	 about	 the	
fundamental	randomness	of	individual	events	(aleatory	uncertainty)	that	meant	population	




Professional	 participants	 demonstrated	 a	 range	 of	 beliefs	 about	 making	 a	 prognostic	
forecast	for	an	individual	patient	and	their	willingness	to	discuss	it,	both	in	the	context	of	a	





real-life	 clinical	 situations	made	prognostication	more	 challenging.	Clinical	 complexity	was	
often	 associated	with	 patients	with	more	 advanced	 cancer,	 such	 as	 those	 on	 Pathway	 B.	
Other	 sources	 of	 medical	 complexity	 included	 patients	 with	 significant	 co-morbid	
conditions,	 those	 whose	 cancer	 had	 pathological	 features	 that	 set	 them	 aside	 from	 the	
norm,	 and	where	 the	 surgical	 resection	was	 incomplete.	 Some	professionals	 nevertheless	
tried	 to	 make	 adjustments	 to	 published	 data	 to	 account	 for	 some	 of	 these	 factors.	 The	
resulting	 estimates	 often	 became	 unspecific	 and	 ambiguous,	 often	 encompassing	 a	 wide	






Much	 previous	 research	 into	 patients’	 prognostic	 awareness	 has	 attempted	 to	 assess	
knowledge	 by	 asking	 patients	 to	 provide	 an	 estimate	 of	 prognosis	 in	 terms	 of	 chance	 of	
cure,	or	survival	(Kelly	et	al.,	2013;	Liu	et	al.,	2014;	Robinson	et	al.,	2008).	However,	others	
argue	that	asking	patients	to	recall	numerical	prognostic	estimates	is	more	a	test	of	memory	
and	 may	 miss	 patients’	 true	 understanding	 of	 their	 situation	 (Salander,	 Bergknut,	 &	
Henriksson,	2014).	Patient	narratives	are	recognised	as	a	way	that	individuals	interpret	and	
make	sense	of	health	events	and	their	consequences.	By	telling	and	re-telling	stories	about	
illness	 patients	 are	 able	 to	 construct	 meaning	 regarding	 their	 situation	 (Frank,	 2013;	
Kleinman,	1988).	A	particular	strength	of	case	study	research	is	the	emphasis	on	maintaining	
the	context	of	 the	participants’	experiences.	 In	this	way,	 the	current	study	has	underlined	
the	 way	 in	 which	 patients	 built	 up	 their	 understanding	 of	 their	 diagnosis	 and	 risk	 of	
recurrence,	described	in	the	subtheme	‘Multiple	and	Changing	Narratives’.		
	






lung	 cancer	 and	 its	 personal	 impact	 as	 a	 process	 that	 evolved	 over	 time.	 Individual	
conceptions	were	formed	from	the	experiences	and	information	gained	since	diagnosis.	But	
patients	 also	 drew	 on	 pre-existing	 personal	 and	 vicarious	 knowledge	 and	 experience	 of	
cancer,	along	with	wider	cultural	beliefs.	Explicit	prognostic	 information	given	by	clinicians	








Come	 Back?’	 To	 sum	 up	 patient	 participants’	 views,	 it	 would	 be	 to	 say,	 “how	 does	 this	
cancer	affect	me,	my	 family	and	my	plans	 for	 the	 future?”	Despite	 the	ostensibly	positive	
connotation	of	 the	 term	survival,	 for	 some	patient	participants	 the	 term	 implicitly	evoked	
the	opposite	outcome,	namely	death.	Most	participants	appeared	not	to	think	about	long-
term	 outcome	 from	 surgery	 in	 relation	 to	 survival.	 The	 abstract	 nature	 of	 the	 concept,	
coupled	with	the	threatening	nature	of	the	end	point	may	be	reasons	for	this,	although	the	
study	provided	limited	direct	evidence.	Recurrence	appeared	to	be	a	less	threatening,	more	






and	 a	 function	 of	 the	 way	 that	 people	 want	 to	 present	 themselves	 to	 others	 (Goffman,	
1959).	However,	findings	from	patient	interviews	in	the	current	study	showed	how	patients	
formed	multiple	narratives	about	their	future,	not	all	of	which	conformed	to	the	restitution	
model.	 Some	narratives	 told	of	 futures	where	patients	did	not	 see	 themselves	 as	healthy	
again	 and	 explored	 what	 would	 happen	 if	 the	 cancer	 returned.	 In	 this	 way,	 patients’	
narratives	were	often	self-contradictory	and	ambivalent	in	nature.		
	
The	 study	 by	 Furber	 et	 al.	 (2015),	 reviewed	 earlier	 in	 chapter	 3,	 also	 identified	 these	
inconsistent	and	apparently	contradictory	accounts	of	prognosis	given	by	patients.	The	team	
conceived	 patients	 as	 “knowing	 and	 not	 knowing”	 (p265)	 about	 their	 illness	 and	 its	
implications	 and	 used	 Awareness	 Contexts	 theory	 to	 explain	 these	 findings	 (Glaser	 &	
Strauss,	 1965;	 Timmermans,	 1994).	 Furber	 and	 colleagues	 suggested	 that	 patients	 knew	
what	they	had	been	told	about	their	prognosis,	but	moved	between	states	where	they	were	
fully	aware	of	this	information	and	mentally	suspended	awareness	and	temporarily	ignored,	
or	 disregarded	 it.	 Awareness	 Contexts	 theory	 suggests	 that	 active	 open	 awareness	 is	
emotionally	 difficult	 to	maintain	 and	patients	 suspend	 this	 awareness	 as	 a	 self-protective	
move.	 Furber	 and	 colleagues	 treated	patients’	 awareness	of	 diagnosis	 and	prognosis	 as	 a	
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the	 need	 to	 consider	 the	 emotional	 dimension	 of	 healthcare.	 He	 described	 the	 two	
paradigms	 as	 “separate	 worlds”	 (p19);	 with	 evidence-based	 care	 seen	 to	 be	 disease	 and	
doctor	 orientated,	 but	 patient-centred	 care	 necessarily	 illness	 and	 patient	 focused.	 The	
findings	presented	 in	 this	 thesis	provide	 further	evidence	 that	 illustrates	 the	 fundamental	
difference	 between	 professional	 and	 patient	 perspectives	 and	 thinking	 about	 long-term	
outcomes	 in	 relation	 to	 a	 common	 cancer,	 such	 as	 lung	 cancer.	 Professionals	 discussed	
prognosis	 based	 on	 available	 biomedical	 knowledge,	 and	 often	 used	 population	 data.	
Nevertheless,	 most	 professionals	 also	 remained	 cautious	 about	 the	 applicability	 of	
population-based	 data	 at	 the	 individual	 level.	 Patient	 participants,	 on	 the	 other	 hand,	
seemed	 to	 think	 about	 their	 future	 after	 their	 lung	 cancer	 surgery	 as	 it	would	 impact	 on	
them	as	an	 individual.	They	understood	their	situation	using	multiple	evidence	sources,	of	
which	medical	 information	 from	 their	 clinicians	might	 only	 form	 a	 small	 aspect.	 Findings	
have	 demonstrated	 numerous	 ways	 in	 which	 patient	 and	 professional	 participants	




as	 something	 that	 is	damaging	 to	patient	hope	 (Christakis	&	 Iwashyna,	1998;	Del	Vecchio	
Good	 et	 al.,	 1990;	 Gordon	&	 Daugherty,	 2003;	 Thorne	 et	 al.,	 2006;	 Thorne	 et	 al.,	 2007).	
Findings	 from	 the	 current	 study	 coincided	 with	 earlier	 studies	 and	 also	 highlighted	







Previous	 research	 has	 indicated	 that	 doctors	 find	 giving	 patients	 prognostic	 information	
stressful	and	difficult	and	 they	 feel	 ill	prepared	 for	 this	 role	 (Christakis	&	 Iwashyna,	1998;	
Rogg,	Loge,	Aasland,	&	Graugaard,	2009).	Most	of	this	has	been	in	the	context	of	advanced	
cancer	 or	 end	 of	 life	 care.	 Research	 exploring	 attitudes	 to	 prognostic	 discussion	 with	
patients	being	treated	with	curative	intent	is	more	limited.	Nevertheless,	the	importance	of	
professionals	 providing	 a	 hopeful	 message	 for	 patients	 has	 been	 recognised	 by	 multiple	




hopeful	 message.	 Findings	 such	 as	 these	 have	 been	 seen	 more	 recently	 amongst	
professionals	 from	 various	 disciplines	 (Blakely	 et	 al.,	 2017;	 Gordon	 &	 Daugherty,	 2003;	
Henselmans	 et	 al.,	 2017;	 Singh	 et	 al.,	 2017).	 A	 recent	 review	 of	 nursing	 attitudes	 to	
prognostic	discussions	has	indicated	that	while	nurses	do	frequently	take	part,	it	is	often	in	a	
supportive	 capacity,	 with	 doctors	 leading	 the	 conversation	 (Newman,	 2016).	 Common	
concerns	 expressed	 by	 nurses	 also	 include	 damaging	 patient	 hope	 through	 prognostic	
discussions,	as	well	as	concerns	about	going	beyond	the	nursing	remit.	However,	specialist	
oncology	nurses	appear	to	be	more	comfortable	with	initiating	prognostic	discussions	(Helft,	
Chamness,	 Terry,	 &	 Uhrich,	 2011;	 McLennon,	 Uhrich,	 Lasiter,	 Chamness,	 &	 Helft,	 2013;	
Reinke,	Shannon,	Engelberg,	Young,	&	Curtis,	2010).		
	
Other	 influential	 studies	 have	 suggested	 that	 doctors	 are	 often	 uncomfortable	 discussing	
what	they	perceive	as	bad	news	more	generally	and	often	try	to	minimise	or	avoid	explicit	
discussion	 (Fallowfield	&	 Jenkins,	 2004;	Maguire,	 Faulkner,	 Booth,	 Elliott,	&	Hillier,	 1996).	
Various	 training	 programmes	 to	 improve	 cancer	 professionals’	 communication	 skills	 have	
been	 developed	 in	 an	 effort	 to	 enhance	 confidence	 and	 ability	 to	 hold	 such	 difficult	










efforts	 to	 facilitate	 patient-centred	 treatment	 decision-making,	 often	 involving	 online	
cancer	 prognosis	 calculators	 and	 decision	 aids	 (Kelly	 et	 al.,	 2013;	 Rabin	 et	 al.,	 2013;	
Solowski,	 Okuyemi,	 Kallogjeri,	 Nicklaus,	 &	 Piccirillo,	 2014).	 However,	 there	 has	 been	 a	
general	 reluctance	 amongst	 oncologists	 to	 adopt	 these	 into	 widespread	 clinical	 practice	
(Herrmann,	 Mansfield,	 Hall,	 Sanson-Fisher,	 &	 Zdenkowski,	 2016).	 While	 reasons	 for	 not	
adopting	 decision	 aids	were	 complex	 and	wide	 ranging,	 reluctance	 to	 engage	 in	 detailed	







of	multidisciplinary	 perspectives.	 The	 imperative	 to	 provide	 a	 hopeful	message	was	 seen	
across	 all	 the	 disciplines	 in	 the	 study	 and	was	 a	 particular	 factor	 in	 the	 decision	 to	 limit	
prognostic	 discussion	 with	 patients.	 Nevertheless,	 despite	 this	 imperative	 to	 provide	 a	
hopeful	 message,	 professional	 participants	 expressed	 a	 range	 of	 differing	 attitudes	 to	
communicating	 prognostic	 information,	 as	 presented	 in	 the	 subtheme	 ‘Painting	 an	
Information	Picture’.	Some	participants	did	place	a	high	value	on	providing	prognostic	data,	
principally	in	relation	to	helping	patients	with	treatment	decisions	and	making	sense	of	their	
situation.	 However,	 many	 other	 professional	 participants	 remained	 highly	 reluctant	 to	
discuss	prognosis	with	patients	in	this	setting.	While	professionals	discussed	the	limitations	
of	 the	 available	 population	 data	 in	 forming	 an	 individualised	 prognosis,	 most	 saw	 the	








formed	 professional	 participants’	 communication	 ethos.	 Current	 findings	 indicated	
professionals	possessed	a	range	of	nuanced	attitudes	and	beliefs	about	communicating	with	
patients	about	prognostic	issues.	These	often	appeared	to	be	deeply	held	convictions.	While	
these	 seemed	 to	 be	 influenced	 by	 discipline,	 experience	 and	 training,	 fundamentally	 it	




Previous	 research	 findings	 have	 been	 ambiguous	 about	 cancer	 patients’	 desire	 for	





















Innes	 and	 Payne	 (2009)	 characterised	 the	 ambiguity	 in	 the	 information	 patients	 with	
advanced	 disease	 wanted	 as	 a	 paradox	 that	 lies	 at	 the	 heart	 of	 communicating	 about	
prognosis.	The	current	study	suggests	that	this	paradox	is	 just	as	present	in	patients	being	
treated	 curatively.	 Patients	 needed	 to	 feel	 informed,	 but	 they	 had	 a	 simultaneous	
expectation	 that	 professionals	would	provide	 information	 that	would	 sustain	hope.	 There	
was	an	expectation	that	professionals	would	process	information	for	patients	so	that	it	was	
truthful	and	relevant,	but	also	given	in	a	form	that	was	comprehensible,	not	overwhelming	
and	 presented	 in	 a	 positive	 light.	 Similar	 needs	 for	 information	 to	 be	 ‘managed’	 by	
professionals	 have	 been	 described	 in	 haemato-oncology	 patients	 (Atherton,	 Young,	
Kalakonda,	&	Salmon,	2018).		
	
Fuzzy	 Trace	 theory	 indicates	 that	 patients	 have	 a	 preference	 for	 information	 at	 the	 gist	




2013).	 Treatment	 decision-making	 often	 appears	 to	 be	 made	 on	 an	 emotional	 level	 and	
many	 patients	 prefer	 to	 be	 guided	 by	 their	 medical	 team.	 Similar	 findings	 were	 seen	
amongst	 lung	 cancer	 patients	 making	 decisions	 about	 undergoing	 surgery	 (Powell	 et	 al.,	
2015).	 The	 current	 study	 involved	 comparatively	 little	 explicit	 treatment	 decision-making,	
but	 participants	 appeared	 happy	 to	 defer	 to	 medical	 recommendations.	 Patients	 largely	
appeared	 to	 use	 information	 to	 make	 sense	 of	 their	 situation	 and	 to	 form	 a	 broad	
conception	 of	 their	 risk	 of	 cancer	 recurrence.	 As	 suggested	 by	 Zikmund-Fisher	 (2013),	
current	study	 findings	 indicated	that	 information	stating	 that	 recurrence	was	a	possibility,	
but	avoided	quantifying	the	risk,	often	appeared	to	be	sufficient	for	patient	participants.		
	
While	 most	 of	 the	 patient	 participants	 appeared	 to	 have	 little	 requirement	 for	 detailed	
information	about	their	individual	risk	of	cancer	recurrence,	there	was	one	case	who	was	an	
outlier.	 Glennis’s	 on	 going	 requirement	 for	 information	 about	 risk	 of	 recurrence	 and	






objectively	 favourable,	 could	not	help	 to	 resolve	 the	complex	and	multifaceted	emotional	
challenges	of	an	uncertain	future.	There	is	evidence	from	other	studies	that	indicates	being	
given	 prognostic	 information	 does	 not	 necessarily	 relieve	 feelings	 of	 uncertainty	 about	
recurrence.	 Findings	 from	 another	 study	 by	 Hope-Stone,	 Brown,	 Heimann,	 Damato,	 and	
Salmon	(2015)	with	patients	with	uveal	melanoma	suggested	that	even	patients	with	good	
prognoses	 might	 never	 be	 able	 to	 fully	 accept	 this	 information,	 while	 others	 struggle	 to	






cancer	process	 and	use	prognostic	 detail	 over	 the	 long-term	 in	 situations	where	 they	 are	
given	this	information.		
9.4.3 Recurrence	risk	communication	and	the	co-construction	of	hope	
The	 findings	 discussed	 so	 far	 have	 highlighted	 patients’	 understanding	 about	 long-term	
outcome	 following	 their	 surgery	 that	 was	 largely	 about	 possible	 alternative	 outcomes,	
rather	than	thinking	in	terms	of	risk.	Professionals	on	the	other	hand	had	access	to	the	full	
range	 of	 biomedical	 understanding,	 but	 appeared	 to	 want	 to	 protect	 patients	 from	
accessing	the	medical	perspective,	which	they	felt	could	overwhelm	patients	and	jeopardise	
hope	 for	 the	 future.	 I	 will	 now	 turn	 to	 explore	 how	 the	 multidimensional	 nature	 of	 the	




The	 idea	 of	 Hope	Work,	 described	 by	 Perakyla	 (1991),	 is	 the	 process	 of	 controlling	 and	
shaping	discussions	between	patients	and	professionals	with	the	principal	aim	of	supporting	
hope	about	the	future.	Some	researchers	have	argued	that	the	reason	professionals	try	to	





(Burkitt	 Wright,	 Holcombe,	 &	 Salmon,	 2004;	 Leydon	 et	 al.,	 2000;	 Salmon	 et	 al.,	 2012).	
Salmon	 and	 Young	 (2017)	 have	 argued,	 provision	 of	 hope	 is	 at	 the	 core	 of	 all	 healthcare	
provision	and	is	fundamental	to	its	endeavour.	However,	there	is	a	note	of	caution	sounded	








coercive,	 such	 as	Maggie’s	 consultation	with	 her	 oncologist	 (Hope	Dances).	Nevertheless,	











Previous	 research	 has	 identified	 the	 active	 mental	 manoeuvres	 patients	 with	 malignant	
brain	tumours	(Salander,	Bergenheim,	&	Henriksson,	1996)	and	lung	cancer	(Salander,	et	al.,	
2014)	use	to	construct	hope.	Authors	suggest	that	patients	do	not	simply	passively	respond	
to	a	stressful	 situation,	but	engage	 in	Hope	Work	and	actively	create	hope	 in	 response	to	
this	stress.	They	highlight	the	essential	role	illusion	can	have	in	creating	a	safe	place	in	which	






Patients’	 narratives	 appeared	 to	 form	 a	 contingency	 that	 had	 the	 effect	 of	 reducing	 the	
potential	 impact	 of	 recurrence	 and	 distancing	 it	 from	 thoughts	 of	 death.	 Lazarus	 and	
Folkman	 (1984)	 describe	 contingency	 coping	 as	 a	 way	 of	 planning	 for	 the	 future	 and	
providing	individuals	with	a	mental	escape	route	and	a	source	of	hope.	Mishel	(1990)	argues	
in	 her	 Uncertainty	 in	 Illness	 Theory	 (UIT)	 that	 coping	 with	 long-term	 health	 conditions	
requires	acceptance	of	uncertainty	being	part	of	normal	 life	and	of	a	 future	with	multiple	





as	 an	 important	 resource	 closely	 aligned	 to	 coping	 strategies	 (Folkman,	 2010;	 Lazarus,	
1999).	 Hope	 allows	 the	 negative	 outcomes	 to	 be	 explored	 and	 acknowledged,	 whilst	
simultaneously	supporting	a	belief	in	the	positive	outcome	(Folkman,	2010).		
	
Although	 patient	 participants	 did	 not	 explicitly	 frame	 hope	 in	 terms	 of	 managing	
uncertainty,	UIT	is	helpful	to	understand	the	strategies	used	by	patient	participants	(Mishel,	
1988;	Mishel,	1990).	Participants	appeared	to	appraise	the	uncertainty	around	lung	cancer	
recurrence	 in	 various	ways,	 as	was	 evident	 in	 the	narratives	 they	 told	 about	 their	 illness.	
According	to	UIT,	uncertainty	surrounding	a	situation	is	appraised	as	either	an	opportunity	
or	 as	 a	 threat	 and	 is	 interpreted	 through	 the	 prism	 of	 patients’	 inferences	 and	 illusions.	
Some	patients,	such	as	Glennis,	Fiona	and	Maggie,	appeared	to	appraise	uncertainty	about	
recurrence	 as	 a	 danger.	 Some	 adopted	 mobilising	 strategies,	 such	 as	 hyper	 vigilance,	
information	 seeking	 and	 attempting	 to	 access	 medical	 care.	 Others	 tried	 to	 reduce	
uncertainty	by	adopting	very	different	coping	strategies,	like	affect	control	and	re-framing	of	
information.	Other	participants	appeared	to	see	the	uncertainty	around	future	recurrence	
as	 more	 of	 an	 opportunity.	 UIT	 suggests	 that	 the	 predominant	 coping	 strategy	 in	 this	
situation	 is	 one	 of	 buffering,	 such	 as	 mental	 distancing,	 avoiding	 dwelling	 on	 things,	 or	




Denise’s	 description	 of	 seeing	 how	 “the	 dices	 roll	 for	 me”.	 UIT	 proposes	 that	 accepting	












also	 provided	 further	 understanding	 around	 the	way	 in	 which	 professionals	 and	 patients	




heart	 of	 medical	 interactions.	 This	 asymmetry	 persists	 despite	 many	 strategic	 initiatives	
promoting	 patient	 centred	 care	 aimed	 at	 addressing	 this	 perceived	 problem	 (Pilnick	 &	
Dingwall,	 2011).	 However,	 Salmon	 and	 Young	 (2017)	 argue	 that	 the	 dependence	 and	
vulnerability	 in	the	clinical	relationship	needs	to	be	acknowledged,	and	patients	cannot	be	













patients	 following	surgery,	 indicated	surgeons	give	prognostic	 information	asymmetrically.	
Patients	 with	 more	 favourable	 prognoses	 were	 more	 likely	 to	 be	 given	 an	 indication	 of	
prognosis,	 whereas	 patients	 whose	 prognoses	 were	 poorer	 were	 given	 more	 details	 of	





The	 findings	presented	 in	 this	 thesis	broadly	coincide	with	 these	studies,	but	also	provide	
new	 insight	 into	 some	 of	 the	 processes	 that	 occur,	 particularly	 in	 relation	 to	 patients	
undergoing	 curative	 treatment.	 Findings	 clearly	 illustrated	 how	 the	 power	 imbalance	was	
present	 during	 consultations,	 reflected	 in	 the	 dance	 metaphor	 ‘Lead	 and	 Follow’.	
Professionals	 led	 by	 shaping	 the	 consultations,	 being	 in	 possession	 of	 the	 required	
information,	 and	 principally	 determining	 the	 patients’	 onward	 management	 plans.	 As	
presented	 in	 Chapter	 5,	 explicit	 information	 about	 recurrence	 risk	 and	 prognosis	 formed	
only	a	very	small	element	of	the	observed	consultations.	Recurrence	risk	was	conveyed	to	
patients	in	a	variety	of	explicit	and	non-explicit	ways	and	these	findings	have	been	explored	
in	 more	 depth	 elsewhere	 (Johnson,	 M.,	 Tod,	 Brummell,	 &	 Collins,	 2018).	 Professionals	
tended	to	present	prognostic	and	staging	information	in	the	least	explicit	manner	possible;	
discussion	 about	 risk	 of	 recurrence	 was	 even	 more	 limited.	 Where	 information	 about	
recurrence	was	discussed	directly,	professionals	 largely	only	did	 so	 in	 response	 to	 specific	
questions	 from	 patients.	 Most	 felt	 that	 this	 was	 not	 information	 that	 patients	 usually	
wanted	 and	 they	 expected	 patients	 to	 ask	 if	 they	 needed	 to	 discuss	 recurrence	 risk.	




A	 feature	 of	 this	 case	 study	 design	 was	 the	 two	 distinct	 treatment	 pathways.	 Findings	
indicated	a	distinct	difference	 in	 the	explicit	 recurrence	 risk	 information	given	 to	 the	 two	











recurrence	 risk,	 but	 this	 only	 happened	once	patients	 had	been	 given	 sufficient	 gist	 level	
indication	 that	 their	 outlook	 was	 apparently	 good.	 The	 study	 did	 not	 give	 any	 direct	
explanation	 for	 this	difference	between	 the	 two	pathways,	but	Mishel’s	UIT	does	provide	
one	possible	rationale	for	this	difference.		
	
Once	 information	 regarding	 the	 results	 of	 the	 surgery	 was	 conveyed	 to	 patients,	 further	






Pathway	 A	 did	 seek	 recurrence	 risk	 information,	 they	 did	 not	 appear	 to	 want	 unlimited	














B	 appeared	 not	 to	 want	 details	 about	 recurrence	 risks.	 In	 the	 context	 of	 Mishel’s	
Uncertainty	 in	 Illness	 Theory	 (UIT),	 patients	 who	 were	 referred	 to	 see	 an	 oncologist	 to	
discuss	adjuvant	therapy	might	interpret	uncertainty	around	recurrence	as	an	opportunity.	
Finding	out	more	explicit	 information	about	recurrence	risks	could	be	interpreted	as	being	
unlikely	 to	 help	 sustain	 hope	 for	 the	 future.	 The	 tension	 that	 particularly	 existed	 for	
professionals	 when	 seeing	 patients	 on	 Pathway	 B	 was	 evident,	 as	 presented	 in	 the	
subtheme	‘A	Realistic	Picture’.	Professionals	wanted	to	promote	a	sense	of	hope	around	the	
outcome	of	surgery,	while	at	the	same	time	raising	the	issue	of	recurrence	and	the	potential	
survival	 benefits	 from	 adjuvant	 therapy.	 Professional	 and	 patient	 participants	 both	
appeared	 to	 want	 to	 limit	 explicit	 prognostic	 discussion.	 Although	 the	 aim	 of	 adjuvant	
therapy	 is	 to	 improve	 chance	 of	 survival,	 discussion	 of	 recurrence	 remained	 largely	
equivocal	 and	 euphemistic.	 Oncologists	 explicitly	 wanted	 to	 preserve	 patients’	 sense	 of	
hope	about	the	outcome	of	surgery	and	long-term	outlook.	They	avoided	discussing	overall	
survival	statistics,	focusing	dialogue	on	potential	incremental	benefit	of	treatment,	as	seen	
in	 Maggie’s	 oncology	 consultation	 described	 in	 ‘Lead	 and	 Follow’.	 Previous	 studies	 with	




The	 importance	 of	 personal	 values,	 beliefs	 and	 approaches	 to	 communication	 and	 the	
multiple	 simultaneous	 messages	 influencing	 the	 final	 exchange	 of	 information	 was	
identified	 in	 the	 conceptual	 framework	 developed	 by	 Feldman-Stewart	 et	 al.	 (2005).	 The	
current	study	findings	provide	empirical	evidence	to	illustrate	these	processes	and	how	both	
professionals	 and	 patients	 influence	 recurrence	 risk	 communication	 leading	 to	 a	 complex	
and	 interactive	 process.	 The	 study	 underlined	 how	 information	 exchange	 is	 tacitly	




information	 about	 recurrence	 risks,	 which	 did	 not	 match	 patients’	 information	
requirements,	other	processes	seemed	to	come	 into	play	 that	allowed	patients	 to	control	
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the	message	 they	 took	 away.	 The	 consultation	 pattern	 described	 in	 ‘Dancing	 to	Different	
Tunes’	illustrated	how	a	patient	(Len)	might	avoid	engaging	in	the	details	of	the	information	
disclosed	 by	 only	 taking	 the	 emotional	 content	 of	 the	 encounter	 where	 unrequested	
numerical	risk	information	was	given.	Alternatively,	other	patients,	like	Maggie,	may	simply	
re-frame	 and	manipulate	 numerical	 information	 so	 it	might	 seem	more	 hopeful	 than	 the	
original	 message	 was	 intended.	 Other	 authors	 have	 identified	 that	 providing	 numerical	
information	to	patients	is	no	guarantee	of	their	understanding,	or	willingness	to	accept	this	
information	(Han	et	al.,	2013).	The	findings	support	the	idea	that	the	salience	of	information	




and	 treatment	 decision-making.	 Information	 given	 about	 recurrence	 risk	 in	 relation	 to	
adjuvant	 treatment	 was	 limited	 and	 the	 study	 also	 provided	 clear	 evidence	 about	 how	




the	 findings	 also	 suggest	 that	 merely	 providing	 risk	 information	 may	 play	 lip	 service	 to	
informed	consent	and	 increases	 the	chance	 that	patients	misunderstand	and	misinterpret	
their	situation.	Herein	lies	a	clinical	challenge	to	ensure	that	information	is	tailored	to	meet	
patients’	communication	and	information	needs	and	in	a	level	of	detail	that	is	appropriate	
for	 the	 purpose	 intended,	 be	 it	 making	 sense	 of	 their	 situation,	 or	 treatment	 decision-
making	 and	 informed	 consent.	 The	 tension	 between	 the	 professional’s	 beliefs	 about	
disclosing	 prognostic	 information,	 patients’	 fluctuating	 need	 for	 information	 given	 at	 the	
right	 level,	 and	 both	 parties’	 sense	 of	 the	 hope	 imperative	 appears	 to	 play	 out	 in	 these	
consultations.	 The	 findings	 suggest	 that	 professionals	 need	 to	 communicate	 in	ways	 that	
can	adapt	to	the	different	needs	and	changing	priorities	of	patients,	to	facilitate	open	and	
honest	 discussions	 with	 patients.	 Identification	 and	 awareness	 of	 the	 tension	 that	 is	








strategic	 priority	 for	 cancer	 care	 and	 research	 in	 the	 UK	 (Independent	 Cancer	 Taskforce,	
2015;	NCRI,	 2018).	 This	 agenda	has	 a	wide-ranging	 remit	 covering	physical	 late	 effects	 of	
treatment	as	well	as	the	emotional	and	social	impacts	of	a	cancer	diagnosis.	This	aspect	of	
care	has	previously	not	 received	much	attention	within	 lung	 cancer	 care,	primarily	 as	 the	
vast	majority	 of	 patients	 were	 not	 treated	 with	 the	 aim	 of	 cure.	 However,	 over	 the	 last	
decade	 there	 has	 been	 a	 significant	 increase	 in	 the	 numbers	 of	 patients	 having	 curative	
treatment	 due	 to	 a	 more	 proactive	 approach	 to	 surgery	 and	 efforts	 to	 promote	 early	
diagnosis.	 Numbers	 are	 set	 to	 increase	 further	 due	 to	 two	 policy	 drivers.	 National	 lung	
cancer	 guidelines	 now	 recommend	 that	 surgery,	 as	 part	 of	 multimodality	 treatment,	 be	
considered	in	a	cohort	of	patients	previously	deemed	not	to	be	suitable	for	surgery	(NICE,	
2019).	 At	 the	 same	 time,	 rollout	 of	 the	 national	 lung	 cancer	 screening	 programme	 has	
begun,	 which	 aims	 to	 detect	 early	 stage	 cancers,	 reducing	 the	 number	 of	 patients	
presenting	with	inoperable	disease	(NHS	England,	2019).	Therefore,	in	the	future	there	will	
be	many	more	surgically	treated	patients,	both	with	very	early	stage	cancer,	as	well	as	those	
with	more	 advanced	 disease.	 The	 problems	 addressed	 in	 this	 study	 around	 how	 best	 to	
support	 and	 talk	with	 patients	 about	 the	 possibility	 of	 future	 lung	 cancer	 recurrence	will	
become	more	significant.	In	this	last	section	I	will	explore	the	findings	of	the	current	study	in	
relation	to	supporting	patients	to	cope	with	uncertainty	around	recurrence,	identifying	and	
helping	 those	 who	 experience	 significant	 fear	 of	 cancer	 recurrence	 and	 looking	 at	 the	
implications	for	follow-up	and	cancer	surveillance.	
Return	to	normality?	
Doyle	 (2008)	 characterised	 life	 after	 a	 diagnosis	 of	 cancer	 as	 being	 changed	 forever,	
inextricably	 linked	 to	 uncertainty.	 Others	 have	 identified	 how	 patients	 can	 anticipate	 life	
returning	 to	 normal	 and	 a	 sense	 of	 relief	 after	 finishing	 treatment,	which	 are	 simply	 not	
matched	by	 the	 reality	of	 their	 situation	 (Thorne	&	Stajduhar,	2012).	Evidence	 from	Head	
and	 Neck	 cancer	 patients	 suggests	 that	 a	 perceived	 sense	 of	 certainty	 at	 the	 end	 of	




not	 collude	 with	 them	 about	 life	 returning	 to	 ‘normality’	 after	 treatment	 (Thorne	 &	
Stajduhar,	 2012).	 At	 the	 end	 of	 treatment	 for	 a	 serious	 illness	 patients	 can	 be	 seen	 to	
transition	from	ill-person	to	cured-person.	Such	transitions	are	characterised	as	involving	a	
‘liminal’	period,	a	word	derived	from	Latin,	meaning	the	threshold	between	one	space	and	




time	 and	 without	 notice,	 reflecting	 the	 ever-present	 threat	 of	 recurrence.	 Members	
continually	 morph	 between	 sickness	 and	 wellness	 in	 response	 to	 symptoms,	 anxiety,	 or	
relapse.	 Uncertainty	 around	 the	 potential	 for	 recurrence	 is	 one	 of	 multiple	 concerns	
experienced	by	patients	after	the	end	of	initial	cancer	treatment.	Studies	report	that	anxiety	
about	 possible	 recurrence	 of	 cancer	 is	 one	 of	 patients’	 principal	 concerns	 (Armes	 et	 al.,	
2009;	Jefford	et	al.,	2008;	Stajduhar,	Thorne,	McGuinness,	&	Kim-Sing,	2010;	Thorne	et	al.,	





the	 current	 study,	 particularly	 noticeable	 in	 the	 longitudinal	 findings.	 For	 several	
participants	 there	 was	 a	 sense	 of	 ambiguity	 about	 their	 status	 following	 surgery.	 Some	
patient	participants	talked	explicitly	about	being	in	a	state	of	“limbo”,	or	reported	how	life	










the	 ultimate	 shared	 goal.	 This	 paradox	 serves	 to	 underline	 the	 uncertain	 and	 ambiguous	
nature	of	the	period	following	lung	cancer	surgery.		
Recurrence	surveillance	after	lung	cancer	surgery	
There	 remains	 a	 lack	 of	 consensus	 on	 the	 optimal	 follow-up	 pathways	 for	 lung	 cancer	
patients,	 with	 arguments	 about	 both	 cost	 and	 clinical	 effectiveness	 (Colt	 et	 al.,	 2013;	
McMurry	 et	 al.,	 2018;	Westeel	 et	 al.,	 2017).	 Lung	 cancer	 also	 lags	 behind	 other	 tumour	
types,	such	as	breast	and	melanoma,	in	terms	of	specific	genetic	tests	on	resected	tumour	
that	might	be	able	 to	distinguish	patients	at	higher	 risk	of	 recurrence	 (Buyse	et	al.,	2006;	
Damato	et	al.,	2007).	Despite	this,	patients	appear	to	gain	reassurance	and	support	from	the	
process	 of	 follow-up,	 even	 beyond	 the	 anxiety	 associated	with	 attendance	 (Sandeman	&	
Wells,	 2011).	 Other	 studies	 indicate	 patients	 want	 to	 be	 followed	 up	 intensively	 in	
secondary	 care	 (Cox,	 K.	 et	 al.,	 2006;	 Krishnasamy,	 Ugalde,	 Carey,	 Duffy,	 &	Dryden,	 2011;	
Moore	et	al.,	2002).		
	
The	 current	 study	 did	 not	 explore	 the	 attitudes	 of	 patients	 regarding	 acceptability	 of	 the	
follow-up	 process.	 However,	 it	 offers	 unique	 insight	 into	 the	 attitudes	 of	 professionals	
caring	 for	 lung	 cancer	 patients	 towards	 current	 follow-up	 strategies.	 Professional	
participants	largely	held	nihilistic	attitudes	to	lung	cancer	follow-up	and	surveillance.	These	
appeared	 to	 stem	 from	 their	 feelings	 about	 treatment	 for	 recurrent	 lung	 cancer,	 as	
discussed	in	the	subtheme	‘Best	Shot	First	Time’.	For	most	professional	participants	 in	the	
current	study	detecting	recurrence	early	appeared	to	be	primarily	about	managing	patients’	
and	 families’	 sense	 of	 being	 cared	 for,	 rather	 than	 aiming	 to	 impact	 patients’	 long-term	
outcome.	 Some	 did	 recognise	 newer	 treatment	 modalities,	 such	 as	 stereotactic	
radiotherapy	and	biological	therapies,	were	beginning	to	open	up	more	treatment	options	
for	 patient	 who	 did	 relapse.	 However,	 it	 was	 apparent	 that	 for	 many	 participants	 these	
newer	 treatment	options	were	 slow	 to	 influence	 attitudes	 to	 follow-up	 care.	While	 these	
sorts	 of	 opinions	 were	 not	 universal,	 as	 evidenced	 by	 the	 proactive	 and	 interventionist	







Professionals’	 attitudes	 to	 lung	 cancer	 follow-up	 are	 also	 likely	 to	 influence	 how	 they	
perceive	patients’	role	in	self-monitoring	and	responding	to	early	signs	and	symptoms	that	
might	 indicate	a	 recurrence.	Thorne	and	Stajduhar	 (2012)	argue	 that	patients	with	cancer	
inevitably	need	to	engage	with	and	play	a	role	in	monitoring	for	potential	recurrence	after	
the	 end	 of	 treatment.	 Engaging	 patients	 necessitates	 a	 sensitive	 and	 planned	 discussion	
about	 the	 potential	 for	 and	 symptoms	 of	 recurrence.	 They	 recognise	 the	 challenges	 all	
parties	face	in	communicating	about	possible	recurrence	at	the	transition	after	treatment,	
but	 they	 argue,	 simply	 denying	 the	 issue	 could	 risk	 not	 addressing	 real	 concerns.	
Professional	 participants	 in	 this	 current	 study	 were	 largely	 reluctant	 to	 discuss	 potential	
signs	 of	 recurrence	 explicitly	 with	 patients,	 for	 several	 reasons.	 The	 damaging	 effects	 on	
hope	 of	 discussing	 recurrence	 issues,	 such	 as	 focusing	 patients’	 attention	 unhealthily	 on	
cancer,	 diluting	 the	 “good	 news”	 of	 the	 surgical	 outcome	 and	 giving	 patients	 mixed	
messages.	Another	big	concern	centred	on	the	non-specific	and	vague	nature	of	recurrence	




The	 findings	 indicated	 a	 clinical	 challenge	 in	 how	 best	 to	 address	 the	 topic	 of	 signs	 and	
symptoms	of	possible	recurrence	with	patients.	Some	professional	participants	tried	to	talk	
to	 patients	 not	 in	 terms	 of	 specific	 symptoms,	 but	 rather	 in	 relation	 to	 the	 duration	 of	
symptoms	 that	 would	 indicate	 the	 need	 for	 further	 investigation.	 However,	 across	 the	
findings,	where	discussion	 took	place	about	 signs	of	 recurrence,	 there	was	 little	 evidence	
that	patient	participants	could	recall	the	 information	later.	There	was	also	evidence	in	the	
findings	 of	 patients	 having	 unanswered	 questions	 about	 possible	 future	 recurrence	 that	
were	 never	 asked	 or	 discussed,	 even	 amongst	 patients	 who	 generally	 tried	 to	 avoid	
information.	 Concerns	 included	where	 cancer	 recurrence	might	manifest	 in	 the	 body	 and	
how	they	might	recognise	it.	Some	patient	participants	even	felt	professionals	deliberately	
withheld	 this	 information	 from	 them.	On	 the	other	hand,	patients	were	often	ambivalent	






adequately	 tackled	within	 the	existing	 format	of	 the	 twenty-minute	medical	 consultation,	
with	multiple	other	competing	issues.		
	
Previous	 studies	have	 indicated	 that	patients	 find	nurse-led	 follow-up	acceptable	and	 can	
address	a	wider	range	of	concerns	than	conventional	follow-up	(Cox,	K.	et	al.,	2006;	Moore	




of	 holistic	 needs	would	 be	 an	 ideal	 starting	 point.	 Examples	 of	 approaches	might	 include	
techniques	 commonly	 used	 in	 difficult	 discussions	 with	 patients	 with	 more	 advanced	
disease	such	as	“hope	for	the	best,	plan	for	the	worst”	(Back,	Arnold,	&	Quill,	2003;	Mori	et	
al.,	 2019).	 This	 method	 allows	 hope	 to	 be	 reinforced,	 whilst	 simultaneously	 facilitating	
discussion	 of	 more	 sensitive	 matters	 that	 might	 make	 a	 difference	 to	 patients,	 such	 as	






about	 cancer	 recurrence	 that	 participants	 experienced	 over	 time	 following	 their	 surgery.	
The	narratives	patients	gave	about	their	condition	indicated	the	potentially	fragile	nature	of	
their	 perceptions	 of	 recovery,	 in	 a	 way	 that	 resembled	 the	 idea	 of	 a	 remission	 society.	
Several	participants	expressed	significant	concerns	about	cancer	 recurrence	as	a	 response	
to	worrying	 symptoms,	 such	 as	 back	 pain	 or	 recurrent	 chest	 infections.	 Similarly,	 routine	
scans,	particularly	if	an	abnormality	was	detected,	could	disrupt	patients’	sense	of	recovery.	
Others	appeared	to	experience	periods	of	worry	about	cancer	recurrence	that	were	more	





Study	 findings	 described	 in	 the	 subtheme	 ‘Pivoting	 the	 Cancer	 Gaze’	 indicated	 that	 both	
professional	 and	 patient	 participants	 principally	 attempted	 to	 manage	 the	 sense	 of	
uncertainty	about	recurrence	by	directing	their	attention	to	the	normal	aspects	of	 life	and	
endeavouring	to	avoid	thinking	about	recurrence	issues.	Professionals	saw	those	who	coped	
best	had	a	 “que	 será,	 será”	attitude	and	did	not	worry	excessively	about	what	 the	 future	
held.	 Professionals	 wanted	 to	 help	 facilitate	 this	 attitude	 by	 focusing	 patients’	 attention	
beyond	 their	 cancer	 diagnosis,	 to	 pick	 up	 the	pieces	 of	 their	 life,	 and	 resume	meaningful	
activities.	In	this	way	professionals	could	be	considered	to	be	engaging	in	Hope	Work	with	




leading	 to	 rumination	 and	 hyper	 vigilance.	 A	 real	 danger	 in	 the	 approach	 that	 only	
attempted	 to	 pivot	 attention	 away	 from	 cancer	 was	 the	 risk	 of	 creating	 a	 conspiracy	 of	
silence	 between	 professional	 and	 patient	 about	 any	 discussion	 regarding	 possible	
recurrence.	 Several	 professional	 participants	 wanted	 to	 deflect	 or	 actively	 close	 down	
discussion	of	 recurrence	where	patients	 raised	 concerns.	 This	was	particularly	 true	of	 the	









concerns	 than	 other	 patient	 groups.	 Lung	 cancer	 patients	 are	 frequently	 perceived	 to	 be	
undemanding	 of	 healthcare,	 potentially	 linked	 to	 feelings	 of	 being	 undeserving	 and	
stigmatisation	 in	 relation	 to	 smoking	 (Chapple,	 Ziebland,	 &	 McPherson,	 2004;	 Conlon,	
Gilbert,	Jones,	&	Aldredge,	2010;	Lehto,	2014).	There	is	little	research	evidence	specifically	










diagnoses	 the	 issues	 with	 fear	 of	 recurrence	 may	 well	 be	 heightened.	 Professionals	 and	













specialist	 interventions	 and	have	 access	 to	 timely	 and	 convenient	 services.	 Alongside	 this	
there	 is	a	need	to	develop	 interventions	that	are	acceptable	to	and	meet	the	needs	of	an	
older	 and	 potentially	 less	 well-educated	 patient	 population	 that	 is	 often	 associated	 with	
lung	 cancer.	 Early	 identification	 of	 those	 patients	 with	 lung	 cancer	 who	 experience	
significant	fear	of	cancer	recurrence	and	provision	of	interventions	that	make	a	difference	is	
a	priority.	 There	 remains	a	 lack	of	evidence	 regarding	how	patients	 cope	with	 the	 fear	of	







about	potential	 recurrence	after	surgery	 in	patients	with	early	stage	 lung	cancer.	Previous	





long-term	 outlook	 with	 patients	 following	 potentially	 curative	 surgery	 for	 primary	 lung	
cancer.	 The	 temporal	 element	 to	 the	 study	 has	 given	 new	 and	 unique	 insight	 into	 the	
process	 of	 information	 disclosure	 across	 sequential	 clinical	 contacts	 with	 different	
disciplines,	 as	well	 as	 a	 patient	 perspective	 that	 has	 incorporated	 longitudinal	 interviews.	





The	 study	 has	 highlighted	 how	 information	 about	 potential	 cancer	 recurrence	 after	 lung	
cancer	 surgery	 is	 disclosed	 according	 to	 the	 individual	 personal	 communication	 ethos	 of	
practitioners,	largely	surgeons,	and	to	a	lesser	extent	the	information	needs	of	patients	and	
their	 families.	 Even	 in	 this	 group	 of	 patients	 with	 relatively	 good	 lung	 cancer	 prognoses	
recurrence	 risk	 communication	 was	 largely	 determined	 by	 the	 shared	 imperative	 to	
maintain	patient	hope.	The	study	has	provided	 insight	 into	the	way	 in	which	professionals	
and	patients	tacitly	negotiate	discussion	around	recurrence	risk,	primarily	by	professionals	
minimising	 discussion	 of	 the	 subject	 and	 adopting	 a	 ‘don’t	 ask,	 don’t	 tell’	 policy.	 This	
included	reluctance	to	discuss	possible	signs	and	symptoms	of	 recurrence	and	what	 to	do	
about	 it.	 This	 policy	 risked	 a	 conspiracy	 of	 silence	 between	 professionals	 and	 patients	
regarding	 discussing	 possible	 future	 recurrence.	 An	 asymmetry	 in	 recurrence	 risk	
information	giving	was	seen	between	groups	of	patients,	whereby	patients	with	 the	most	
favourable	prognoses	felt	able	to	ask	for	more	explicit	detail.	Patients	who	perceived	they	
had	 a	 less	 favourable	 prognosis	 did	 not	 ask	 for	 more	 details,	 possibly	 because	 this	
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information	 would	 not	 support	 future	 hope.	 These	 findings	 are	 consistent	 with	 Mishel’s	















The	 case	 study	 presented	 in	 this	 thesis	 has	 highlighted	 several	 key	 areas	 for	 developing	
clinical	practice.		
• Specific	training	should	be	offered	to	all	professionals	involved	in	discussing	the	results,	
management	 plans	 and	 the	 future	 implications	 following	 curative	 lung	 cancer	 surgery	
and	 should	 be	 focused	 on	 communication	 approaches	 that	 support	 patients’	 coping	
strategies,	while	also	conveying	necessary	information.	
	
• Clinicians	 should	 consider	 the	 implications	 of	 the	 way	 numerical	 information	 is	 used	




outside	 the	 medical	 consultation,	 probably	 with	 their	 designated	 LCNS,	 to	 allow	 an	














support	 and	 equip	 patients	 to	 manage	 the	 uncertainty	 of	 potential	 recurrence	 following	
their	surgery.		
• Further	 research	 is	 needed	 into	 the	 communication	 of	 lung	 cancer	 recurrence	 risk	 to	
identify	possible	 strategies	 that	patients	 are	 able	 to	engage	with,	 in	ways	 that	do	not	
significantly	increase	worry	about	recurrence	and	that	are	acceptable	for	patients.	This	
would	be	particularly	suitable	for	research	using	the	principles	of	collaborative	research,	
such	 as	 Experienced	 Based	 Co-design	 (Donetto,	 Pierri,	 Tsianakas,	 &	 Robert,	 2015;	
Hinchcliff,	Greenfield,	&	Braithwaite,	2014).	
	
• Studies	 should	 be	 developed	 aimed	 at	 scoping	 the	 extent	 and	 significance	 of	 fear	 of	
cancer	recurrence	 in	the	post-surgical	 lung	cancer	population	throughout	the	five-year	
follow-up	period	up	to	ultimate	discharge	from	the	service.	This	should	be	with	the	aim	
of	 developing	 suitable	methods	 of	 screening	 patients	with	 clinically	 significant	 fear	 of	
lung	cancer	recurrence,	or	those	at	high	risk	of	developing	problems.		
	







• A	 broader	 health	 services	 research	 challenge	 is	 how	 to	 provide	 coordinated	 and	
integrated	follow-up	care	after	 the	end	of	acute	treatment	 for	 the	growing	number	of	




The	 key	 strength	 of	 this	 study	 lies	 in	 its	 comprehensive	 case	 study	 design;	methods	 that	
were	ultimately	able	to	deliver	the	stated	research	aims.	Multi	perspectival	data	were	used	
to	 gain	 an	 in-depth	 understanding	 of	 communication	 regarding	 recurrence	 risk	 during	
sequential	multidisciplinary	 consultations.	 This	was	 combined	with	 data	 from	 longitudinal	
patient	 interviews	 to	 gain	 insight	 into	 patient	 perceptions	 during	 the	 first	 six	 months	
following	surgery.	The	methods	used	allowed	me	to	preserve	the	integrity	of	the	individual	
cases	and	reflect	the	complexity	of	the	interactions.	Rather	than	trying	to	triangulate	these	





purposive	 sampling	 strategy	enabled	me	 to	 include	a	wide	 range	of	 patients,	which	were	
diverse	in	terms	of	background,	cancer	stage	and	treatment	pathway.	Using	three	referring	
LMDTs	 and	 two	 surgical	 centres	 also	 widened	 the	 range	 of	 patient	 experiences	 and	
increased	the	diversity	of	professional	views	included	in	the	study.	Another	strength	was	the	
rigour	with	which	I	approached	data	analysis	and	interpretation.	Complete	immersion	in	the	
data	 from	 its	 collection	 and	 subsequent	 data	 management	 resulted	 in	 a	 comprehensive	




on	 findings	 generated	 from	 cases	 within	 a	 particular	 clinical	 context.	 As	 such	 it	 is	 not	
possible	 to	 draw	 direct	 universal	 conclusions	 from	 these	 findings,	 even	 in	 relation	 to	 the	
wider	 population	 of	 post-surgical	 lung	 cancer	 patients.	 However,	 the	 themes	 developed	
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focused	 on	 the	 broad	 principles	 and	 fundamental	 needs	 of	 participants,	 such	 that	 the	
findings	may	have	broader	application	than	those	of	the	specific	cases	studied.	In	common	






of	 the	 supervisory	 team	 independently	 read	 and	 coded	 early	 interview	 and	 consultation	























conducting	and	analysing	 research,	and	 in	my	personal	and	 team	clinical	practice	working	
alongside	patients	and	their	families	undergoing	diagnosis,	treatment	and	follow-up	for	lung	
cancer.	 The	 study	 has	 also	 charted	 changes	 in	 my	 own	 assumptions	 and	 thinking	 about	
recurrence	risk	communication	and	how	best	to	approach	this	with	patients.	I	came	into	the	
research	with	the	opinion	that	patients	largely	wanted	detailed	information	regarding	their	
risk	 of	 cancer	 recurrence,	 but	 that	 this	 was	 not	 generally	 given	 by	 surgeons.	 I	 assumed	
recurrence	 risk	 information	 was	 given	 as	 part	 of	 the	 process	 of	 decision-making	 about	
adjuvant	 therapy,	 due	 to	 previous	 experience	 with	 patients	 with	 breast	 cancer	 where	
patient	decision-aids	were	 routinely	used.	Although	such	data	can	be	seen	as	neutral	and	
scientific,	 I	 was	 surprised	 at	 how	 patient	 participants	 viewed	 it	 as	 value-laden	 and	
threatening,	even	where	objectively	it	could	be	considered	as	good	news.	My	assumptions	
suggested	that	patients	with	a	higher	objective	risk	of	 recurrence	would	be	more	 likely	 to	
both	want	and	receive	detailed	recurrence	risk	 information	than	those	where	the	risk	was	
lower.	The	findings,	however,	suggested	the	opposite,	with	the	information	not	being	used	
in	 relation	 to	 treatment	 decision-making,	 but	 rather	 as	 a	 coping	 strategy	 linked	 to	
maintaining	hope.	
	
The	 study	has	 allowed	me	 to	 consider	 the	 complexities	 of	 providing	 individual	 prognostic	
forecasts	based	on	 the	available	population	data,	 that	 I	 had	not	 fully	 appreciated.	Within	
this	 small	 case	 study,	most	patients	had	 confounding	 factors	 that	might	 impact	prognosis	
assessments	 based	 on	 population	 data.	 However,	 it	 was	 the	 fundamental	 differences	
between	 this	population	data	and	 the	way	patients	 thought	about	 their	 future,	extending	
beyond	the	simple	differences	between	recurrence	and	survival	that	has	perhaps	changed	
the	way	 in	which	 I	approach	discussions	with	patients	after	 their	surgery	the	most.	 I	have	
become	aware	of	 a	personal	willingness	 to	disclose	numerical	 prognoses	 to	patients	with	
stage	 I	 lung	 cancers	 as	 a	 way	 of	 bolstering	 hope	 and	 that	 this	 information	 may	 not	
necessarily	match	the	needs	of	the	patient	concerned.	I	now	appreciate	the	need	for	a	more	





for	 the	 future.	 In	 particular	 I	 have	 a	 greater	 awareness	 of	 the	 potential	 for	 patients	 to	
experience	 significant	 unmanaged	 fears	 about	 possible	 cancer	 recurrence	 that	 may	 not	




real-life	 context,	 and	 being	 able	 to	 see	 this	 background	 as	 part	 of	 the	 answer.	 The	
importance	of	qualitative	methodology,	such	as	case	study,	in	being	able	to	deliver	nuanced	
and	complex	answers	 to	 research	questions	 is	evident	 in	 these	 findings.	 In	particular,	 this	
underlines	the	potential	danger	of	research	that	requires	simple	and	constrained	answers	to	
questions	that	are	multidimensional.	Nevertheless,	this	focus	on	the	particularities	of	cases	
provides	 a	 real	 challenge	 to	 the	 researcher	 in	 terms	 of	 dealing	 both	with	 the	 extent	 and	
complexity	 of	 the	 data,	 as	 well	 as	 in	 being	 able	 to	 identify	 findings	 with	 sufficient	
universality	that	have	applicability	to	a	wider	context.	What	 is	clear	from	the	findings	was	
that	practice	around	this	aspect	of	care	is	highly	individual,	influenced	by	practitioners’,	and	
by	 extension	 team	 ethos,	 as	well	 as	 the	 clinical	 situation	 and	 the	 patients’	 needs	 at	 that	
particular	 time.	Nevertheless,	 I	 believe	 that	 the	 study	 has	 resulted	 in	 rich	 data	 that	 have	
informed	 findings,	 which	 although	 remain	 grounded	 within	 the	 cases	 of	 the	 study,	 have	





The	 findings	 presented	 in	 this	 thesis	 have	 provided	 novel	 insight	 into	 communication	
between	 patients	 and	 professionals	 about	 the	 risk	 of	 lung	 cancer	 recurrence	 following	
potentially	 curative	 surgery.	 I	 believe	 this	 is	 the	 first	 qualitative	 study	 to	 explore	
communication	 involving	 sequential	 consultations	 between	 different	 professional	
disciplines	and	patients	with	lung	cancer,	revealing	how	prognostic	discussions	are	managed	
across	 these	 settings.	 The	extant	 literature	around	prognostic	 communication	 in	 cancer	 is	
large,	but	often	with	contradictory	findings.	There	is	no	literature	that	specifically	looked	at	
communication	in	early	stage	lung	cancer,	a	group	of	patients	often	seen	as	undemanding	in	
terms	 of	 information	 requirements.	 This	 study	 arose	 out	 of	 challenges	 I	 had	 experienced	
when	talking	with	patients	about	their	risk	of	recurrence	following	surgery	for	lung	cancer.	
The	multiple	 qualitative	 case	 study	 approach	was	 chosen	 as	 the	 best	 fit	with	 achieving	 a	





limited	 information	about	 their	 risk	of	 cancer	 recurrence,	but	 their	 needs	 for	 this	 type	of	
information	 were	 circumstantial,	 individual,	 and	 sometimes	 ambivalent.	 Similarly,	
professionals’	 views	 and	 behaviours	 varied	 between	 individual	 practitioners.	 Practice	was	
influenced	 by	 clinical	 situation	 and	 patients’	 needs	 at	 that	 particular	 time,	 but	 primarily	
appeared	 to	be	a	matter	of	professionals’	 communication	ethos.	Most	professionals	were	
sceptical	 about	 the	 relevance	 of	 population	 outcome	 statistics	 to	 individual	 patients	 that	










These	 findings	have	 implications	 for	how	the	 issue	of	possible	 future	cancer	 recurrence	 is	
discussed	with	lung	cancer	patients	after	surgery.	While	both	patients	and	professionals	are	
cautions	 about	 opening	 discussions	 around	 long-term	 outcomes	 in	 an	 effort	 to	 protect	
patients,	 relentlessly	 pivoting	 attention	 away	 from	 the	 topic	 of	 recurrence	might	 prevent	
useful	conversations	being	facilitated	that	could	help	patients	deal	with	the	uncertainty	of	
their	 situation.	 The	 strategy	 risks	 developing	 a	 conspiracy	 of	 silence,	 where	 patients	 and	
professionals	 do	 not	 openly	 discuss	 issues	 around	 possible	 cancer	 recurrence.	 This	 could	
result	 in	patients	being	unable	 to	engage	 in	 their	 follow-up	care,	having	no	conception	of	
early	signs	and	symptoms	of	recurrence,	being	more	likely	to	have	misunderstandings	about	
their	 condition	 and	 having	 unvoiced	 concerns.	While	many	 patients	 ultimately	 cope	 well	














Implications	 for	 clinical	 practice	 from	 this	 study	 include	 training	aimed	at	highlighting	 the	
importance	 of	 flexible,	 self-aware	 and	 responsive	 communication	 about	 potential	
recurrence	after	surgery	that	can	address	both	professionals’	and	patients’	communication	
aims	 and	 does	 not	 simply	 ignore	 this	 important	 subject.	 Professionals	 should	 develop	 an	
awareness	 of	 patients’	 perspectives	 of	 future	 long-term	 outlook.	 Research	 should	 aim	 to	
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































T1	 Tumour	 ≤	 3	 cm	 in	 greatest	 dimension,	 surrounded	 by	 lung	 or	 visceral	 pleura,	















≤	 2cm	 distal	 to	 the	 carina,	 but	 without	 involvement	 of	 the	 carina;	 or	
associated	 atelectasis	 or	 obstructive	 pneumonitis	 of	 the	 entire	 lung	 or	
separate	tumour	nodule(s)	in	the	same	lobe	
T4	 Tumour	of	any	size	that	invades	any	of	the	following:		
Mediastinum,	 heart,	 great	 vessels,	 trachea,	 recurrent	 laryngeal	 nerve,	





N1	 Metastasis	 in	 ipsilateral	 peri-bronchial	 and/or	 ipsilateral	 hilar	 lymph	 nodes	 and	
intrapulmonary	nodes,	including	involvement	by	direct	extension	
N2	 Metastasis	in	ipsilateral	mediastinal	and/or	sub-carinal	lymph	node(s)	
















Occult	Carcinoma	 TX	 N0	 M0	
Stage	0	 Tis	 N0	 M0	
Stage	IA	 T1a,	b	 N0	 M0	
Stage	IB	 T2a	 N0	 M0	
Stage	IIA	 T1a,	b	 N1	 M0	
	 T2a	 N1	 M0	
	 T2b	 N0	 M0	
Stage	IIB	 T2b	 N1	 M0	
	 T3	 N0	 M0	
Stage	IIIA	 T1,	T2	 N2	 M0	
	 T3	 N1,	N2	 M0	
	 T4	 N0,	N1	 M0	
Stage	IIIB	 T4	 N2	 M0	
	 Any	T	 N3	 M0	













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Type of research  
Recruitment context (e.g. where people were 
recruited from) 
 
Curative / palliative / mixed setting  
Participants  
Theoretical background  
Sampling  
Sample (participant) characteristics  
Data collection  
Data analysis  
Themes  
Data extracts  
Author explanation  
Recommendations  
Ethics – how ethical issues were addressed  
Is the study context clearly described?  
Is there evidence of researcher reflexivity?  
Is sampling method clearly described and 
appropriate for research question? 
 
Is the method of data collection clearly described 
and appropriate for the research question? 
 
Is the method of data analysis clearly described and 
appropriate for the research question? 
 
Are the claims made supported by sufficient evidence 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































I	would	 like	to	 invite	you	to	take	part	 in	this	research	study.	Before	you	decide,	 I	




The	study	 is	 looking	at	the	 information	 that	you	are	given	 following	your	 surgery	
and	 involves	myself	 (Matthew	 Johnson)	being	present	during	 some	consultations	
with	your	medical	 teams.	You	would	also	be	asked	to	take	part	 in	three	recorded	
interviews	following	these	consultations.	I	would	also	like	to	collect	some	relevant	













treatment	for	 lung	cancer	by	their	medical	teams	and	lung	cancer	nurse	specialists.	 I	would	 like	to	
compare	 information	provided	by	 the	health	professionals	with	 information	 that	patients	want	 to	






















of	 issues	 that	 you	want	 to	 talk	 about.	 I	will	 also	 record	 this	 interview.	 This	will	 take	place	on	 the	
same	day	as	the	clinic	visit	or	within	the	next	2	weeks.	
I	will	arrange	two	further	follow-up	interviews	to	take	place	about	three	and	six	months	after	your	
surgery.	This	 can	coincide	with	one	of	your	 regular	appointments	at	 the	hospital,	or	at	a	 separate	









that	 I	 have	 already	 collected	 unless	 you	 specifically	 ask	 me	 to	 remove	 this	 from	 the	 study	 and	
destroy	any	information	that	I	have	already	collected.	
Towards	the	end	of	the	research	I	will	contact	patients	who	might	be	willing	to	take	part	in	a	focus	
group.	A	 focus	group	would	 involve	a	meeting	 lasting	no	more	 than	 two	hours	with	around	six	 to	
eight	patients	and	their	carers	who	have	had	similar	experiences	to	you.	I	would	lead	the	group	and	

















in	three	and	six	months	time	 is	one	disadvantage.	 It	 is	possible	that	the	 interviews	could	touch	on	
topics	 which	 some	 people	may	 find	 difficult	 or	 upsetting,	 as	 I	 would	 like	 to	 cover	 the	 long	 term	
effects	of	your	diagnosis.		












Matthew	 Johnson	 via	 m.johnson@rbht.nhs.uk	 or	 020	 7352	 8121	 x	 XXXX	 at	 Royal	 Brompton	 and	
Harefield	NHS	Foundation	Trust.	








The	 clinic	 consultations	 and	 the	 interviews	 will	 be	 audio-recorded	 and	 then	 written	 up	 word	 for	
word.	Any	names	or	identifying	details	will	be	removed	or	replaced	with	a	code.	The	transcript	will	
be	kept	on	a	password-protected	computer.	The	recording	will	be	erased	once	it	has	been	checked.	
The	written	transcripts	will	have	all	 links	 to	you	removed	at	 the	end	of	 the	study	and	will	 then	be	
kept	for	as	long	as	they	might	be	useful	 in	future	research.	In	the	final	report	and	any	publications	
relating	 to	 this	 study	 I	 may	 use	 direct	 quotes	 from	 interviews	 or	 clinic	 consultations.	 When	 this	
happens,	identifying	details	will	be	taken	out	of	the	quotes	so	people	reading	these	will	not	be	able	
to	identify	you.	


























All	 research	 in	 the	NHS	 is	 looked	 at	 by	 an	 independent	 group	 of	 people	 called	 a	 Research	 Ethics	
Committee,	to	protect	your	safety,	rights,	wellbeing	and	dignity.	This	study	has	been	reviewed	and	






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































I	 am	 a	 qualified	 nurse	 working	 at	 Royal	 Brompton	 and	 Harefield	 NHS	 Foundation	
Trust	and	I	am	also	a	part-time	student	studying	at	Sheffield	Hallam	University	for	a	
PhD.		
I	would	 like	 to	 invite	 you	 to	 take	 part	 in	 this	 research	 study.	 Before	 you	 decide,	 I	














purpose	of	 this	 study	 is	 to	 understand	 the	 information	 that	 is	 given	 to	 patients	 following	 surgical	













If	 you	 agree	 to	 participate	 in	 the	 study	 I	 will	 arrange	 to	 attend	 the	 clinic	 when	 you	 are	 seeing	 a	
patient	already	recruited	to	the	study,	in	which	they	have	agreed	to	observation	of	the	clinic	and	to	
be	 interviewed	 afterwards.	 I	 will	 audio	 record	 the	 consultation	 and	 take	 notes	 of	 what	 happens	
during	the	clinic	visit	(having	received	written	consent	from	yourself	and	the	patient).		

























Alternatively,	 you	 can	 contact	my	 supervisor:	 Professor	Karen	Collins,	 k.collins@shu.ac.uk	or	 0114	
225	5732	at	Sheffield	Hallam	University,	Centre	for	Health	and	Social	Care	Research	





transcript	 will	 be	 kept	 on	 a	 password-protected	 computer	 and	will	 not	 be	 available	 to	 any	 other	
member	 of	 the	 team.	 Identifying	 details	 will	 be	 taken	 out	 of	 the	 transcript.	 Patients,	 staff	 and	
locations	will	be	anonymised	in	the	final	thesis	and	any	publication	resulting	from	this	study.	People	
reading	 these	will	not	be	able	 to	 identify	you	or	your	patient.	The	written	 transcripts	will	have	all	
links	to	you	removed	at	the	end	of	the	study	and	will	then	be	kept	for	as	long	as	they	might	be	useful	
in	future	research.	









The	 results	 of	 this	 research	will	 go	 to	 form	 the	main	part	 of	 a	 PhD	 thesis.	 The	 final	 thesis	will	 be	
placed	in	the	university	library	and	are	also	available	on	a	public	database	of	research	dissertations.	
Findings	 from	 the	 study	 will	 be	 written	 up	 in	 one	 or	 more	 academic	 papers	 and	 submitted	 for	
publication	in	medical	and	nursing	journals.	
11.	Who	is	sponsoring	the	study?	
The	sponsor	of	the	study	has	the	duty	to	ensure	that	 it	runs	properly	and	that	 it	 is	 insured.	 In	this	
study,	the	sponsor	is	Sheffield	Hallam	University.	
12.	Who	has	reviewed	this	study?	
All	 research	 in	 the	NHS	 is	 looked	 at	 by	 an	 independent	 group	 of	 people	 called	 a	 Research	 Ethics	
Committee,	to	protect	your	safety,	rights,	wellbeing	and	dignity.	This	study	has	been	reviewed	and	
given	 a	 favourable	 opinion	 by	 Mr	 John	 Richardson,	 Chair	 of	 the	 London	 –	 Camberwell	 St	 Giles	
Research	Ethics	Committee.	
13.	Further	information	and	contact	details	
Chief	 investigator:	 Matthew	 Johnson	 m.johnson@rbht.nhs.uk	 or	 020	 7352	 8121	 x	 4710,	 or	 the	
Principal	investigator	for	the	[Name	of	site],	[Name	of	PI]	via	[email],	or	on	XXXXX	XXXXXX.	
Alternatively,	 you	 can	 contact	my	 supervisor:	 Professor	Karen	Collins,	 k.collins@shu.ac.uk	or	 0114	
225	5732	at	Sheffield	Hallam	University,	Centre	for	Health	and	Social	Care	Research.	























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Clinic observation sheet 
    
Date of clinic  Clinic speciality  
Patient ID  Doctor ID  
DoB  Grade of doctor  
  Nurse ID  
    
     
Consultation start time:    
     




































Observations and queries  
	
	 	 	 	 	 	
	 	 	 	 	 	
Consultation end time	 	 	 Length of consultation	 	 	
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Appendix	12:	research	diary	extract	
6 Nov 2015: 
First clinic observations and staff interviews. Glad to be getting going. Attended SMH 
MDT and caught P03 MDT discussion and initially thought that she would not be seen in 
clinic today, but in fact she was, so I was able to see both of them. Not sure when P03 will come 
back to oncology clinic as she is an in patient at the moment. 
Clinic with S01 and P03  
P03 was brought down form the ward as she had been admitted yesterday afternoon 
with an infection. She was there with her son, who I briefly met while she was I/p. She was 
anxious and in a great deal of pain and not really having a great hospital experience. A&E 
had said that she needed to have fluid drained from her chest, but they did finally manage to 
contact HH and were told not to! This has also slightly dented her confidence in the local team. 
I think she was worried that things were quite seriously wrong and that there might be an 
infection in the pneumonectomy space. 
During the interaction with S01, she was enormously reassured that there wasn't a 
serious infection and that it was a minor chest infection that she can get over totally. S01 
also was able to reassure her that someone can sort out her pain control and felt that S01 had 
been able to sort out the prescription. S01 went through all the information about the surgery, 
and P03 appeared to be relieved to hear this information. However, I am not too sure how much 
of this she has taken on board about the seriousness of the situation with the tumour being a 
Large Cell Neuroendocrine tumour. This has a similar prognosis to a small cell cancer, as I 
understand it. I also do not feel that much of this was made by S01, but in fact she did spell 
out the name and was aware that the patient would likely go and look it up on the internet, or 
at least her son. She will come back to Onc clinic once she is able to get over this infection. 
S01 has pointed out that she may end up with more problems with chemotherapy in relation to 
her pneumonectomy, although I don't think that this was said to her directly. I will try and 
keep an eye on when she is due back to find out when she is able to come to the clinic. 
Clinic with S01  and P04  
P04 turned up ahead of the appointment with her husband and she was feeling very well, 
seemed to be recovering well, pain settled and feeling good. Quite a positive interaction with 
S01. Feel that the interaction with S01 went well and that was very up beat. P04 took a lot of 
the information in and seemed to understand it and seemed to have some good questions 
about what was going on. The fact that she has also got a long term condition of RA will 
affect the way she and her husband approaches the matter of her cancer. She is well informed 
about her RA treatment and seems not to be phased by this new medical information. I have 
agreed that I might ring her ahead of the appointment with Oncology with the idea of trying 
to schedule the next appointment. She seemed very happy to take part and I feel that went 
really well. I have told her that the next appointment will be the time that I do the patient 
interview afterwards and she was OK about that. 
Interviews with S01 
S01 agreed to do the interviews today. I was nervous about doing these. I feel slightly 
intimidated. She did well to put me at my ease! I know her, but really only in a limited way. 
However, she has been very supportive ever since I told her about the study and PhD. I thought 
first interview went well, and this was the first time that I did these interviews. These will be 
the same questions for each patient so then following that on with the second interview was 
quite hard, because it was repetitive and I couldn’t ask the same questions again. Some if 
what I had asked about in the first interview were general points about giving prognostic 
information and limitations and her own professional boundaries. When I came on to the 
second interview it felt wrong to keep asking the same questions again, going over and over 
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again. I'm going to have to think about this in the future if there are more patients who S01 
sees again and not by her Reg or another surgeon. I am keen to get these interviews 
transcribed to see how they have gone. Very relieved to get some data down. Overall, I am 
feeling upbeat and getting somewhere with this. The process seems good. The sheets for the 
clinic observations do not seem quite right and do not really have the right spaces on them in 
order to get the right information down and it may be helpful to rethink these and get 
something more structured. Just about remembering to get times down for start and finish, 
but will hopefully overall will improve with practice! 
 
9 Nov 2015: 
This weekend I have transcribed both the clinic encounters. I have attempted some initial 
coding of the surgical clinic data for P04. This is really trying to apply descriptive codes to 
what was happening throughout the clinics. Need to think about how to do this, as these are 
specifically related to the surgical clinic and I will probably end up with other specific codes 
for the other clinic types and the interviews. I have picked out one in vivo code "It has all been 
removed". I think it seems helpful to initially try and chunk the data up into smaller types of 
data before trying to do anything more complicated with it, but it will require a second, third 
etc rounds of coding to make anything more analytical out of the data.  I have started out 
numbering them, but I think this may prove too difficult to do at the moment as the codes are 
all going to be pretty fluid until I am a bit further down the process. 
 
13 Nov 2015 
Some reflection on the way to SMH whilst reading the transcripts of the two clinic 
encounters in order to prepare questions for P04. Thinking about the interview with S01, I 
may have missed out on finding out more detail on why different information is presented or 
not. She was fairly detailed re: type of cancer, lymph node involvement, and size. But there 
was no indication of the chance of recurrence. She does state that it is not her role to be 
negative or too gloomy. I feel that maybe she does not want to put a dampener on the 
proceedings by bringing up recurrence too specifically.  However, in the final part of the 
consultation she does bring in survival advantage. I should have picked up on this and need 
to make sure that I am specifically identifying this and making a clear note of the context 
when I am jotting things down in the consultation for use later on - although this is quite 
hard to do! Ideally i should listen through to the tape again ahead of the interview with the 
professional / patient. However, this wasn't possible this time around as I didn't have 
earphones. Also this time around, it was not possible for the interview with P04, as there was 
no time as she had to get away, so this is likely to be an on going issue in this situation.  
Oncology Clinic with O01 & P04 
First time that I had met this doctor today. I had spoken with him on the phone 
yesterday and he had seemed very helpful and willing to be involved. I raised the post 
interview with him and he has to leave clinic promptly at 12 in order to go to another site and 
therefore I won't be able to schedule face-to-face interview. I have emailed him today to try and 
schedule a telephone interview, but I have not yet worked out how to undertake recorded 
telephone interview! Quite a long and thorough clinic assessment and he was very good at 
listening to the patient's agenda. I felt very welcome and it was easy for me to be present. 
Clinic room was large and not cramped and difficult for me to be there. I was involved with 
patient in consultation by constant eye contact and I found myself nodding and smiling a 
lot! The arrangement in the other clinic rooms meant that I was at more of a angle and not 
quite so involved in the patient's eye line. 
Interview with P04 
I thought that P04 might not agree to have an interview today, as she had said that she 
wanted to go to see her daughter for lunch after clinic and was tight for time. I think she 
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might not have done the interview if the outcome of the clinic had been different, as she had 
said that she was very anxious about this clinic, in a way that she was not before the surgical 
clinic. I met her in the waiting room before hand and made myself known. I raised the issue 
of the interview and she was dubious and I said wait and see how you feel after the clinic 
appointment. I was keen not to sit with her prior to the clinic appointment and chat, as I felt 
that this might dilute the material that she might give me in the interview and feel like she 
had already done the interview! It was quite a long wait and I didn't think I could keep up 
small talk!  I went for a coffee, but was also anxious about missing her, so I came back early 
again!  
P04 came to quiet room after the consultation and agreed to go ahead. Husband has 
come in too for the discussion regarding going ahead with the interview and once he was 
settled into the room and the decision was made to go ahead, it was too difficult to ask him to 
leave. He did not say a lot, but did chip in at times, usually when P04 invited him to by a 
look or directly. I was aware of him fidgeting and perhaps not wanting to stay too long. I 
wondered whether it was him that had said for P04 not to do the interview today, maybe.  
I was pleased generally with the interview when it was completed (about 40 mins in 
length). P04 did stop the interview, but I was on the point of wrapping it up at that time any 
way and I told her this. I felt there were good insight into smoking, fatalism, not thinking 
about the future, the unreality to her of having lung cancer (you can't see it, you can't feel it, 
you don't have any pain...) . Does her Rheumatoid play a big actor in this attitude of 
STOICISM ??  Is this cause or effect? Main driver for her is to optimise QoL. She therefore 
values getting back onto her RA drugs as soon as possible, as she feels noticeable deterioration 
in her condition, the more so since the beginning of winter. Chemotherapy would interfere 
with this and so she was not keen to go down this route. I think that this was a lesser driver for 
her than the idea that RA might lead to greater complications for her with the chemotherapy, 
which was alluded to by O01. There was a clear sense of fatalism in her attitude to her cancer. 
She stated that she was surprised that she had "got away with not having cancer for as long as 
she had". She feels she was due this by virtue of her smoking Hx. However, she continued to 
smoke up until her diagnosis and her husband has continued to smoke.  Interestingly he has 
given up in relation to various health scares, but has resumed later on saying that it had 
failed (ie further blockage of coronary artery post treatment) and that he might as well 
continue to smoke, what the hell! 
Hope appears important to her. However, would this have come out spontaneously in the 
interview without me introducing it? Uncertainty was not there as a theme for her as she was 
not entertaining the idea - or she would "face it if it happens". Overall there was great relief in 
not having to have chemo. I feel this was not her decision, as she stated that she would have 
gone through with it if it had been advised. The message was clear that this was not advised 
from O01 and she did not argue or feel that she should have been offered it. She has been 
advised that the main benefit was by going through the surgery.   
She will now be referred to the chest physician for follow up and she be seen again in 
about 3 months time and this would be about Mid February. I have put this in my work diary 
to chase up in Mid January.  
General comments 
P03 remains an in patient and I need to make sure that I keep tabs on when she goes 
home and when scheduled for oncology clinic. 
I returned to RBH to meet a lady who had initially not felt well enough to be approached, 
but is well now she has had operation. Worried that if I had not gone today she would have 
already gone home. She was pleased to have been approached and had already declined another 
(RCT) study, but felt that she would be able to take part in this study. Info sheets given and I 
will see when she is back in clinic in 1 - 2 weeks time. NB previous Breast Ca. 
Appendix	13:	Thematic	framework	



















































    52	
Appendix	15:	Framework	Matrix	example	
	 	
Glennis (P09) within case analysis of Risk of Recurrence Theme











P09 asks about chance of recurrence in the lung at 
some point. Cure rates high, but can't promise a cure 
or that cancer has not spread to somewhere else. Not 
100%.
P09 asks about recurrence, but prefaces this 
with it being an "impossible question ". 
N02 says it is unlikely that cancer has 
spread elsewhere, but "I can't promise you"
Not discussed " the cure rate is relatively 
high, but it is not one 










Towards end of consultation P09 initiates a question 
about whether to expect any recurrence. This was 
answered both qualitatively (think personally this 
done and  you don't have to worry about this again) 
and by giving a numerical estimate of disease free 
survival (85%). NB - did not specifically ask for a 
number
P09: Will they expect any sort of 
reoccurrence?
S05: It is all about statistics, but when it is 
this size, the very best, we er, the figures 
suggest that you have an eighty-five per 
cent chance of nothing coming back in five 
years [...]  Okay, so that's why we follow 
up, just to make sure 
But I think, I think that personally, this is 
done and you don't need to worry about 
this again























T=0 Asked in clinic about risk of recurrence, told 
85% chance on no recurrence. Felt good, but would 
prefer higher. Didn't ask where it would recur lung or 
somewhere else. Avoided looking survival rates on 
Internet. Concerned about being more cancer prone 
due to Hx.
T=3 Unsettling if survival rates not very good. 
Cannot unsee it. Unsure what she would do if told 
WAS more cancer prone.
T=6 Recalls being told risk of cancer in other lung 
lobes is as good as anyone else. Seeing poor survival 
figures unsettling and stayed with her. Concerned by 
current symptoms and not reassured by CXR, so 
asked for CT. Thinks inevitable will have another 
cancer at some point.
T=0 Asked in clinic about risk of 
recurrence and was told 85% chance on no 
recurrence. Felt good, but would prefer it to 
be higher. Didn't ask where it would recur 
lung or somewhere else.
T=6 Recalls being told that cancer removed 
within lobe and there was no cancer in the 
lymph nodes. Cancer in any other part of 
the lung risk is as good as anyone else
Survival in lung ca not as 
good as breast ca.
T=0 Avoided looking 
survival rates on Internet
T-=3 Unsettling if survival 
rates not very good. 
Cannot unsee it.
T=6 Found poor survival 
figures given during Stand 
up for Cancer unsettling 
(particularly as had 
another chest infection) 
and figures stayed with 
her.
Not discussed T=0 Concerns about being 
more cancer prone
T=3 But no one can answer 
this. Unsure what she would 
do with the information if was 
told was more prone. Would 
remove organs that were not 
essential ie ovary.
T=6 Feeling unwell and feels 
inevitable that will have  






Question asked at end of clinic may reflect that P09 
did not want an answer. P09 was concerned about 
both recurrence and new cancer possibilities. Wants 
to avoid giving a false expectation that this could 
never recur, but also avoid having them scared most 
of the time . Need to play it down and reassure. 
Patients do worry as they have been told they have 
lung cancer. No discussion in the interviews of estimations of risk of 
recurrence or survival. Implication was that this was slow growing and 
therefore the risk of recurrence would be very low, but we did not actually 
discuss this.
P09 asked about possible recurrence at the 
very end of clinic N02 feels this may be 
because she didn't really want an answer. 
P09 was concerned about both recurrence 
of this current lung cancer and getting 
another primary. N02 does not want to give 
a false reassurance that this would never 
recur, but also doesn't want them "to live 
the rest of their life in fear that another 
lung cancer’s going to come "
Not discussed Even though patients have a 
potentially curable cancer, 
they will worry about 
symptoms and need 
reassurance or investigations.
She was also concerned about 







Uses IASLC survival curves to estimate. Does not 
feel giving exact numbers will help a patient cope, but 
she is someone who needed to know this. Statistics 
are population figures, which does not say how an 
individual will be. P09 unusual in asking for exact 
(recurrence) percentage(asked, but not for numbers). 
Statistics can be hard to interpret. Patients will 
interpret figures differently; what seems good to 
someone will seem bad to someone else. 
Patients want to hear "cancer free" or "cure", but S05 
only uses these with care and won't say "cured".
Question was phrased about risk of 
recurrence, but answered as survival
When someone asks 
survival statistics, uses 
IASLC curves. In her 
case there are 15% [who 
don't survive] which you 
can't predict. But she 
didn't ask about that bit.
NB P09 asked about 
recurrence and he has 
given survival statistics.
Patients want to hear those 
words often they’re free of 
cancer or it’s all been 
resected or you are cured 
which I don’t think you can 
actually say in any cancer. 
[...] I’ve always used them 
carefully. So really only in 
the Stage 1a when I say it’s 










I was important for P09 to be given figures, not just 
reassurance. P09 was happy with these. Way 
surgeon put risk of recurrence emphasised the 
positive and not the 15% who might see recurrence. 
Surgeon did not say anything about possible 
recurrence after 5 years.
P09 was not happy to just be reassured all 
okay at the beginning of the consultation, 
but wanted to know more details. She 
seemed happy with the statistics she was 
given. S05 did not talk specifically about 
the proportion of patients where this could 
recur ie this was presented positively.
Not discussed S05 did not specifically say 
that he could not promise 
cure ie not being able to 
promise that the cancer will 
never come back
Also did not discuss the 
implication that still 
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F : e5 Numerical G : e6 Possibility H : e7 Fear of recurrence or actual recurrence I : f1 Decision-making for further management J : f2 Further lung cancer treatment
Cure rate less than 100% Likelihood of it having 
spread is low. Cure rate 
relatively high, but not 100%
Not discussed P09 discusses her relief that she does 
not need chemo. N02 reflects on 
rationale for telling patients that they 
might need chemo, even when probably 
is that they would not.
N02 has a practice of telling patients that they 
might need chemo ahead of the operation to 
help manage expectations and to ease in the 
subject if there were to require chemo. There is 
an assumption that being later told the good 
news that this is NOT required is better than 
Not discussed
when it is this size, the very best, [...] figures 
suggest that you have an eighty-five per cent chance 
of nothing coming back in five years
I think that personally, this 
is done and you don't need 
to worry about this again
Not discussed Not discussed No chemotherapy 
For routine post operative follow up.
T=0 Recalls 85% chance of no recurrence
T=6 Recent TV programmes flashed up survival 
statistics 85% lung cancer patient do not survive 5 
years. Figure stayed with her and increased her 
anxiety.
Not discussed T=0 not discussed
T=3 Talks about general 
symptoms that make her 
think cancer 
T=6 Current chest infection 
is worrying her. Not 
satisfied by CXR in clinic 
(in view of experience at 
diagnosis) and has pushed 
to have a scan
Not discussed Biggest concern was whether lymph 
nodes were involved and so would 
not need chemo or radiotherapy
Not discussed Not discussed Not discussed Not discussed
" I don't think [knowing] the exact percentage is 
going to make much difference to how you deal with 
it, but some patients need the exact number "
"it’s all population-based so you can never say that 
an individual patient will follow the curve".
"without a statistical background it’s difficult to 
interpret those numbers"
"most patients [...] don’t ask for the exact number 
but I think she’s unusual in the fact that she did"
"Some patients won’t be happy until they know the 
exact number, and I think she’s definitely one of 
them"
Not discussed Decision for "follow up care" is 
straightforward in this case (stage 1) 
and does not need to wait for MDT 
outcome
Not discussed
S05 gave statistics and she seemed happy to hear 
these. Stats are 5 year survival figures and match the 
standard FU period. He mentioned the 85% positive 
outcome, but not the 15% that is the "other way"
Not discussed S05 has said does not need chemo. In 
this case decision was clear cut. 
However, MDT may feel it is worth he 
seeing oncologist just to discuss risks 
and benefits.
If the situation had been more 
borderline, then could risk confusing 
patient if given conflicting advice about 
need to see oncologist.
S05 was able to reassure her that no 
chemotherapy was required 
according to guidelines
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